{
    "__type__": "Deck",
    "children": [
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "96995a49-7dd0-11eb-bedc-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-54ee8d36443a2c01bdc9034e41cd9d82a0568ab3.jpg",
                "paste-60fd306326dd6436b68b2fbd082edfb2a6bece1b.jpg",
                "paste-66380030c70b63942931b8bca4a54dafe427f38b.jpg",
                "paste-b8aeb6599ca50cbc08ea6b5c55af29fa44b7e510.jpg",
                "paste-c7ab4b4a3705c4b49371df4eaf4577a772d2ec34.jpg",
                "paste-de91a7ac21cd455c08219ddcb00b9c7d3fa3b00d.jpg"
            ],
            "mid": 1602236504918,
            "name": "02/08 Immunopharm 1",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::Autoimmune disease}}: Immune system cannot distinguish between self and non-self<br><div><br></div><div>{{c1::Chronic inflammatory diseases}}: Over activation of the immune system<br></div>",
                        "<div>Autoimmune</div>Rheumatoid arthritis<br>Systemic lupus erythematosus<div><br></div><div>Chronic Inflammatory&nbsp;</div><div>Inflammatory bowel disease<br>Vasculitis</div><div>Psoriasis<br></div>"
                    ],
                    "guid": "Qf{)1Y%nFW",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Is it innate or adaptive immunity?<div><br></div><div>Higher organisms only&nbsp;{{c1::a}}<br><div>Pathogen-associated molecular patterns (PAMPs){{c1::i}}<br></div></div><div>Non-specific{{c1::i}}</div><div>T-lymphocytes&nbsp;{{c1::a}}</div><div>Monocytes{{c1::i}}</div><div>Polymorphonuclear leukocytes{{c1::i}}<br></div><div>Neutrophils{{c1::i}}</div><div>Barrier defenses{{c1::i}}</div><div>Antibodies&nbsp;{{c1::a}}</div>",
                        ""
                    ],
                    "guid": "t*-r@de/YB",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why would you use an immunosupressant?",
                        "Autoimmune disease, Chronic inflammatory disease, Organ Transplant"
                    ],
                    "guid": "IS0!6I%}jf",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Opportunistic Infections:{{c1::Infections that do not normally occur in patients with a normal immune system}}<div><br></div><div>Most {{c1::immune suppressant}} drugs increase the risk of opportunistic<br>infections<br></div>",
                        "Immunosuppressants may also lower vaccine efficacy."
                    ],
                    "guid": "p%5K)|0X=m",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement about<br>Immunosuppression is true?<br><br><div>1. It increases the risk of opportunistic infections<br>2. It only affects the adaptive immune system<br>3. It should be employed in patients with infections<br>4. Transplant recipients don’t need it<br>5. Vaccines are immunosuppressants</div>",
                        "1"
                    ],
                    "guid": "Fuo(I3tSp2",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of organ failure does it cause?<div><br></div><div>{{c1::Chronic Kidney Disease}}: Diabetes, glomerulonephritis, hypertension, others<br></div><div><br></div><div>{{c1::Chronic cirrhosis}}: Alcohol, Hepatitis C, NAFLD, autoimmune<br></div><div><br></div><div>{{c1::Acute liver failure}}: Paracetamol overdose, Hepatitis A, others....<br></div>",
                        ""
                    ],
                    "guid": "EdnLe]G}Yb",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Liver transplantation</b><br>Most commonly performed for complications of {{c1::cirrhosis}}, such as:<br>Hepatic encephalopathy:{{c1::confused thinking}}<br>Refractory ascites:{{c1::Buildup of fluid in the abdomen}}<div>{{c1::Variceal}} haemorrhage<br>Liver cancer</div><div><br></div><div>Transplant can be cadaveric or living related<br></div><div>Must be ABO&nbsp;{{c1::compatible}}</div>",
                        ""
                    ],
                    "guid": "AjQE4sHj_B",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Complications of liver transplantation</b><br>Acute cellular rejection<br>Recognition of {{c1::allo}}antigens<br>Lymphocyte activation<br>Clonal expansion of lymphocytes",
                        "<img src=\"paste-54ee8d36443a2c01bdc9034e41cd9d82a0568ab3.jpg\">"
                    ],
                    "guid": "Mkf)W*31A8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Corticosteroids</b><br><br><div>Hydrocortisone (cortisol) produced in the adrenal cortex<br>&nbsp;</div><div>Essential for health – deficiency results in a disease: {{c1::Addisons disease}}<br><br></div><div>Excess endogenous hydrocortisone results in adisease: {{c1::Cushings syndrome}}<br><br></div><div>Secretion controlled by pituitary hormone: {{c1::ACTH}}</div><div><br></div><div>Is it a corticosteroid target?</div><div>Glucocorticoid receptors{{c1::y}}<br></div><div>Mineralocorticoid{{c1::n}}</div><div>Monocytes{{c1::y}}<br></div><div>Endothelial cells{{c1::y}}</div><div>B-Lymphocytes{{c1::n}}</div><div>T-Lymphocytes{{c1::y}}</div><div>Neutrophils{{c1::y}}</div><div><br></div><div>Is it an acute or chronic side effect?</div><div>Hypertension{{c1::a}}<br>Oppurtunistic Infections{{c1::a}}</div><div>Adrenal suppression{{c1::C}}<br>Muscle atrophy{{c1::c}}<br>Osteoporosis{{c1::c}}<br>Psychosis{{c1::a}}<br>Weight gain{{c1::a}}</div><div>Striae{{c1::c}}<br>Increased triglycerides{{c1::a}}<br>Diabetes{{c1::a}}<br>Hirsutism{{c1::a}}<br>Acne{{c1::a}}<br></div><div>Cataracts{{c1::c}}<br>Growth retardation{{c1::c}}<br></div><div><br></div><div>Side effects of corticosteroids mimic&nbsp;{{c1::Cushings Syndrome}}</div><div><br></div><div>{{c1::Topical}} administration minimizes systemic adverse effects allowing chronic use<br>With chronic {{c1::systemic}} administration, adverse effects outweigh benefits<br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-60fd306326dd6436b68b2fbd082edfb2a6bece1b.jpg\"><div>Hirsutism=unwanted hair growth</div><div>Striae= Stretch marks</div><div><img src=\"paste-66380030c70b63942931b8bca4a54dafe427f38b.jpg\"><br></div><div>Topical corticosteroids: Uses<br>z Inflammatory skin diseases<br>z Asthma<br>z Inflammatory bowel disease – controlled ileal-release<br>budesonide<br>z Uveitis<br></div><div><br></div><div>Systemic corticosteroids: Uses<br>z Life-saving in severe asthma exacerbations<br>z Use coincided with reduction in mortality from ulcerative colitis – a form of<br>inflammatory bowel disease<br>z Vasculitis<br>z Inflammatory arthritis<br>z Blood cancers<br>z Glomerulonephritis<br>z Multiple sclerosis<br>z Vasculitis<br>z Autoimmune hepatitis<br></div>"
                    ],
                    "guid": "Q<:L;YZnvk",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Which statement about corticosteroids is correct?</b><br><br>1. Anti-inflammatory effects are mediated by the mineralocorticoid receptor<br>2. They are hydrophilic and traverse plasma membranes poorly<br>3. They must be administered systemically<br>4. Their actions affect both innate and adaptive immune cells<br>5. Side effects are uncommon even with prolonged administration",
                        "4"
                    ],
                    "guid": "l?+(1:_v|,",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Cyclosporine or Tacrolimus?<br><br>Binds FKBP&nbsp;{{c1::t}}<br><div>Fungal metabolite{{c1::c}}<div>Binds cyclophilin{{c1::c}}<br>Inhibits T cell activation{{c1::both}}</div></div><div>Macrolide antibiotic{{c1::t}}</div><div><br></div><div>How Cyclosporine and Tacrolimus inhibit T-cell activation</div><div><br></div><div>-Cyclosporine A and Tacrolimus inhibit&nbsp;{{c1::calcineurin}}</div><div>-The transcription factor&nbsp;{{c1::NFAT}} cannot be dephosphorylated</div><div>-{{c1::IL-2}} is not produced leading to inhibition of t-cell&nbsp; activity</div><div><br></div><div>Cyclosporine and Tacrolimus<br>Major Uses:<br>Prevention of organ transplant {{c1::rejection}}<br>Autoimmune &amp; Inflammatory diseases<br>{{c1::- Vasculitis<br>- Arthritis<br>- IBD<br>- Psoriasis<br>- Eczema}}(5)<br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-b8aeb6599ca50cbc08ea6b5c55af29fa44b7e510.jpg\">"
                    ],
                    "guid": "N4i+,B~A4$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cyclosporine:</b><div><b><br></b></div><div>-{{c1::Unpredictable}} oral biovailability due to&nbsp;{{c1::Emulsion formulation}}<b><br></b></div><div><br></div><div>-&nbsp;{{c1::Narrow}} therapeutic index</div><div><br></div><div>Blood concentration monitoring essential<br></div><div><br></div><div>Side Effects:</div><div>Oppurtunistic infections</div><div>{{c1::Nephro}}toxicity<br>{{c1::Hyper}}tension<br>Gum {{c1::hyperplasia}}<br>{{c1::Skin}} cancer<br>Seizures<br>Neuropathy<br></div><div><br></div><div>Cyclosporine is metabolized by&nbsp;{{c1::CYP3A4}}.</div><div>Patients should not drink&nbsp;{{c1::grapefruit juice}}</div><div><br></div>",
                        "<img src=\"paste-de91a7ac21cd455c08219ddcb00b9c7d3fa3b00d.jpg\">"
                    ],
                    "guid": "B?[6@AM;}z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Cyclosporine and Tacrolimus:<br></div><div><br></div>Have few adverse effects<br>Have a low therapeutic index<br>Block the binding of IL-2 to its receptor<br>Are considered \"designer\" drugs<br>Cause bone marrow suppression",
                        "2"
                    ],
                    "guid": "Cx%^{%ySHX",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>Polyclonal Anti-Thymocyte Globulin</b></div><div><b><br></b>Developed by immunising <b>rabbits</b> with human thymocytes<br><br></div><div>{{c1::Gamma globulins}} purified from serum<br><br></div><div>Polyclonal mixture of antibodies reactive against lymphocyte expressed surface antigens<br><br></div><div>Administration results in profound killing of {{c1::host lymphocytes}}<br><br></div><div>{{c1::Profound}} immunosuppression – {{c1::loads of}} opportunistic infections<br><br></div><div>Effective treatment for {{c1::acute kidney transplant rejection}}<br></div><div><br></div><b>Monoclonal Anti IL-2 receptor antibodies</b><br><br><div>Drug names: {{c1::Daclizumab}} and {{c1::basiliximab}}<div><div><br></div><div>&nbsp;IL-2 is a pivotal cytokine in the development of acquired<br>immune responses<div>&nbsp;</div><div>Effective treatment for {{c1::acute rejection}}</div><div><br></div><div>{{c1::Less}} profound immunosuppression than polyclonal anti-</div><div>thymocyte globulin<br><br>{{c1::Less}} opportunistic infections</div><div><br></div><div><br></div></div></div></div>",
                        "<img src=\"paste-c7ab4b4a3705c4b49371df4eaf4577a772d2ec34.jpg\">"
                    ],
                    "guid": "h5z;5AQJia",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "activeTags": [],
            "children": [],
            "crowdanki_uuid": "969b06d1-7dd0-11eb-90ff-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "inactiveTags": [],
            "media_files": [
                "paste-0e2c9412ce0aca914f907704cd19b83a6326c549.jpg",
                "paste-21d1fc81c1df399811bf77b1fc25cbca52e86529.jpg",
                "paste-2c16030f7bbad0aae58469728e9ec99ad70e754a.jpg",
                "paste-349deda8407f33fddff82f32c7fc68bce04e6e16.jpg",
                "paste-521e34d1481afc8f77546d5f5f63d6ee034d6d8d.jpg",
                "paste-5a3f1da69e87543b5e326b2e8b34f1547ffb52a8.jpg",
                "paste-6e11f86a3a2f079914e586feb06e318572c9d599.jpg",
                "paste-70c1f3f5ee73f098af0130b689a0e46e41293d27.jpg",
                "paste-78a7b028675910c3caf97435028307ab132e9e56.jpg",
                "paste-8b7e889ebcb82dfebf8b6318f737b424c680509d.jpg",
                "paste-db1e580a6cc12279fcd69fc4b9a01885235c8265.jpg",
                "paste-e21e877e9b74fdaa51531524267b04ba43fb419e.jpg",
                "paste-f9774e4df0afe6979adf00357fd159d02b7bf277.jpg",
                "paste-fadc0bc99d401125fb76db8c2a92ed4801aa03b6.jpg"
            ],
            "mid": 1602236504918,
            "name": "02/09 Immunopharm 2",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "IBD: Histology<br><br><div>{{c1::Epithelium}} is ulcerated<br><br></div><div>{{c1::Lamina propria}} is infiltrated with acute and chronic inflammatory cells<br><br></div><div>Crypts have {{c1::abscesses}}</div><div><br></div><div><img src=\"paste-0e2c9412ce0aca914f907704cd19b83a6326c549.jpg\"><br></div><div>For extra points, where is the ulcer</div>",
                        "Ulcer is the big crypt with the white outline<div><img src=\"paste-8b7e889ebcb82dfebf8b6318f737b424c680509d.jpg\"><br><div><br></div><div><br></div></div>"
                    ],
                    "guid": "dKxe?|0,)T",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Thiopurines (immunosupressants)&nbsp;</b><div><br></div><div>Mechanism of action:<br>Deplete {{c1::purine nucleotides}}<br><br></div><div>Inhibits:<br></div><div>- {{c1::DNA}} synthesis<br>- {{c1::RNA}} synthesis<br><br></div><div>Results in:<br>- Apoptosis of {{c1::activated lymphocytes}}<br>- Impaired cell-mediated immunity, specifically {{c1::adaptive}} cell-mediated immunity<br></div><div><br></div><div>{{c1::chronic}} Immunosuppression.<br></div><div><br></div><div><br></div><div><b>Azathioprine (A thiopurine)</b><br></div><div><br></div><div>Originally developed as an anti-leukemia drug<br></div><div>Pro-drug of {{c1::6-mercaptopurine}}<br></div><div><br></div><div>Has a&nbsp;{{c1::narrow}} therapeutic index</div><div>{{c1::oral}} administration<br></div><div>{{c1::slow}} onset of action<br></div><div><br></div><div>Is the side effect acute or chronic?</div><div>Opportunistic infections&nbsp;{{c1::b}}<br></div><div>Allergy: Fever, skin rash&nbsp;{{c1::a}}</div><div>EBV-associated lymphomas&nbsp;{{c1::c}}<br>Bone marrow suppression, esp. leukopenia&nbsp;{{c1::a}}<br>Pancreatitis&nbsp;{{c1::a}}<br>Liver injury&nbsp;{{c1::c}}</div><div><br></div><div>Azathiopurine dose is based on the patients levels of the enzyme&nbsp;{{c1::thiopurine methyltransferase}}</div><div><br></div><div>If there is low levels of this enzyme, Azathiourine is&nbsp;{{c1::more}} effective, but there are more&nbsp;{{c1::ADRs}} such as&nbsp;{{c1::myelosuppression}}</div><div><br></div><div><br>AZATHIOPURINE IS CONVERTED TO&nbsp;{{c1::6-MERCAPTOPURINE}} WHICH IS CONVERTED TO&nbsp;{{c1::6-THIOGUAMINE}}</div>",
                        "Azathiprine is apparently a prototype<div>Leukopenia= Too little WBCs</div><div>EBV=Epstein Barr Virus</div><div>TPMT levels are genetic</div><div><img src=\"paste-fadc0bc99d401125fb76db8c2a92ed4801aa03b6.jpg\"><br></div><div><img src=\"paste-78a7b028675910c3caf97435028307ab132e9e56.jpg\"><br></div>"
                    ],
                    "guid": "Kx~%f6R6H`",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement is false?&nbsp;<div> Azathioprine is a pro-drug&nbsp;</div><div> Hereditary factors affect responses to thiopurines&nbsp;</div><div> Azathioprine does not cause significant immunosuppression&nbsp;</div><div> Thiopurines are administered orally&nbsp;</div><div> Patients full blood count should be monitored</div>",
                        "3"
                    ],
                    "guid": "IrZ-Y:4#}D",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Methotrexate:</b><br><br>Competitive analog of {{c1::folic acid}}<br>Blocks&nbsp;{{c1::dihydrofolate reductase}}<br>Prevents accumulation of {{c1::4H-folic acid}}<br>Blocks {{c1::purine}} biosynthesis<br>{{c1::S}}-phase cells most sensitive to methotrexate&nbsp;<div><br></div><div>Causes:</div><div>Apoptosis of {{c1::activated lymphocytes}}</div><div>Inhibition of {{c1::neutrophil}} functions<br></div><div><br></div><div>Methotexate is given once weekly, why?</div><div>{{c1::Because it accumulates in cells}}<br></div><div><br></div><div><br></div><div>{{c1::oral, SC or IM}} Administration<br></div><div>SLow onset of action</div><div><br></div><div>Adverse effects<br>Bone marrow suppression which leads to&nbsp;{{c1::leukopenia}}<br>{{c1::Liver}} toxicity<br>Hypersensitivity {{c1::pneumonitis}}<br></div><div><br></div>",
                        "<img src=\"paste-db1e580a6cc12279fcd69fc4b9a01885235c8265.jpg\"><div><img src=\"paste-21d1fc81c1df399811bf77b1fc25cbca52e86529.jpg\"><br></div>"
                    ],
                    "guid": "lA.^J?njhM",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement is true about\nmethotrexate?&nbsp;<div> Methotrexate blocks accumulation of dihydrofolate&nbsp;</div><div> It is structurally similar to purine nucleotides&nbsp;</div><div> Methotrexate can only be administered parenterally&nbsp;</div><div> Adverse effects include kidney damage&nbsp;</div><div> Administered once weekly</div>",
                        "5"
                    ],
                    "guid": "KZtu$Svam$",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Monoclonal antibodies&nbsp;</b><div>Advantages:&nbsp;<div> Highly {{c1::specific}} to their target&nbsp;</div><div> {{c1::Long}} duration of action&nbsp;</div><div> Most side effects are intrinsic ie\nextensions of the action of the drug\nat its target&nbsp;</div><div> New drug targets available&nbsp;</div><div>&nbsp; &nbsp; -{{c1::Extracellular}} proteins&nbsp;</div><div>&nbsp; &nbsp; -{{c1::Cell surface}} proteins&nbsp;</div><div> Big in immune-mediated disease\nand {{c1::oncology}}</div></div><div><br></div><div>Disadvantages&nbsp;</div><div> Expensive&nbsp;</div><div> Parenteral administration&nbsp;</div><div> Immuno{{c1::genicity&nbsp;}}</div><div> Infusion reactions<br></div><div><br></div><div>{{c1::parenteral injection (Iv or sc)}} administration.<br></div><div><br></div><div>Extravasation dependant on&nbsp;{{c1::convection}} rather than&nbsp;{{c1::diffusion}}.</div><div>&nbsp;</div><div>Transcytosis via {{c1::Fc}} receptors\nalso relevant<br></div><div><br></div><div>Antigen binding takes place in {{c1::tissues}}<br></div><div><br></div><div>Eliminated by Receptor-mediated {{c1:: endocytosis}}</div><div>Intracellular catabolism by\n{{c1::lysosomal}} degradation<br></div><div>Protective effect of FcRn\nleading to some {{c1::recycling}}<br></div><div><br></div><div>If there is an anti-drug immune response:</div><div>Drug clearance is&nbsp;{{c1::faster}}</div><div>{{c1::loss}} of clinical efficacy<br></div><div>Increased risk of&nbsp;{{c1::allergic-type\nreactions}}</div><div><br></div><div><br></div><div><br></div>",
                        "Immunogenicity=immune response can be mountded against it<div><img src=\"paste-2c16030f7bbad0aae58469728e9ec99ad70e754a.jpg\"><br></div><div><img src=\"paste-e21e877e9b74fdaa51531524267b04ba43fb419e.jpg\"><br></div>"
                    ],
                    "guid": "bQ[D$N^a>@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TNF-alpha is central in Pathogenesis of many\ndiseases eg {{c1::IBD}}, {{c1::RA}}, {{c1::psoriasis}}",
                        ""
                    ],
                    "guid": "F:A0;TqMo@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement about monoclonal\nantibodies is false?&nbsp;<div> They are highly selective in binding their target&nbsp;</div><div> They are much more complex and costly to produce than small molecule\ndrugs</div><div>&nbsp; They must be administered parenterally (by injection)&nbsp;</div><div> They are metabolized by cytochromes P450 in the liver&nbsp;</div><div> They are dosed much less frequently than small molecule drugs</div>",
                        "4"
                    ],
                    "guid": "r(hYwSbA4q",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TNF-alpha can stimulate production of&nbsp;{{c1::TNF-alpha}}",
                        "<img src=\"paste-521e34d1481afc8f77546d5f5f63d6ee034d6d8d.jpg\">"
                    ],
                    "guid": "e4Y;@@&`#;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Etanercept&nbsp;<div> Soluble TNFalpha receptor\n{{c1::fusion}} protein&nbsp;</div><div> Affectively neutralises\nbiological activity of TNF alpha</div><div> Does not bind to {{c1::membrane}}\nassociated TNF alpha</div><div> Does not induce apoptosis\nof TNF alpha expressing cells&nbsp;</div><div> Effective in {{c1::RA}} but not {{c1::IBD}}</div><div>Is it a monoclonal antibody?&nbsp;{{c1::no}}</div><div><br></div><div>Infliximab</div><div>{{c1::mouse}}-human chimeric antibody<br></div><div>Binds to TNF-alpha expressing cells and induces&nbsp;{{c1::apoptosis}}</div><div>Why do they lose their effectiveness over time?&nbsp;{{c1::anti-inflixamab antibodies}}</div>",
                        "<img src=\"paste-5a3f1da69e87543b5e326b2e8b34f1547ffb52a8.jpg\"><div><img src=\"paste-349deda8407f33fddff82f32c7fc68bce04e6e16.jpg\"><br><div><br></div></div>"
                    ],
                    "guid": "NGSt#YM.VT",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Adverse Effects of TNFalpha Inhibitors:<div>Reactivation of {{c1::latent tuberculosis }}&nbsp;</div><div>Increased risk of {{c1::opportunistic infections&nbsp;}}</div><div>Emergence of {{c1::Multiple Sclerosis}}&nbsp;</div><div>Injection and infusion reactions<br></div>",
                        ""
                    ],
                    "guid": "LRzrsyCzP{",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "True statements concerning anti-TNF\nbiologics include&nbsp;<div> Infliximab is a mouse-human chimeric anti-TNF monoclonal antibody&nbsp;</div><div> Patients should be screened for latent tuberculosis before starting any anti-TNF drug&nbsp;</div><div> Loss of response to anti-TNF biologics is often due to their immunogenicity&nbsp;</div><div> These drugs have proved highly beneficial in treating several chronic inflammatory diseases&nbsp;</div><div> All of the above</div>",
                        "5"
                    ],
                    "guid": "c;#!r2c`5z",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-integrin biologics: Leukocyte extravasation inhibitors<div><br></div><div>Block the binding of&nbsp;{{c1::leukocyts}} to&nbsp;{{c1::vascular cell adhesion molecules}}</div>",
                        "<img src=\"paste-6e11f86a3a2f079914e586feb06e318572c9d599.jpg\">"
                    ],
                    "guid": "b.wjSl~R_&",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Natalizumab: anti-{{c1::α4}} integrin<br>Vedolizumab: specific anti-{{c1::α4β7}} integrin<div><br></div><div>Treat&nbsp;{{c1::IBD}} and&nbsp;{{c1::MS}}&nbsp;</div>",
                        "<img src=\"paste-f9774e4df0afe6979adf00357fd159d02b7bf277.jpg\">"
                    ],
                    "guid": "Phk~nJjtcB",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Anti-cytokine biologics</b><br>Drug Name: Ustekinumab<br><div>Monoclonal {{c1::anti-p40}} subunit<br></div><div><br></div><div>Inhibits:</div><div>IL-{{c1::12/23}}<br><br></div><div>T/F this IL is:</div><div>Derived from hepatocytes&nbsp;{{c1::F}}<br>Elevated in only Rheumatic Arthrits{{c1::F}}<br>Stimulate Th1 and Th17 signalling{{c1::T}}<br><br><br></div>",
                        "Derived from many types of<br>immune cells<br>Elevated in many inflammatory<br>diseases<br>Stimulate Th1 and Th17<br>signalling<div><img src=\"paste-70c1f3f5ee73f098af0130b689a0e46e41293d27.jpg\"><br></div>"
                    ],
                    "guid": "s`Ojf`q3=I",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-B lymphocyte biologics<br>B cells involved in pathogenesis of RA<br>B cell malignancies ie lymphoma common<br>Rituximab<br>Anti-CD20 monoclonal<br>Blocks B cell activation<br>&nbsp;Kills B cells by multiple<br>mechanisms",
                        ""
                    ],
                    "guid": "PaP|FF}lUY",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [
                {
                    "__type__": "Deck",
                    "children": [],
                    "crowdanki_uuid": "5235f631-872b-11eb-8da3-b10d551bd690",
                    "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
                    "desc": "",
                    "dyn": 0,
                    "extendNew": 0,
                    "extendRev": 0,
                    "media_files": [
                        "paste-9f4a3c6ed368210df719db3091aba16c81edacdd.jpg",
                        "paste-b38d69c994278815cf149d87e68d527141d373a2.jpg",
                        "paste-c536f1fde99ba424ef2fb86dfa8a032d14de5606.jpg"
                    ],
                    "mid": 1602236504915,
                    "name": "02/15 IMMUNOPHARM 3 ALLERGIES V2",
                    "notes": [
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis</b><br>Severe acute allergic, {{c1::IgE}}-mediated,immediate {{c1::hypersensitivity}} reactions<br>Accounts for 1% A&amp;E visits<br>Life-threatening (5000-10,000 deaths per year in US)<br><br><div>Commonest allergens<br>{{c1::z Insect stings<br>z Foods<br>z Drugs<br>z Protein drugs (such as infliximab)<br>z Radiocontrast agents}} (5)<br></div><div><b><br></b></div><div><b>Milder allergic reactions</b><br>Confined to body surfaces<br>{{c1::Sites of contact}} with allergens<br>Very common<br>&nbsp;Symptoms trivial and recurrent<br><br></div><div>Commonest allergens<br>{{c1::Pollen</div>z House dust mite dander<br><div>z Latex}} (3)<br></div>",
                                ""
                            ],
                            "guid": "u%Dk^K?@]8",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<div>Examples of Allergic reactions:</div><div><br></div><b>Food allergy</b><br>Cause:{{c1::Peanut, shell fish, kiwi, strawberry..........}}<div>Rxn; GI upset to {{c1::Anaphylaxis}}<br><br><div><b>Asthma</b><br>Cause: {{c1::House dust mite dander, pollen.......}}<br>Rxn: {{c1::Wheezing}}, can be life threatening<br><br></div><div><b>Allergic rhinitis</b><br></div><div>Cause: {{c1::Fungal spores...}}<br>Rxn: {{c1::Nasal congestion, mild}}<br><br></div><div><b>Drug allergy</b><br>Cause: {{c1::PCN.......}}<br>Rxn: Rash to {{c1::Anaphylaxis}}<br><b><br></b></div><div><b>Contact dermatitis</b><br>Cause: {{c1::Latex.....}}<br>Rxn: {{c1::Rash}}</div></div>",
                                ""
                            ],
                            "guid": "v+wh7(D8!4",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Hypersensitivity type I:</b><div><b><br></b></div><div>{{c1::IgE}} anti-bodies binds to the allergen, IgE corss links allergen with mast cell by binding onto the {{c1::Fc}} receptor.&nbsp; The mast cell releases {{c1::histamine}} and eicanosoids such as {{c1::Lymphotoxins}} and {{c1::Prostoglandins}}</div><div><br></div><div>This reaction is called&nbsp;{{c1::degranulation}}</div>",
                                "<img src=\"paste-b38d69c994278815cf149d87e68d527141d373a2.jpg\">"
                            ],
                            "guid": "v*:OS]|ire",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Histamine</b><br><br>Basic {{c1::amine}}<br>Stored in {{c1::mast}} cell granules<div>&nbsp;Acts on specific histamine receptors H1, H2.... which are {{c1::G protein couples}} receptors<br></div><div><br></div><div>&nbsp;H1 receptors present on<br>-{{c1::Bronchial}} smooth muscle – contraction<br>- {{c1::Endothelial}}&nbsp;cells – vasodilatation &amp; vascular permeability<br>- {{c1::Vomiting}} centres in brain<br><br><br></div>",
                                "<img src=\"paste-c536f1fde99ba424ef2fb86dfa8a032d14de5606.jpg\">"
                            ],
                            "guid": "qFgS(b~[#.",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Hypersensitivity type I reactions</b><br><br><div>Anaphylactic or immediate {{c::1hypersensitivity}} reaction<br>Develops only in genetically susceptible individuals<br>Mediated by allergen-specific {{c1::IgE}} antibodies<br>Central role of local histamine release in mild allergic reactions<br><br></div><div>Increased capillary permeability which causes {{c1::Wheal}} and {{c1::urticarial (hives)}}<br><br></div><div>Vasodilatation which causes {{c1::Erythema}}<br><br></div><div>Itch caused by {{c1::Sensory nerve irritation}}<br><br></div>",
                                ""
                            ],
                            "guid": "GQ;;iVu$f_",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis: Clinical presentation&nbsp;</b><div><br></div><div>{{c1::5-60}} minutes after exposure to allergen<br><br></div><div>{{c1::Urticaria}} and {{c1::angioedema}} due to Capillary leakage of plasma<br><br></div><div>Bronchospasm causing wheezing due to {{c1::Histamine}}-induced {{c1::bronchoconstriction}}<br><br></div><div>{{c1::Hypo}}tension and CV collapse due to {{c1::Hypo}}volemia, myocardial depression</div><div><br></div><div>Vomiting, diarrhea&nbsp;</div>",
                                ""
                            ],
                            "guid": "bCQV&!IU<R",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Concerning allergy, which statement is false?</b><div><b><br></b></div><div>1. Allergic reactions are antigen-specific<br>2. IgE triggers histamine release from mast cells<br>3. Histamine acts on H1 receptors to cause bronchodilatation and vasoconstriction<br>4. Allergic diseases range from mild everyday symptoms to life-threatening emergencies<br>5. Can to diagnosed by skin prick testing<b><br></b></div>",
                                "3"
                            ],
                            "guid": "j+(;#ox.vI",
                            "note_model_uuid": "afe9bf23-7dce-11eb-b4f3-a0b2d6ecb02c",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Epinephrine</b><div><b><br></b>Stimulates:<br></div><div>{{c1::beta2}} adrenoceptors – bronchodilation<br>{{c1::beta1}} adrenoceptors – increased cardiac contractility<br>{{c1::alpha}} adrenoceptors - vasoconstriction<br><br></div><div>Life saving<br>No absolute contraindication<br>Needs to be administered {{c1::rapidly}}&nbsp;</div>",
                                ""
                            ],
                            "guid": "v^e1~+uQKD",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis after Epinephrine:</b><div>Anti-histamines<br>Drug Name: {{c1::Diphenhydramine}}<br>{{c1::H1}} receptor inverse agonist<br>Administered {{c1::IV}} or {{c1::orally}}<br>Continue for duration of symptoms<br>Inhibit {{c1::vasodilation}}, vascular leakage and bronchospasm<b><br></b></div><div><br></div><div>Beta 2 adrenoceptor agonists<br>Given to {{c1::Wheezing}} patients<br>Drug Name: {{c1::Salbutamol}}<br>{{c1::Nebulised}} administration<br>Not a substitute for epinephrine<br></div><div><br></div><div><br>2nd phase of {{c1::anaphylaxis}} often occurs 8-72 hours after initial symptoms<br>Markedly inflammatory<br>Mediated in part by {{c1::eicosanoids}} and {{c1::cytokines}}<br><br>Corticosteroids<br>Inhibit the 2nd phase<br>Must be administered {{c1::early}}<br>Drug Name: {{c1::Methylprednisolone&nbsp;}}</div><div>Administered IV, high dose<br></div><div><br></div><div>Agressive fluid&nbsp;{{c1::resuscitation}}</div><div>Airway Management</div>",
                                ""
                            ],
                            "guid": "p_>8BhV/!4",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis</b><br>1. Is difficult to diagnose<br>2. Should only be treated in a hospital setting<br>3. Causes severe hypertension<br>4. Requires immediate administration of anti-histamines and corticosteroids<br>5. Should be treated with IM adrenaline",
                                "5"
                            ],
                            "guid": "B_54Fl}U6F",
                            "note_model_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Atopic diseases</b><br>Skin: {{c1::eczema}}<br>Airways: {{c1::asthma}}<br>GIT: {{c1::food allergy}} (differentiate disease from common use of this term)<br>Eyes: {{c1::conjunctivitis}}<br>Nose: {{c1::allergic rhinitis}}",
                                ""
                            ],
                            "guid": "tC/I%ZA!?Z",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Drugs for atopy</b><br><br>Corticosteroids<br><br><div>&nbsp;Administered at time/season of symptoms<br><br><div>&nbsp;Slow-acting – must be used {{c1::prophylactically}}<br><br><div>&nbsp;Inhibit recruitment of {{c1::immune cells eg mast cells, lymphocytes etc}}<br><br><div>&nbsp;Topical use minimizes systemic exposures<br>z Nasal spray<br>z Cream/ointment<br>z Eye drops&nbsp;</div></div></div></div><div><br></div><div><br>Drug Name: {{c1::Fluticasone, triamcinolone, beclomethasone}}<br><br></div><div>Structural modification of {{c1::hydrocortisone}} to<br>{{c1::increase}} lipophilicity<br>{{c1::increase}} first-pass metabolism<br> Glucocorticoid potency &gt; mineralocorticoid<br><br></div><div>z ADR:<br>z Some systemic exposure even with topicals<br>z Skin – {{c1::thinning}} with chronic use<br></div>",
                                ""
                            ],
                            "guid": "lY!_xgvC#`",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Mast cell stabilizers<br>Drug Names: {{c1::Cromolyn sodium}} and {{c1::nedocromil}}<br>z Inhibit {{c1::Cl}} channel on mast cells, and others<br>z Prevents mast cell {{c1::degranulation}} and {{c1::histamine}} release<br>z Ineffective once that has already happened<br>z Used {{c1::prophylactically}}<div><br></div><div>Route of administration</div><div>z {{c1::Inhalation}}: Allergic asthma<br>z {{c1::Nasal spray}}: Allergic rhinitis<br>z {{c1::Ophthalmic drops}}: Allergic conjunctivitis<br>z {{c1::Oral}}: Mastocytosis<br></div><div><br></div>",
                                ""
                            ],
                            "guid": "DQOOz_KQ<C",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anti-histamines: H1 receptor partial agonists:</b><div><b><br></b><div>First Generation<br>Drug Name: {{c1::diphenhydramine, chlorpheniramine}}<br>z Lipop{{c1::hilic}}, cross BBB<br>z Act as “{{c1::inverse agonists}}”<br>z Drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist<br><br></div><div>Used for<br>z {{c1::Anaphylaxis}}<br>z Nausea and vomiting<br><br></div><div>Adverse effects<br>z {{c1::Sedation}}<br>z {{c1::Dry mouth}}<b><br></b></div></div><div><br></div><div>Second generation:<br>Drug Names: {{c1::Cetirizine}}, {{c1::loratadine}}, {{c1::fexofenadine}}<br>z Lipo{{c1::phobic}}, don’t cross BBB<br>z Additional anti-inflammatory effects<br><br></div><div>Uses:<br>z {{c1::Allergic rhinitis}} (↓ sneezing, rhinorrhoea)<br>z {{c1::Urticaria}}<br><br></div><div>Orally administered</div><div><br></div><div>&nbsp;Available OTC<br></div><div><br></div><div>Why Don't second-gen Anti-histamines cause sedation?&nbsp;{{c1::They don't cross the blood brain barrier}}</div>",
                                "<img src=\"paste-9f4a3c6ed368210df719db3091aba16c81edacdd.jpg\">"
                            ],
                            "guid": "f3SlmKh(#+",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "What was the name of the first non-sedating anti-histamine that got pulled due to suddden cardiac deaths?",
                                "Terfenadine"
                            ],
                            "guid": "h4+.ifPJ~G",
                            "note_model_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Topical calcineurin inhibitors<br>{{c1::Tacrolimus}} (FK506) ointment<br>z Inhibits production of {{c1::IL-2}} by activated T lymphocytes<br><br><div>Uses:<br>z Atopic eczema dependent on {{c1::corticosteroids}}<br><br></div><div>&nbsp;ADR:<br>z {{c1::Burning sensation in skin}}<br>z Possibly&nbsp;{{c1::lymphoma}}</div><div><br></div>",
                                ""
                            ],
                            "guid": "j?#uOb<jl;",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Which statement about anti-histamines is<br>false?<br><br>1. Diphenhydramine is a H1 receptor antagonist<br>2. Diphenhydramine crosses the blood brain barrier<br>3. Loratadine does not cross the blood brain barrier<br>4. Terfenadine can be subject to a clinically significant drug-drug interaction<br>5. Many anti-histamines are available over the counter",
                                "1"
                            ],
                            "guid": "jTq47*,%e#",
                            "note_model_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
                            "tags": []
                        }
                    ]
                }
            ],
            "crowdanki_uuid": "969fe5ce-7dd0-11eb-8411-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-1-A.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-1-Q.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-2-A.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-2-Q.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-3-A.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-3-Q.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg",
                "d1f829bd93fa4637b526c3ffbd0c2069-oa-1-A.svg",
                "d1f829bd93fa4637b526c3ffbd0c2069-oa-1-Q.svg",
                "d1f829bd93fa4637b526c3ffbd0c2069-oa-O.svg",
                "tmphj6msyzl.png",
                "tmpvsmuyas5.png"
            ],
            "mid": 1602236504914,
            "name": "02/15 IMMUNOPHARM 3: Allergies",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "1544a2db81e54eb3aea4ea1f5f3af765-oa-1",
                        "",
                        "<img src=\"tmphj6msyzl.png\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-1-A.svg\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg\" />"
                    ],
                    "guid": "GkI9gYkEaA",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1544a2db81e54eb3aea4ea1f5f3af765-oa-2",
                        "",
                        "<img src=\"tmphj6msyzl.png\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-2-A.svg\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg\" />"
                    ],
                    "guid": "vERa%nE~.w",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1544a2db81e54eb3aea4ea1f5f3af765-oa-3",
                        "",
                        "<img src=\"tmphj6msyzl.png\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-3-A.svg\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg\" />"
                    ],
                    "guid": "s_Ghr#zRE`",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::IgE}} binds to an Allergen, then&nbsp;{{c1::IgE}} binds to the&nbsp;{{c2::FC}} receptor on the mast cell, causing the release of&nbsp;{{c3::Histamine}}<br>",
                        ""
                    ],
                    "guid": "NIXG`tQK!j",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "d1f829bd93fa4637b526c3ffbd0c2069-oa-1",
                        "",
                        "<img src=\"tmpvsmuyas5.png\" />",
                        "<img src=\"d1f829bd93fa4637b526c3ffbd0c2069-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"d1f829bd93fa4637b526c3ffbd0c2069-oa-1-A.svg\" />",
                        "<img src=\"d1f829bd93fa4637b526c3ffbd0c2069-oa-O.svg\" />"
                    ],
                    "guid": "qhD]=Ua!)9",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Epinephrine stimulates&nbsp;{{c1::vasoconstriction}} on alpha-adrenoreceptors,&nbsp;{{c1::increased cardiac contractility}} on beta-1 receptors and&nbsp;{{c1::bronchodilation}} on beta-2 adrenoceptors",
                        ""
                    ],
                    "guid": "m;Nd1?~}j|",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Atopic individuals often have&nbsp;{{c1::multiple allergies}}",
                        ""
                    ],
                    "guid": "lPP/3y,1-e",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "For Atopy, corticosteroids should be administered&nbsp;{{c1::prophylactally}} as they are slow acting, and&nbsp;{{c1::topically}} to minimize systemic exposure",
                        ""
                    ],
                    "guid": "-d+eCU8^m",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroids such as fluticasone, triamcinolone, beclomethasone are structurally modified&nbsp;{{c1::hydrocortisone}} and they have high&nbsp;{{c1::lipophilicity}}, high&nbsp;{{c1::first-pass metabolism}} and are more potent at&nbsp;{{c1::glucocorticoid}} receptors",
                        ""
                    ],
                    "guid": "p|,0e4h2l$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Mast cell stabilizers inhibit&nbsp;{{c1::sodium channels}} on mast cells which prevent {{c1::degranulation}} and&nbsp;{{c1::histamine}} release.",
                        ""
                    ],
                    "guid": "ik&v|AiIBQ",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1st generation&nbsp; anti-histamines are lipo{{c1::phillic}}and they act as&nbsp;{{c1::inverse agonists}} (effect on receptor)",
                        ""
                    ],
                    "guid": "c(64x=H#ua",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is anaphylaxis mediated by?",
                        "IgE"
                    ],
                    "guid": "H&w35r.AP*",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Where is the effect of a mild allergic reaction felt?",
                        "At the site of contact with the allergen"
                    ],
                    "guid": "fiF,Hvx.O{",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name 5 clinical examples of allergic diseases",
                        "Food allergy, Asthma, Allergic Rhinitis, Drug Allergy, Contact dermatitis"
                    ],
                    "guid": "uoD!cIX>zZ",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of cells produce IgE?",
                        "Plasma Cells"
                    ],
                    "guid": "yS_Ms_[Vmu",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the process of mast cells releasing Histamine called?",
                        "De-granulation"
                    ],
                    "guid": "Hc2I^#C{/1",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What other substances are produced by the mast cells?",
                        "Eicosanoids"
                    ],
                    "guid": "vjZXOa;tot",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What does H1 agonism cause in the bronchial smooth muscle?",
                        "Contraction"
                    ],
                    "guid": "Go[l5s+,p3",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What does H1 agonism cause in endothelial cells",
                        "? Vasodilation and vascular permeability"
                    ],
                    "guid": "i/~tBX,ec/",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What cohort of people does type 1 hypersensitivity reactions affect?",
                        "Those who are genetically susceptible"
                    ],
                    "guid": "wT|7)hnyDW",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the itch caused by, in mild allergic reaction?",
                        "Sensory Nerve irritation"
                    ],
                    "guid": "fm6Sx*6ey/",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is urticaria?",
                        "Hives"
                    ],
                    "guid": "Iov{rk9A?@",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is angioedema?",
                        "Rapid oedema of the area beneath the skin or mucosa."
                    ],
                    "guid": "K>XEz}rto",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How long after exposure to allergen does anaphylaxis occur?",
                        "5-60mins"
                    ],
                    "guid": "jP=r9ZXe@o",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What substance should you administer straight away if someone has anaphylaxis?",
                        "Epinephrine"
                    ],
                    "guid": "gg9gKORe).",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why is there only a limited benefit of giving anti-histamines during anaphylaxis?",
                        "The histamine is already in the body."
                    ],
                    "guid": "eg|L=ve54{",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are three other types of drugs that can be given to those who suffer from anaphylaxis?",
                        "Anti-histamines, beta-2 adrenoceptors, corticosteroids"
                    ],
                    "guid": "d6)m*kh[.x",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "When does the 2nd phase of anaphylaxis occur?",
                        "8-72 hours after initial symptoms"
                    ],
                    "guid": "prnQe|i~=|",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What drugs inhibit the 2nd phase of anaphylaxis?",
                        "Corticosteroids."
                    ],
                    "guid": "nuuEY)l3_(",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why can corticosteroids&nbsp; diffuse through membranes and get to the affected tissues easily",
                        "They ar lipophillic&nbsp;"
                    ],
                    "guid": "rWJ>c{Mc;&",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What affect does chronic use of topical corticosteroids have on the skin?",
                        "It thins the skin"
                    ],
                    "guid": "gEK34XTOqb",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name two mast cell stabilisers",
                        "Cromolyn sodium and nedocromil"
                    ],
                    "guid": "Hx#|LuguwA",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name two 1st generation anti-histamines",
                        "diphenhydramine and chlorpheniramine"
                    ],
                    "guid": "MA7z&&]3^f",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are 1st generation anti-histamines used for?",
                        "Anaphylaxis and nausea"
                    ],
                    "guid": "cB5)whh^v6",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why do 1st geration anti-histamines cause sedation but 2nd generation don't?",
                        "Because 1st cross the blood brain barrier"
                    ],
                    "guid": "t4q}*ycuuT",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name three 2nd gen anti-histamines",
                        "Cetirizine, loratadien and fexofenadine"
                    ],
                    "guid": "f00&ez9qyR",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the uses for 2nd gen anti-histamines?",
                        "Allergic rhinitis and urticaria"
                    ],
                    "guid": "PkP0&|aebm",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is allergic rhinitis?",
                        "Inflammation on the inside of the nose due to an allergen"
                    ],
                    "guid": "EnjkZg2Uq!",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What drug interacted with terfenadine that caused a build up of it?",
                        "Erythromycin"
                    ],
                    "guid": "to_c;iD|-X",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the MoA for topical calcineuron inhibitors?",
                        "Inhibits production of IL-2 by activated T lymphocytes"
                    ],
                    "guid": "gUve:QM_5[",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [
                {
                    "__type__": "Deck",
                    "children": [],
                    "crowdanki_uuid": "5237cb5f-872b-11eb-805f-b10d551bd690",
                    "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
                    "desc": "",
                    "dyn": 0,
                    "extendNew": 0,
                    "extendRev": 0,
                    "media_files": [
                        "paste-d97c47d5b40b9b2d047a17e0481165984b50f014.jpg"
                    ],
                    "mid": 1602236504918,
                    "name": "02/16 IMMUNOPHARM 4 ALLERGIES V2",
                    "notes": [
                        {
                            "__type__": "Note",
                            "fields": [
                                "<div>Traditional attenuated virus</div><div><br></div><div>{{c1::2.}} The cultured virus is used to infect monkey cells<br></div>{{c1::1}}.Pathogenic virus is isolated from a patient and grown in human cultured&nbsp;<div>{{c1::4.}} The virus no longer grows well in human cells and can be used in a vaccine</div><div>{{c1::3}}&nbsp;The virus acquires many mutations that allow it to grow well in&nbsp; monkey cells<br></div>",
                                ""
                            ],
                            "guid": "snyF9fKhWt",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "With recombinant DNA techniques, attenuation can be achieved by removing the&nbsp;{{c1::virulence}} part of pathogen, but leaving behind the&nbsp;{{c1::receptor binding protein}} and&nbsp;{{c1::core proteins}}",
                                ""
                            ],
                            "guid": "j?eXlUEpzV",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "What sort of vaccine is it?<div><br></div><div>MMR&nbsp;{{c1::LAV}}</div><div>HEP B&nbsp;{{c1::SUB/CON}}</div><div>Passed Through cell cultures&nbsp;{{c1::LAV}}</div><div>HEP A&nbsp;{{c1::Inactivated}}</div><div><br></div>",
                                ""
                            ],
                            "guid": "K;7rpnQp5#",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "{{c1::Antigen}} provides specificity of response to adaptive immunity<br><br><div>{{c1::Adjuvant}} provides innate immune activity to boost adaptive immunity</div><div><br></div><div>Adjuvants bind to&nbsp;{{c1::Toll-like}} receptors on&nbsp;{{c1::antigen presenting}} cells or it can be&nbsp;{{c1::phagocytosed}}</div><div><br></div><div>Inflammasomes induce production of {{c1::cytokines}}</div><div><br></div><div>{{c1::APC}} presents the antigen which activates the immune response</div>",
                                "<img src=\"paste-d97c47d5b40b9b2d047a17e0481165984b50f014.jpg\">"
                            ],
                            "guid": "p,VE%AeC+$",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Which immune response<div><br></div><div>Slow and not strong{{c1::primary}}</div><div><br></div><div>Fast and Strong&nbsp;{{c1::secondary}}</div>",
                                ""
                            ],
                            "guid": "NY{Qb-/XJ&",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Reasons for inability to develop effective<br>vaccines: HIV<br><br>z Lack of {{c1::natural immunity}} to HIV<br>z {{c1::Variability}} of HIV types<br>z Lack of correlates of protective immunity<br>z Lack of an {{c1::animal model}} that reliably predicts vaccine efficacy in humans",
                                ""
                            ],
                            "guid": "Ais5c]%xS^",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "HPV is a common STI<br>Infection at sexual debut<br>Most infected persons clear<br>HPV infection<br>Chronic HPV16 infection causes certain cancers:<br>{{c1::z Cervical<br>z Anal<br>z Penile<br>zHead and neck}} (4)<br>",
                                ""
                            ],
                            "guid": "Ou7~`U3mXd",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "1.{{c1::APC}} takes up antigen&nbsp;<div>2. {{c1::T helper cell}} exposed to antigen</div><div>3.&nbsp;{{c1::Naive}} T and B lymphocytes activated</div><div>4.{{c1::B-cells}} make antibodies,&nbsp;{{c1::T-cells}} kill the infected cells</div><div>5.&nbsp;{{c1::memory b-cells, memory t-cells and memory helper t-cells}}(3) stay behind</div>",
                                ""
                            ],
                            "guid": "H`0R;;t,XT",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        }
                    ]
                }
            ],
            "crowdanki_uuid": "96a16b70-7dd0-11eb-be8a-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "0505c55ce9654e369f14c06fdd858660-oa-1-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-1-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-2-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-2-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-3-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-3-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-4-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-4-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-5-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-5-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-6-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-6-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-O.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-1-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-1-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-2-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-2-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-3-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-3-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-4-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-4-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-5-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-5-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-6-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-6-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-O.svg",
                "Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG"
            ],
            "mid": 1602236504914,
            "name": "02/16 IMMUNOPHARM 4",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Who did the experiment of smallpox and cowpox?",
                        "Edward Jenner"
                    ],
                    "guid": "GX27QRm+vE",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How many laboratories in the world hold smallpox?",
                        "2"
                    ],
                    "guid": "CfY+cbdii]",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-1",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-1-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "HZ[|~D:}JQ",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-2",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-2-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "y@LnEK^*a%",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-3",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-3-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "j]_Vg1_*9I",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-4",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-4-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "O2[*Pts9j@",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-5",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-5-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-5-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "m(op>`!W:;",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-6",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-6-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-6-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "G?@nB4h:_N",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-1",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-1-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "pF2ld2#v0s",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-2",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-2-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "uKy}_z7Ux(",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-3",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-3-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "l|Usy:*G_4",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-4",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-4-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "d;HQEC7F/J",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-5",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-5-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-5-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "tIQ-NBTDY>",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-6",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-6-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-6-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "qkiie]/_?E",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In traditional vaccines, virus is isolated from{{c1::humans}} and is used to infect&nbsp;{{c1::animal}} cells, the virus acquires many mutations that do not allow it to grow in&nbsp;{{c1::human}} cells anymore.",
                        ""
                    ],
                    "guid": "j$V1OeqNmt",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the three parts of a virus DNA?",
                        "Receptor binding protein.<div>Virulence</div><div>Core proteins</div>"
                    ],
                    "guid": "ySm@5DeIfO",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "With recombinant DNA techniques the&nbsp;{{c1::virulence}} gene of the virus is deleted.",
                        ""
                    ],
                    "guid": "h-`pFVhA}A",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In a live attenuated vaccine the&nbsp;{{c1::virus}} is selected. It is passed through tissue cultures and a&nbsp;{{c2::weakened strain}} of the virus is used.",
                        ""
                    ],
                    "guid": "QfaU(NS],y",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give an example of a live attenuated vaccine",
                        "MMR"
                    ],
                    "guid": "Q5_jn>sM[S",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Who should a live attenuated vaccine not be given to?",
                        "People with weak immune systems"
                    ],
                    "guid": "z9!1,o8*>?",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In an inactivated vaccine, a&nbsp;{{c1::bacterial}} or&nbsp;{{c1::viral}} strain is isolated, it is&nbsp;{{c1::inactivated}} using heat or chemicals.",
                        ""
                    ],
                    "guid": "jAr~<|}XHo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give an example of an inactivated vaccine",
                        "Hepatitis A"
                    ],
                    "guid": "b;b&QZW)30",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is different about a subunit/conjugated vaccine, compared to the rest?",
                        "Only the part of pathogen that provokes an immune response is used"
                    ],
                    "guid": "tgZJXSbG!2",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of immune response does an antigen evoke?",
                        "An adaptive immune response"
                    ],
                    "guid": "ho(TvU6`zG",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of immune response does an adjuvant evoke?",
                        "AN innate imkune response."
                    ],
                    "guid": "d_)i=22?8J",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What type of cell takes up the vaccine?",
                        "APC"
                    ],
                    "guid": "K<g(H=Pv%z",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of diseases are affected by herd immunity?",
                        "Diseases that spread from human to human contact.<div><br></div>"
                    ],
                    "guid": "e[&B!vLdj=",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give some reasons why HIV is unable to be vaccinated against?<div><br></div>",
                        "Lack of natural immunity against it<div>Variability of HIV types</div><div>Lack of correlates of protective immunity&nbsp;</div><div>Lack of an animal model that reliably predicts vaccine efficacy in humans</div>"
                    ],
                    "guid": "mDn6hc`NoY",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is passive immunity?",
                        "Administration of antibodies from an exposed donor specific to the infectious agent."
                    ],
                    "guid": "Q+Y4u(d{e5",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the name of the vaccine for HPV?",
                        "Gardasil."
                    ],
                    "guid": "p<=HuU^_K~",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "96a27bd7-7dd0-11eb-bab2-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 50,
            "media_files": [
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-1-A.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-1-Q.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-2-A.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-2-Q.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-O.svg",
                "Capture-d97a4aec839f97ed34efc1c4e421661ed3ffd1bf.PNG",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-1-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-1-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-2-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-2-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-3-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-3-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-4-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-4-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-1-A.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-1-Q.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-2-A.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-2-Q.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-3-A.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-3-Q.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg",
                "b06073520ebe46d38482969be733a8f6-ao-1-A.svg",
                "b06073520ebe46d38482969be733a8f6-ao-1-Q.svg",
                "b06073520ebe46d38482969be733a8f6-ao-2-A.svg",
                "b06073520ebe46d38482969be733a8f6-ao-2-Q.svg",
                "b06073520ebe46d38482969be733a8f6-ao-O.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-1-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-1-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-2-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-2-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-3-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-3-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-4-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-4-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg",
                "f8968587c7b04c86a378c679301108d5-ao-1-A.svg",
                "f8968587c7b04c86a378c679301108d5-ao-1-Q.svg",
                "f8968587c7b04c86a378c679301108d5-ao-2-A.svg",
                "f8968587c7b04c86a378c679301108d5-ao-2-Q.svg",
                "f8968587c7b04c86a378c679301108d5-ao-O.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-1-A.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-1-Q.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-2-A.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-2-Q.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-O.svg",
                "paste-0d2756215775a5261efd3f41fb4a6a35a0ae28a8.jpg",
                "paste-1dde4f442d303b53a70387313522fa9212e73744.jpg",
                "paste-41e82ef870068aea652215b939aee75720ef16f0.jpg",
                "paste-44af17c986fdc1d9a6b5db867d9de4c65cf23900.jpg",
                "paste-5919a7fe2153dc365a7d2b98536f60c48b0b1f71.jpg",
                "paste-854dac1f54a21a3026dc78215d4949c8f71f810f.jpg",
                "paste-8e6c84ba755d94c51d3946488f0710fb06b14080.jpg",
                "paste-f8ed57f377933dc5de967a98b519cf08ed3da6ba.jpg",
                "tmp1t7h0jab.png",
                "tmp62gv7z57.png",
                "tmpbk8kbydk.png",
                "tmppkgd49wt.png",
                "tmpqsrwmzoe.png",
                "tmpz7vvox8i.png",
                "tmpzxuh_fh8.png"
            ],
            "mid": 1602236504918,
            "name": "02/21 Resp Pharm 1+2",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Asthma is common: affects up to&nbsp;{{c1::10%}} of children<div>Wheezing due to airflow&nbsp;{{c1::limitation}}</div><div>Is episodic , meaning that airflow&nbsp;{{c1::limitation}} is&nbsp;{{c1::reversible}}</div><div>Triggers<br>{{c1::z Allergens<br>z Exercise<br>z Cold air<br>z Virus infections}} (4)<br></div>",
                        "Limitation due to narrow bronchi<div>Goes from mild and occasional, to serious and persistent</div>"
                    ],
                    "guid": "f28vE+Yj+v",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In asthma, the airflow limitation arises as a result of the&nbsp;{{c1::bronchi}} being too narrow.<div>It is felt mainly at&nbsp;{{c1::exhalation}} as the positive pressure in the chest cavity when the&nbsp;{{c1::diaphragm}} and the&nbsp;{{c1::intercostal muscles}} relax constricts the&nbsp;{{c1::bronchii}} even further.</div>",
                        "<img src=\"paste-44af17c986fdc1d9a6b5db867d9de4c65cf23900.jpg\"><div>Lungs full and diaphragm flattened</div><div><img src=\"paste-854dac1f54a21a3026dc78215d4949c8f71f810f.jpg\"><br></div><div>Exhalation much slower in asthma</div><div><br></div>"
                    ],
                    "guid": "m)nxlv>9!>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Causes of asthma<div>1. Allergic effect:&nbsp;{{c1::Mast}} cells, that release&nbsp;{{c1::histamine}} which constrict bronchial smooth muscle cells.</div><div><br></div><div>2. Neurological cause:{{c1::Vagus}} nerve acts on bronchial smpoth muscle cells through the neurotransmitter&nbsp;{{c1::Ach}}</div>",
                        ""
                    ],
                    "guid": "RfT3K<8?,-",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "FEV1 stands for&nbsp;{{c1::forced expiratory volume in 1second}}<div><br></div><div>During an asthma attack the FEV1 can decrease to as low as&nbsp;{{c1::75%}} (% of normal fev1)</div><div><br></div><div>Phase 1 asthma attack, Mast cell releasing histamine or Vagus nerve problem</div><div><br></div><div>Phase 2: CHronic&nbsp;{{c1::inflammation}}: Mast cells, eosinophils, neutrophils etc. infiltrate the bronchial&nbsp;{{c1::submucosa}} and {{c1::lamina propria}} which narrows the airway even more.</div><div><br></div><div><br></div>",
                        "<img src=\"paste-1dde4f442d303b53a70387313522fa9212e73744.jpg\"><div>CD4+ T lymphocytes contribute to the inflammation</div>"
                    ],
                    "guid": "RdWP=WEvY2",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-1",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-1-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "lAm&|rycq9",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-2",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-2-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "E%RNEP/M=>",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-3",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-3-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "n>(#M<H,AY",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-4",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-4-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "vEB[.W1c},",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "COPD, {{c1::COAD}}, {{c1::chronic bronchitis}}, {{c1::emphysema}}<br>&nbsp;Almost universally linked with {{c1::cigarette smoking}}<br>{{c1::Irreversible}} damage to airways<br><br>",
                        "Airflow limitation<br>Susceptibility to lower respiratory tract infections<br>Loss of lung function"
                    ],
                    "guid": "tRvOl_`CFr",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Emphysema<div>Loss of&nbsp;{{c1::alveoli}} in centrilobar or {{c1::acinar}} area.</div><div>Oxygen and gas exchange is compromise, chronically&nbsp;{{c1::hypoxemic}}</div>",
                        "<img src=\"paste-41e82ef870068aea652215b939aee75720ef16f0.jpg\">"
                    ],
                    "guid": "HcJ3%d(d-h",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-1",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-1-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "wu62~iUgRL",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-2",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-2-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "tI6gH5diK-",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-3",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-3-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "N$W53mMpCz",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-4",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-4-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "w./U7U6x=+",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "f8968587c7b04c86a378c679301108d5-ao-1",
                        "",
                        "<img src=\"Capture-d97a4aec839f97ed34efc1c4e421661ed3ffd1bf.PNG\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-1-A.svg\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-O.svg\" />"
                    ],
                    "guid": "sx%mFKRf4s",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "f8968587c7b04c86a378c679301108d5-ao-2",
                        "",
                        "<img src=\"Capture-d97a4aec839f97ed34efc1c4e421661ed3ffd1bf.PNG\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-2-A.svg\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-O.svg\" />"
                    ],
                    "guid": "iAaEzILp%&",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "573b238c9bcd409eb3e1cc105c7694d2-ao-1",
                        "",
                        "<img src=\"tmpzxuh_fh8.png\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-1-A.svg\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-O.svg\" />"
                    ],
                    "guid": "J=CN-G:Y?M",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "573b238c9bcd409eb3e1cc105c7694d2-ao-2",
                        "",
                        "<img src=\"tmpzxuh_fh8.png\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-2-A.svg\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-O.svg\" />"
                    ],
                    "guid": "KHU@V#Y;06",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "ff17189e02f44a3da6fd7c1b9f060933-ao-1",
                        "",
                        "<img src=\"tmpqsrwmzoe.png\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-1-A.svg\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-O.svg\" />"
                    ],
                    "guid": "rFK@KTXGKH",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "ff17189e02f44a3da6fd7c1b9f060933-ao-2",
                        "",
                        "<img src=\"tmpqsrwmzoe.png\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-2-A.svg\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-O.svg\" />"
                    ],
                    "guid": "vjW[Lk*{c?",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a866c98ccddb4d9f8ee8934854b9af52-ao-1",
                        "",
                        "<img src=\"tmp1t7h0jab.png\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-1-A.svg\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg\" />"
                    ],
                    "guid": "h|tEc9><.A",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a866c98ccddb4d9f8ee8934854b9af52-ao-2",
                        "",
                        "<img src=\"tmp1t7h0jab.png\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-2-A.svg\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg\" />"
                    ],
                    "guid": "c>xDgy)%{R",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a866c98ccddb4d9f8ee8934854b9af52-ao-3",
                        "",
                        "<img src=\"tmp1t7h0jab.png\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-3-A.svg\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg\" />"
                    ],
                    "guid": "G4y2>>gek1",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "b06073520ebe46d38482969be733a8f6-ao-1",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-1-A.svg\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-O.svg\" />"
                    ],
                    "guid": "pX$Wen`~[L",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "b06073520ebe46d38482969be733a8f6-ao-2",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-2-A.svg\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-O.svg\" />"
                    ],
                    "guid": "s#m:8mm?=b",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-1",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "EX6-;[ddHP",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-2",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "m-x#V#fe~4",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-3",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "smj<,dA]MU",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-4",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "MMjc9GuU3",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Salbutamol and terbutaline are selective beta 2&nbsp;{{c1::agonists}}<div><br></div><div>How much of the drug (cannisters being measurement) suggests the treatment of asthma is inadequate?&nbsp;{{c1::more than one}}</div><div><br></div><div>SHould only be used for bouts of asthmatic symptoms, if used regularly it may&nbsp;{{c1::lower effectiveness}} or increase {{c1::airway hyper responsivenss}}</div><div><br></div><div>Side effects<br>{{c1::z Tremor<br>z Tachycardia<br>z Nausea<br>z Light-headedness}} (4)<br></div>",
                        "side effects mostly related to stimulation of Beta1 receptors in<br>CVS, would need to take a lot tho for this to happen"
                    ],
                    "guid": "jksI+U-/N;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::salmeterol}} is a long acting b-adrenoceptor agonist<br><div>Has a&nbsp;{{c1::slower}} onset of action</div><div>It is not used for&nbsp;{{c1::acute}} symptoms</div>",
                        ""
                    ],
                    "guid": "mkH|g|T[Ep",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "MUSCARINIC RECEPTOR ANTAGONISTS<br>Anticholinergic<br>Target is {{c1::vagally}}-mediated, acetylcholine-dependent<br>{{c1::parasympathetic}}(type of neuron) airway smooth muscle tone<br>Inhibits muscarinic receptors<br>&nbsp;Example: ipratropium bromide<br>T/F More useful in asthma than COPD&nbsp;{{c1::false}}<div>T/F Inhaled&nbsp;{{c1::True}}<br>T/F Many clinically significant side effects&nbsp;{{c1::False}}</div>",
                        ""
                    ],
                    "guid": "A&SB>dl)-]",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Methylxanthines<br></div>{{c1::Phosphodiesterase}} inhibitors<br>Examples:{{c1::Theophylline}} (oral) and {{c1::Aminophylline}} (IV)<br>Cause relaxation of bronchial smooth muscle<br>May have other mechanisms of action<br>Anti-inflammatory effects<br><br><br>Side effects<br>Narrow therapeutic index<br>{{c1::Nausea}}<br>Gastro-oesophageal reflux<br>{{c1::Tachycardia}}<br>Agitation",
                        "This is for when the patient cannot take any other medication whatsoever, it is shit compared to the others"
                    ],
                    "guid": "r-)CcVk9,T",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-5919a7fe2153dc365a7d2b98536f60c48b0b1f71.jpg\"><div>Why does Albuterol(salbutamol) and ipratropium have an additive effect on their change in FEV1?</div>",
                        "Two different mechanisms of action producing the same effect<div><br></div>"
                    ],
                    "guid": "gmek$wxq&T",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "O*ZTPJe@^Q",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "jdq=62<Hx1",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "rK{w5)A%ka",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "mt6IQ;h+Go",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroid treatment in asthma patients is primarily used as prophylactic&nbsp;{{c1::anti-inflammatory}} to prevent the&nbsp;{{c1::2nd phase }} of an asthma attack.<div><br></div><div>They are taken prophylactically because corticosteroids are relatively&nbsp;{{c1::slow}} acting</div><div><br></div><div><br>{{c1::Glucocorticoid}} receptors&nbsp;<br>&nbsp;Innate immune cells such as&nbsp; {{c1::Monocytes}} and {{c1::macrophages}}<br>&nbsp;Adaptive immune cells<br>&nbsp;T lymphocytes<br>&nbsp;Non-immune cells<br>Endothelial cells<br><br>inalldifferentcelltypes<br><br>Inhaled corticosteroid side effects<br><br>z Local side effects<br>z Dysphonia Oropharyngeal candidiasis Cough<br>z Systemic side effects<br>z Adrenal suppression Growth suppression Bruising<br>Osteoporosis Cataracts Glaucoma Metabolic<br>abnormalities (glucose, insulin, triglycerides)<br>Psychiatric disturbances<br><br>bcitdampensdowntheIs<br>morepronetoinfectious<br><br>chronic<br><br>ofuoia q<br><br>hyperglycemia<br><br>Corticosteroid use in asthma and COPD<br><br>z By inhalation<br>z Often combined with inhaled E2-adrenoceptor agonist<br>z Slow onset of action (hours)<br>z Not used for immediate symptom relief<br>z Use to prevent attacks<br>z Long duration of benefit (hours)<br>z Systemically<br>z Oral or IV<br>z Used in more severe cases<br></div>",
                        "<img src=\"paste-8e6c84ba755d94c51d3946488f0710fb06b14080.jpg\"><div><img src=\"paste-0d2756215775a5261efd3f41fb4a6a35a0ae28a8.jpg\"><br></div>"
                    ],
                    "guid": "CXB*8MY2qo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroid Targets:<br>{{c1::Glucocorticoid}} receptors&nbsp;<br>Innate immune cells: Monocytes, {{c1::macrophages}}<br>Adaptive immune cells: {{c1::T lymphocytes}}<br>Non-immune cells: {{c1::Endothelial cells}}<br><br><br><br>Inhaled corticosteroid side effects<br>&nbsp;Local side effects:<br>&nbsp;Dysphonia:&nbsp;{{c1::hoarseness of voice}}<div>&nbsp;Oropharyngeal candidiasis:&nbsp;{{c1::thrush infection}}</div><div>&nbsp;Cough<br>&nbsp;</div><div>Systemic side effects:<br>&nbsp;{{c1::Adrenal}} suppression, {{c1::Growth}} suppression, Bruising<br>Osteoporosis, Cataracts, Glaucoma,&nbsp;</div><div>Metabolic abnormalities (glucose, insulin, triglycerides)<br>Psychiatric disturbances<br><br>Corticosteroid use in asthma and COPD T/F<br><br>&nbsp;By inhalation&nbsp;{{c1::true}}<br>&nbsp;Often combined with inhaled E2-adrenoceptor agonist&nbsp;{{c1::true}}<br>&nbsp;Slow onset of action (hours){{c1::True}}<br>&nbsp;Used for immediate symptom relief&nbsp;{{c1::False, is used prophylactilly}}<br>&nbsp;Use after phase 1 part of attacks&nbsp;{{c1::true, still before phase 2}}<br>&nbsp;Long duration of benefit (hours)&nbsp;{{c1::True}}<br>&nbsp;</div><div>Systemically:</div><div>&nbsp;Only used orally&nbsp;{{c1::False can be used IV}}</div><div>&nbsp;Used in more severe cases{{c1::True}}</div>",
                        "<img src=\"paste-0d2756215775a5261efd3f41fb4a6a35a0ae28a8.jpg\">"
                    ],
                    "guid": "xWN+)wKM9t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "During an asthma attack, leukotrienes contribute to the&nbsp;{{c1::inflammaotry}} process. But they also further constrict the bronchial smooth muscle by acting on the&nbsp;{{c1::CysLT}} receptor.<div><br></div><div>Lukasts</div><div>{{c1::&nbsp;Inhibit}} these receptors expressed on respiratory epithelium and infiltrating leukocytes<br>Improve airflow in both early and late phases<br>{{c1::Orally}} administered<br>Well tolerated<br>Example: {{c1::Montelukast}}<br>Slow acting: used to prevent attacks<br></div>",
                        "<img src=\"paste-f8ed57f377933dc5de967a98b519cf08ed3da6ba.jpg\"><div>Lukasts quicker acting than corticosteroid, but shorter lasting</div>"
                    ],
                    "guid": "l>cOEItcl)",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Anti-IgE therapy of asthma</b><br>In some patients asthma triggers are {{c1::allergic}}<br><br><div>Anti-IgE treatment may be considered if:</div><div>-Moderate-to-severe {{c1::persistent}} asthma<br>-Asthma symptoms are inadequately controlled with inhaled<br>glucocorticoids<br><div>-A total serum IgE level is between {{c1::30}} and 1500 international units/mL, which is the range over which the drug can reduce enough free IgE to ensure a therapeutic effect<br>-Allergic sensitization demonstrated by positive skin testing or in vitro testing for allergen-specific IgE to an allergen that is present year-round e.g.&nbsp;{{c1::house dust mites, animal danders, cockroaches, or molds}}<br><br><br><br>{{c1::Omalizumab}} is a recombinant humanized anti-IgE antibody<br><br>Used in selected asthmatic patients&nbsp;</div><div>Results in marked fall in serum IgE&nbsp;</div><div>&nbsp;May be useful also in other IgE-mediated diseases eg {{c1::recurrent anaphylaxis}}</div></div>",
                        ""
                    ],
                    "guid": "gW}$kGrS=g",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "969cda51-7dd0-11eb-acdf-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-4301241840ed16771b4dc018189a975f932e9ddc.jpg",
                "paste-49d6a82bda0677d16d9eaab0aea03fc49a72bc98.jpg",
                "paste-e137da2c0499e34f58c7d3191720c5073a791963.jpg",
                "paste-e463ac68b4c3d6bf86769a48fab0e5038e923531.jpg",
                "paste-e95f601c181141294f3fb2a4ab05a57ff748b8ef.jpg"
            ],
            "mid": 1602236504918,
            "name": "03/01 GIT PHARM",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Mesalazine is used to treat IBD especially&nbsp;{{c1::ulcerative collitis}}<div>Another name for Mesalazine is&nbsp;{{c1::5-Aminosalicytic acid}}</div><div><br></div><div>Mesalazine is administered&nbsp;{{c1::orally}} or&nbsp;{{c1::rectally}}</div><div><br></div><div>The concentration of mesalazine achived in the large intestine is&nbsp;{{c1::10-30}}mmol/l this is a very&nbsp;{{c1::high concentration}}</div><div><br></div><div>It is&nbsp;{{c1::well}} tolerated</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "c,$aj|:M]=",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroids are used sometimes in patients with&nbsp;{{c1::moderate to severe}} IBD<div><br></div><div>There are&nbsp;{{c1::many}} side effects associated with&nbsp;{{c1::long}} term use of corticosteroids</div>",
                        ""
                    ],
                    "guid": "V?8=_!~}g",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>IMMUNOSUPPRESSANTS:</div><div>{{c1::Slow}}-acting&nbsp;<br></div><div><br></div><div><br></div>Azathioprine/6-mercaptopurine&nbsp;<div> {{c1::Purine}} analogues&nbsp;</div><div> Decrease {{c1::nucleotide}} biosynthesis selectively in {{c1::lymphoid}} cells&nbsp;</div><div> S/Es: Bone marrow suppression, pancreatitis, allergy, lymphoma&nbsp;</div><div><br></div><div>Methotrexate&nbsp;</div><div> {{c1::Folic acid}} analogue&nbsp;</div><div> Competitive inhibitor of {{c1::dihydrofolate reductase}}</div><div>&nbsp; Induces apoptosis of activated {{c1::lymphocytes&nbsp;}}</div><div> S/Es: Liver fibrosis, pneumonitis, bone marrow suppressions</div><div><br></div>",
                        ""
                    ],
                    "guid": "E1il]@`8F9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TNFalpha&nbsp;<div> Pro-inflammatory {{c1::cytokine&nbsp;}}</div><div> Produced by activated {{c1::macrophages}} in inflamed gut&nbsp;</div><div><br></div><div>ANTI-TNFalpha drugs</div><div>Infliximab&nbsp;</div><div> Neutralizes {{c1::soluble}} and {{c1::membrane-associated}} TNFalpha</div><div> Induces {{c1::apoptosis}} of cells expressing TNFalpha&nbsp;</div><div><br></div><div>Highly effective in induces and maintaining responses in {{c1::IBD}} patients&nbsp;<br></div><div><br></div><div><br></div><div>There is a loss of&nbsp; response to Infliximab over time, why?</div><div>{{c1::Production of anti infliximab antibodies}}<br></div><div><br></div><div>Adverse effects of TNFalpha inhibitors</div><div> Reactivation of latent {{c1::tuberculosis&nbsp;}}</div><div> Increased risk of opportunistic infections&nbsp;</div><div> Emergence of {{c1::Multiple Sclerosis&nbsp;}}</div><div> Injection and infusion reactions<br></div><div><br></div><div><br></div><div><br></div>",
                        "V#<img src=\"paste-4301241840ed16771b4dc018189a975f932e9ddc.jpg\">"
                    ],
                    "guid": "JOZt<go-o0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-integrin Biologics for IBD patients<div>Drug Name:{{c1::Vedolizumab\n(Entyvio)}}</div><div> {{c1::Slow}} acting&nbsp;</div><div> {{c1::IV}} administered</div><div> {{c1::Good}} efficacy&nbsp;</div><div> {{c1::Very few}} side effects<br><div><br></div></div>",
                        "<img src=\"paste-e137da2c0499e34f58c7d3191720c5073a791963.jpg\">"
                    ],
                    "guid": "D+TNtPW]ep",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-cytokine biologics in IBD<div>Drug Name:&nbsp;{{c1::Ustekinumab (Stelara)}}</div><div> Combines IL-{{c1::12/23}}</div><div> Derived from many types of\nimmune cells</div><div> Elevated in many inflammatory\ndiseases</div><div> Stimulate {{c1::Th1}} and {{c1::Th17}}\nsignalling&nbsp;</div><div> Monoclonal anti-{{c1::p40}} subunit</div><div> Good efficacy&nbsp;</div><div> Well tolerated&nbsp;</div><div> First dose {{c1::IV}} then SC<br></div>",
                        "<img src=\"paste-49d6a82bda0677d16d9eaab0aea03fc49a72bc98.jpg\">"
                    ],
                    "guid": "O!4O:h@8LU",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Vomiting<div><br></div><div>GI Irritation:&nbsp;</div><div>Cytotoxic Drugs, Radiation &amp; other GI irritants release 5-HT from the\n{{c1::enterochromaffin}} cells&nbsp;</div><div>\nStimulation of the {{c::15-HT3}} Receptors present on vagal afferents</div><div>\nStimulation of {{c1::CTZ&nbsp;}}</div><div>\nVomiting<br></div><div><br></div><div>Vestibular Irritation:</div><div>-The vestibular apparatus generates impulses when body is\nrotated or {{c1::equilibrium}} is disturbed or when {{c1::ototoxic}} drugs\nact.&nbsp;</div><div>-These impulses reach the vomiting centre mainly relayed by\nthe {{c1::M}} and the {{c1::H1}}\nreceptors.&nbsp;</div><div>-Various sensory stimuli such as bad odour, ghastly sight,\nsevere pain as well as fear cause {{c1::nausea}} and vomiting by\ndirect stimulation of higher centres<br></div>",
                        "CTZ=Chemoceptor trigger zone<div><img src=\"paste-e463ac68b4c3d6bf86769a48fab0e5038e923531.jpg\"><br></div>"
                    ],
                    "guid": "t&&F!<`+3N",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Vomiting Mediators and Receptors</div>5-HT: an important mediator involved in such\nsignals, many other mediators and peptides are also\ninvolved.&nbsp;<div><br></div><div>The CTZ expresses a variety of receptors e.g.\nHistamine H{{c1::1}}\n, Dopamine D{{c1::2}}\n, Cholinergic M, Opioid u and the Serotonin 5-HT{{c1::3}}\nreceptors, through which\nthe emetic signals are relayed.</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "P2O=UI*mhD",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Anticholinergics,&nbsp;H1 Antihistamines,&nbsp;Neuroleptics,&nbsp;D2 Receptor Antagonist,&nbsp;5-HT3 Receptor Antagonist,&nbsp;Others<br></div><div><br></div><div> {{c1::D2 Receptor Antagonist}}: Domperidone, Metoclopramide&nbsp;<br></div><div> {{c1::Neuroleptics}}: Chlorpromazine, Haloperidol</div><div> {{c1::Anticholinergics}}: Hyoscine, Dicyclomine&nbsp;<br></div><div> {{c1::Others}}: Dexamethasone, BZD, Cannabinoids<br></div><div> {{c1::H1 Antihistamines}}: Promethazine, Cyclizine, Diphenhydramine, Cinnarizine<br></div><div> {{c1::5-HT3 Receptor Antagonist}}: Ondansetron, Granisetron&nbsp;<br></div><div><br></div>",
                        ""
                    ],
                    "guid": "G~E%%,93U4",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anticholinergics<div>Hyoscine is an effective drug for\n{{c1::motion sickness&nbsp;}}</div><div> Blocks {{c1::muscarinic}} receptors</div><div> suitable for short journeys</div><div> blocks the conduction of nerve impulses\nacross a cholinergic link pathway\nleading from the {{c1::vestibular apparatus}} to\nthe vomiting centre.&nbsp;</div><div> anticholinergic side effects such as {{c1::dry\nmouth}} and {{c1::sedation}}</div>",
                        ""
                    ],
                    "guid": "CD_[-bT+j;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "H1 Antihistamines&nbsp;<div>Promethazine, Diphenhydramine&nbsp;</div><div> Anticholinergic, antihistaminic and {{c1::sedative}}\neffects&nbsp;</div><div> Protect from motion sickness for {{c1::4-6}} hrs.&nbsp;</div><div> {{c1::Cyclizine}}, {{c1::Meclizine}}, are less sedative&nbsp;</div><div> {{c1::Meclizine}} has a long duration of action used\nin sea sickness.</div>",
                        ""
                    ],
                    "guid": "mg~(U2=vAX",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Neuroleptics&nbsp;<div>prochlorpromazine&nbsp;</div><div>-Potent {{c1::antiemetics}}&nbsp;</div><div>-Block {{c1::D2}} receptors in the CTZ.&nbsp;</div><div>-Broad spectrum antiemetic effect and is\nuseful in&nbsp;</div><div> Drug induced and postanaesthetic {{c1::nausea}} and\nvomiting&nbsp;</div><div> Vomiting due to diseases: {{c1::gastroenteritis}},\nmigraine etc.&nbsp;</div><div> {{c1::Hyperemesis gravidarum}}</div><div>-Second line agents&nbsp;</div><div>-Sedation++</div>",
                        ""
                    ],
                    "guid": "r`_liF.^H?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "D2 receptor antagonist:&nbsp;<div>-Metoclopromide&nbsp;<div> It increases GI {{c1::peristalsis}} leading\nto increased gastric emptying&nbsp;</div><div><br></div><div> The tone of {{c1::lower oesophageal\nsphincter}} is increased&nbsp;</div><div><br></div><div> ADR&nbsp;</div><div>&nbsp; &nbsp;  sedation, dizziness, movement\ndisorders (extrapyramidal)&nbsp;</div><div>&nbsp; &nbsp;  acute {{c1::dystonias}} eg spasmodic torticollis&nbsp;</div><div>&nbsp; &nbsp;  {{c1::occulogyric}} crisis&nbsp;</div><div>&nbsp; &nbsp;  Managed with antihistamines eg\ndiphenhydramine&nbsp;</div><div><br></div><div> Long term use can cause\n{{c1::Parkinsonism}} (tardive dyskinesia)&nbsp;</div><div><br></div><div>-Domperidone&nbsp;</div><div>&nbsp; &nbsp; &nbsp; Similar but does not cross BBB – fewer\nside effects but less&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;effective&nbsp;<br></div><div>&nbsp; &nbsp; &nbsp; Associated with long {{c1::QT}} Syndrome</div></div>",
                        "<b>Oculogyric crisis</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;refers to spasms of extraocular muscles leading to tonic eye deviation</span>"
                    ],
                    "guid": "iMg6Wc&n)Q",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>5-HT3 Receptor Antagonists<br></div><div><br></div>Very effective in treating {{c1::Cancer\nChemotherapy/Radiotherapy}} induced vomiting&nbsp;<div><br></div><div>It is effective in vomiting due to any cause\n&nbsp;</div><div><br></div><div>Blocks the emetogenic impulses both at their\nperipheral origin and their central relay.\n&nbsp;</div><div><br></div><div>It has no {{c1::DA}} blocking effects\n&nbsp;</div><div><br></div><div>It is given {{c1::orally}} or {{c1::i.v}}\n&nbsp;</div><div><br></div><div>Generally well tolerated and very few side effects\n&nbsp;</div><div><br></div><div>Granisetron is {{c1::10}} times potent than Ondansetron</div>",
                        ""
                    ],
                    "guid": "ekH/K5GGA+",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Constipation usually the result of {{c1::slow colonic}} transit (lazy\nbowel)&nbsp;<div> Intermittent constipation is best prevented with a {{c1::high fibr}}e\ndiet, adequate fluid intake, regular exercise&nbsp;</div><div><br></div><div> Those not responding to the above measures should be\nmedically evaluated before started on laxatives</div>",
                        ""
                    ],
                    "guid": "zuakqU~yT!",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Does it cause constipation?<div>Opioid analgesics?&nbsp;{{c1::yes}}</div><div>Cationic Drugs?&nbsp;{{c1::yes}}</div><div>Anionic Drugs?&nbsp;{{c1::its not in the lecture so we'll say no}}</div><div>NSAID Drugs?&nbsp;{{c1::Nah}}</div><div>Calcium Channel blockers&nbsp;{{c1::Yes}}</div><div>Cholinergic&nbsp;{{c1::No, anti-cholinergic}}</div>",
                        ""
                    ],
                    "guid": "P!-Ih1~d.:",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Bulk Forming Laxatives&nbsp;<div><br></div><div> Indigestible, hydrophilic colloids that absorb\nwater, forming a bulky {{c1::emollient gel}} that\ndistends the colon and promotes {{c1::peristalsis}}&nbsp;</div><div><br></div><div> Natural plant products:&nbsp;</div><div>-{{c1::Psyllium}} husk&nbsp;</div><div>-{{c1::Methylcellulose}}&nbsp;</div><div><br></div><div> Synthetic fibres – Polycarbophil&nbsp;</div><div><br></div><div> ADR of these preparations include {{c1::bloating of\nabdomen}}</div>",
                        ""
                    ],
                    "guid": "PM~A<T(QDI",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Stool Softeners&nbsp;<div> Soften the stool material, permitting {{c1::water}} and {{c1::lipids}}\nto penetrate&nbsp;</div><div><br></div><div> They are administered {{c1::orally}} or {{c1::rectally}}.&nbsp;</div><div><br></div><div> Common agents</div><div>-Docusate (orally and as an enema)&nbsp;</div><div>-{{c1::Glycerine}} suppository&nbsp;</div><div><br></div><div> Mineral oil is a clear, viscous oil which lubricates\nfaecal material, retarding water absorption from the\nstool (for treating faecal impaction in {{c1::children}})</div>",
                        ""
                    ],
                    "guid": "rdXTI1Q`f@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Osmotic Laxatives&nbsp;<div> Osmotic laxatives are soluble but {{c1::nonabsorbable}}\ncompounds&nbsp;</div><div>&nbsp;-result in increased stool liquidity due to an increase in faecal\nfluid&nbsp;</div><div><br></div><div> Magnesium oxide – to be used with caution in patients with\n{{c1::renal}} impairment (may cause {{c1::hypermagnesemia}})&nbsp;</div><div><br></div><div> Sorbitol &amp; Lactulose –&nbsp;</div><div>-Treatment of {{c1::chronic}} constipation&nbsp;</div><div>-Metabolized by the colonic bacteria&nbsp;</div><div>-May cause severe {{c1::flatus}} and {{c1::cramps}}</div>",
                        ""
                    ],
                    "guid": "N?#)l&&Kdx",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Motility stimulant&nbsp;<div> Prucalopride&nbsp;</div><div>-{{c1::5HT4}} agonist&nbsp;</div><div>-Stimulates colonic\nsmooth muscle\n{{c1::contraction&nbsp;}}</div><div>When is it used?&nbsp;{{c1::The other treatments have failed}}</div>",
                        "<img src=\"paste-e95f601c181141294f3fb2a4ab05a57ff748b8ef.jpg\">"
                    ],
                    "guid": "m[a%Y<J7n*",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "WHen should anti-diarrhoetic drugs NOT be used?",
                        "When there is stool in the diarrhoea"
                    ],
                    "guid": "F,Iw,U1`#k",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Opioid Agonists (for diarrhoea)<div><br></div><div> These agents have significant constipating effects&nbsp;</div><div><br></div><div> Inhibition of {{c1::pre}}synaptic cholinergic nerves in {{c1::submucosal}} and\n{{c1::myenteric}} plexus and lead to increased colonic transit time.&nbsp;</div><div>-Loperamide&nbsp;&nbsp;</div><div>-{{c1::Diphenoxylate&nbsp;}}</div><div><br></div><div> Less CNS effect than conventional opiates, why?&nbsp;{{c1::Doesn't usually cross the BBB}}</div><div><br></div><div> At higher than recommended doses, CNS effects can occur&nbsp;</div><div><br></div><div> Codeine can also be used (morphine pro-drug)</div>",
                        ""
                    ],
                    "guid": "H@qYQ<XY6U",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-cholinergics (for diarrhoea)<div><br></div><div>Atropine&nbsp;</div><div><br></div><div> Combined with opioids in certain pharmaceutical preparations</div><div>-Low dose&nbsp;</div><div>-Uncertain benefit at such low doses&nbsp;</div><div><br></div><div>What happnes at doses sufficient to inhibit diarrhoea?&nbsp;{{c1::Many bad side effects Dry mouth, tachycardia, sedation}}</div><div><br></div>",
                        ""
                    ],
                    "guid": "O=rr/X;&h9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "969eadd5-7dd0-11eb-9fbb-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "1ad708726cb340fabbd48a89a486f940-ao-1-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-1-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-2-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-2-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-3-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-3-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-4-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-4-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-O.svg",
                "paste-0df824779fe0fd45e809249e1e283d49489e328f.jpg",
                "paste-4a5a63dedccb023ede42c065be9707f2979c8937.jpg",
                "paste-4aadf770ecaa2186ef02bc180460e81420380e28.jpg",
                "paste-833c5702fc009736b1ec143329d762ce03850f30.jpg",
                "paste-f351da7749cb8c28dcaf7246b7ed24f940bb1b97.jpg",
                "tmpye0sogmy.png"
            ],
            "mid": 1602236504918,
            "name": "03/02 GIT Pharm, Ulcers",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Peptic Ulcer Disease:<div><br></div><div>Three areas where ulcers occur in it;&nbsp;{{c1::Esophagus}}(due to acid reflux),&nbsp;{{c1::stomach}} and{{c1::small intestine}} .</div><div><br></div><div>Most common symptom of PUD is&nbsp;{{c1::a gnawing pain}} &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<br></div>",
                        ""
                    ],
                    "guid": "nm[%*`@jFw",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "PUD: Pathogenesis&nbsp;<div><br></div><div>Normal defences against ulcers T/F</div><div><br></div><div>Peristalsis&nbsp;{{c1::F}}</div><div>Mucus&nbsp;{{c1::t}}</div><div>Cell renewal&nbsp;{{c1::t}}&nbsp;</div><div>Blood flow&nbsp;{{c1::t}}<br></div><div>Secretin&nbsp;{{c1::f}}</div><div>Cytokines&nbsp;&nbsp;{{c1::f}}</div><div>Bicarbonate layer&nbsp;&nbsp;{{c1::t}}</div><div>Sphincters&nbsp;&nbsp;{{c1::f}}</div><div>Prostaglandins&nbsp;{{c1::t}}<br></div><div>Cell renewal&nbsp;&nbsp;{{c1::t}}</div><div><br></div><div>Pathogenic Factors:</div><div><br></div><div>Most Common:</div><div>{{c1::helicobacter}} infection and&nbsp;{{c1::NSAIDs}}<br></div><div><br></div><div>Least Common:&nbsp;</div><div>Excess {{c1::Acid}}<br></div><div><br></div><div><br></div><div>ULCER OCCURS WHEN&nbsp;{{c1::PATHOGENIC}} FACTORS OUTWEIGH&nbsp;{{c1::DEFENSES}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "rQ;)x1WMa8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-0df824779fe0fd45e809249e1e283d49489e328f.jpg\"><div>Helicobacter&nbsp;{{c1::Pylori}}</div><div><br></div><div>Gram&nbsp;{{c1::negative}} bacillus</div><div>Causes&nbsp;{{c1::Chronic Gastritis}}</div><div><br></div><div>Present in most patients with a non-NSAID linked&nbsp;{{c1::duodenal}} Ulcer</div><div><br></div><div><br></div><div><br></div>",
                        "H. pylori infection is detectable before the occurrence of DU\nand appears to be a risk factor for the disorder.<div><br></div><div>Eradication of H. pylori prevents disease recurrence<br></div>"
                    ],
                    "guid": "lKCwHKk&uA",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "PUD and NSAIDs<div><br></div><div>NSAIDs decrease protective {{c1::prostaglandin}} production in the\nstomach (systemic effect)<br></div><div><br></div><div>Maybe additional direct irritant effect (local effect)<br></div>",
                        ""
                    ],
                    "guid": "q^Ek|?*<`J",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is a Gastrinoma?<div>What disease causes Gastrinomas?</div><div>How can Gastrinomas cause Peptic Ulcers?</div>",
                        "Gastrin secreting tumour<div>Zollinger-Ellison Syndrome</div><div>Gastrin is acidic and excess acid causes ulcer.</div>"
                    ],
                    "guid": "j7qs<7X]:?",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-1",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-1-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "G>ztJ7ogmd",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-2",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-2-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "L<I5nGhZEp",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-3",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-3-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "to[n/dzM-q",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-4",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-4-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "q-hhml@QYB",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The Three Gastric Acid Secretagogues are<div>{{c1::Histamine}}: Produced by&nbsp;{{c1::M}} cells</div><div>{{c1::Ach}}: Produced by&nbsp;{{c1::Cholinergic}} Nerves<br></div><div>{{c1::Gastrin}}: Delivered via Blood vessels<br></div>",
                        "<img src=\"paste-4aadf770ecaa2186ef02bc180460e81420380e28.jpg\">"
                    ],
                    "guid": "nED1=O+X[A",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Inhibition Of Gastric Acid:<div><br></div><div><b>ANTACIDS</b>:</div><div><br></div><div>-{{c1::Neutralizes}} Gastric Acids and {{c1::raises}} pH</div><div><br></div><div>-Contains:</div><div>&nbsp; &nbsp; &nbsp; &nbsp;{{c1::Magnesium}} salts,which can cause diarrhoea</div><div>&nbsp; &nbsp; &nbsp; &nbsp;{{c1::Aluminium}} salts, which can cause constipation</div><div>&nbsp; &nbsp; &nbsp; &nbsp; {{c1::Sodium Hydroxide}}</div><div>Most preparations use various anatacids together.</div><div><br></div><div><b>H2 receptor antagonists&nbsp;</b></div><div><br></div><div> {{c1::Competitive}} antagonists of the receptor&nbsp;</div><div><br></div><div> Inhibit {{c1::basal acid}} secretion&nbsp;</div><div><br></div><div> Decrease acid secretion in response to&nbsp;</div><div>- Histamine&nbsp;</div><div>- Gastrin&nbsp;</div><div>- Acetylcholine&nbsp;</div><div>Why?&nbsp;{{c1::All have an effect on m cells}}</div><div><br></div><div> Examples&nbsp;</div><div>- {{c1::Cimetidine}}&nbsp;</div><div>- {{c1::Ranitidine}}<br></div><div>Very Effective</div><div><br></div><div><b>Proton pump inhibitors</b><br></div><div><br></div><div>Irreversible inhibition of the {{c1::H+/K+-ATPase (the proton pump}})&nbsp;</div><div><br></div><div>&nbsp;Final common pathway of basal and induced acid secretion&nbsp;</div><div><br></div><div>Are administered as {{c1::prodrugs}}</div><div><br></div><div>Weak bases, accumulate in the acid environment of the canaliculi of\nthe stimulated parietal cell where they are activated</div><div><br></div><div>Examples:&nbsp;{{c1::Omeprazole, lansoprazole, rabeprazole}} (3)</div><div><br></div><div><br></div>",
                        "Antacid example:&nbsp;Maalox:\nEach 5 ml of oral solution contains:\nAluminium hydroxide 175mg\nMagnesium hydroxide 200mg<div><br></div><div><img src=\"paste-833c5702fc009736b1ec143329d762ce03850f30.jpg\"><br></div>"
                    ],
                    "guid": "y(mL?C-&z0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Cimetidine and ranitidine&nbsp;<div><br></div><div> {{c1::High}} oral bioavailability&nbsp;</div><div> Usually given twice daily&nbsp;</div><div> Low side effect profile :{{c1::Diarrhoea}} and {{c1::Rash}}&nbsp;</div><div><div> Available OTC&nbsp;</div><div> Renal excretion – reduce dose in renal insufficiency</div></div><div><br></div><div>Cimetidine inhibits {{c1::CYP450&nbsp;}}</div><div> Drug interactions (Higher {{c1::Warfarin}} and {{c1::TCA}} levels)&nbsp;</div><div><br></div>",
                        ""
                    ],
                    "guid": "QC<m#WC(M9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Omeprazole&nbsp;<div> Best taken 30 minutes before a meal&nbsp;</div><div> Also IV&nbsp;</div><div><br></div><div> Adverse effects are {{c1::Very well}} tolerated:&nbsp;</div><div> {{c1::Diarrhoea&nbsp;}}</div><div> {{c1::Allergic skin rash&nbsp;}}</div><div><br></div><div> S-enantiomer available also (esomeprazole)&nbsp;</div><div> Metabolized by {{c1::CYP2C19}}</div>",
                        ""
                    ],
                    "guid": "bKhGIs8?!s",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Proton Pump Inhibitors have a half life of 1-1.5 hours, yet their duration of action is 24-36 hours, how?",
                        "Canalicular trapping by protonation (weak base in an acidic pH)&nbsp;<div> Irreversible inhibition of H+/K+ ATPase so requires Requires new pump synthesis to start secreting acid again.</div>"
                    ],
                    "guid": "ILf8Zoi``,",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The recurrent rate of PUD is &gt;&nbsp;{{c1::30%}}<div><br></div><div>Requires long-term {{c1::H2RA}} or {{c1::PPI}} therapy</div><div><div><br></div></div>",
                        " Expense&nbsp;<div> Inconvenience&nbsp;</div><div> Potential for side effects</div>"
                    ],
                    "guid": "dq(zhLFuz}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1. Antacids block gastric acid\nsecretion&nbsp;<div>2. Cimetidine inhibits the final\ncommon pathway for acid\nsecretion&nbsp;</div><div>3. Acid inhibition causes\nmalabsorption&nbsp;</div><div>4. Omeprazole has a long\nplasma half life, explaining\nits 24h duration of action&nbsp;</div><div>5. Omeprazole is trapped in\nthe parietal cell and\nirreversibly inhibits the\nproton pump</div>",
                        "5. Omeprazole is trapped in\nthe parietal cell and\nirreversibly inhibits the\nproton pump"
                    ],
                    "guid": "n%u3iN+&nU",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "H. pylori eradication<div><br><div>{{c1::multi}} drug regimens<br></div></div><div><br></div><div>Answer Penicillin tolerant, penecillin allergic or both to treatrment options</div><div><br></div><div>Metronidazole&nbsp;{{c1::PCN allergic}}<br></div><div>Clarithromycin&nbsp;{{c1::both}}</div><div>Amoxicillin&nbsp;{{c1::PCN tolerant}}</div><div>PPI&nbsp;{{c1:: Both}}</div><div><br></div><div>7-14 days</div><div>{{c1::80-90}}% eradication rate.<br></div>",
                        " Variable efficacy&nbsp;<div> Gradual increase in prevalence of drug-resistant strains</div>"
                    ],
                    "guid": "HQD)Kps}:`",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>NSAIDs</b>&nbsp;&nbsp;<div>Aspirin and Non-aspirin anti-inflammatory pain killers&nbsp;</div><div> Used to treat pain, especially arthritic pain&nbsp;</div><div><br></div><div> Block the actions of {{c1::cyclo-oxygenase}}&nbsp;</div><div> {{c1::↓}} levels of PGE2&nbsp;</div><div> {{c1::↓}} Mucous and bicarbonate secretion&nbsp;</div><div>&nbsp;{{c1::increase}} acid production</div><div><br></div><div>To mitigate this you use&nbsp;</div><div><b>Misoprostol</b><br></div><div><b><br></b></div><div> Stable analogue of {{c1::PGE2}}&nbsp;</div><div> Oral – produces high concentration at gastro-duodenal\nmucosa&nbsp;</div><div> Mitigates harmful effects of NSAIDs on {{c1::PG}} production in\nstomach&nbsp;</div><div> Decreases rate of NSAID-induced {{c1::ulceration&nbsp;}}</div><div> Usefulness limited by\n {{c1::Diarrhoea}}\n Effects on {{c1::cervix}}<b><br></b></div>",
                        ""
                    ],
                    "guid": "NKi&:<F5`t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1. Peptic ulcers can be caused by an\ninfection with H pylori&nbsp;<div>2. Eradication of H pylori with 2\nantibiotics and a PPI is 100%\neffective&nbsp;</div><div>3. Misoprostol blocks prostaglandin\nreceptors&nbsp;</div><div>4. NSAIDs decrease gastro-protective\nprostaglandins&nbsp;</div><div>5. PPIs are available over the counter</div>",
                        "2 and 3 smh Larry"
                    ],
                    "guid": "ehx0t>3i1o",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Gastro-oesophageal reflux disease</b>&nbsp;<div> Incompetence of {{c1::lower\noesophageal sphincter}} (obesity,\ndrugs, heredity…….)&nbsp;</div><div> Reflux of acidic gastric contents\ninto lower oesophagus</div><div> Heartburn&nbsp;</div><div><br></div><div> Complications&nbsp;</div><div>&nbsp; &nbsp; -{{c1::Stricture&nbsp;}}</div><div>&nbsp; &nbsp; -{{c1::Barretts oesophagus &amp; cancer}}</div><div><br></div><div>Diagnosis:&nbsp;</div><div> {{c1::Heartburn}} symptoms&nbsp;</div><div> Reflux oesophagitis&nbsp;</div><div><br></div><div> Gold standard test</div><div>&nbsp;-24 hour oesophageal pH</div><div>&nbsp;-{{c1::De Meester}} score<br></div>",
                        "<div><img src=\"paste-f351da7749cb8c28dcaf7246b7ed24f940bb1b97.jpg\"><br></div><img src=\"paste-4a5a63dedccb023ede42c065be9707f2979c8937.jpg\">"
                    ],
                    "guid": "j|#%5|3!Q4",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "GORD: Treatment&nbsp;<div> Prevent acid reflux&nbsp;</div><div> Weight loss, drug avoidance, elevate head of bed etc&nbsp;</div><div> Surgical {{c1::fundoplication&nbsp;}}</div><div> Increase tone of {{c1::LOS&nbsp;}}</div><div><br></div><div> Medical&nbsp;</div><div> Suppress gastric acidity (requires chronic therapy)&nbsp;</div><div> {{c1::PPI}} or {{c1::H2RA}}<br></div>",
                        ""
                    ],
                    "guid": "U-Zk|]xw?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13665ee2-948a-11eb-971c-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-2c6d1a0e917bf340f56af66d6997d02564bdbbac.jpg",
                "paste-6e3250f7d98c3ae816a51e6065c47512f2f52393.jpg",
                "paste-b00dffe6f2f58c1ab8a50b3b588f5904bb60bad2.jpg"
            ],
            "name": "03/19 NSAIDS",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Name the 3 dimensions of experience of pain,<div>{{c1::Sensory/discriminative&nbsp;<div>Motivational/affective&nbsp;</div><div>Cognitive/evaluative}}</div></div>",
                        ""
                    ],
                    "guid": "PS%qOZ?tl0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the two types of chronic pain?<div>{{c1::inflammatory and neuropathic}}<br></div>",
                        ""
                    ],
                    "guid": "L{sl=kgSjt",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Ascending pain pathway:</b><div><br></div><div>The painful stimulus is picked up by&nbsp;{{c1::C nociceptor}} and&nbsp;{{c1::A delta nociceptor}} (types of receptor)</div><div><br></div><div>The nerve enters the spinal cord in the&nbsp;{{c1::dorsal horn}}</div><div>It then decussates and ascends in the&nbsp;{{c1::spinothalamic}} tract</div><div><br></div><div>It passes through the&nbsp;{{c1::brainstem}} and&nbsp;{{c1::midbrain}} before synapsing at the&nbsp;{{c1::VP}} or&nbsp;{{c1::IL}} nuclei of the thalamus.<br><br></div><div>The pathway then divides into 3 pathways, leading to the&nbsp;{{c1::somatosensory cortex}},{{c1::cingulate cortex}} and&nbsp;{{c1::limbic system}}</div><div><br></div><div>Is it a substant released from adamged cells? Y/N</div><div>Bradykinin</div><div>Haemoglobin</div><div>Cations</div><div>Anions</div><div>Free radicals</div><div>Histamine</div><div>Choline</div><div>Prostanoids</div><div>Purines</div><div>Serotonin</div><div>GABA</div><div>Tachykinins</div><div><br></div><div>{{c1::everything except Hb, anions, GABA and choline}}<br><div><b><br></b></div></div>",
                        "<img src=\"paste-6e3250f7d98c3ae816a51e6065c47512f2f52393.jpg\">"
                    ],
                    "guid": "NB6|Q$!o$|",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Descending Pain Pathway<div>Begins at the {{c1::Periaqueductal grey matter}} and synapses in the {{c1::Nucleus Raphe Magnus}}, is carried by {{c1::A beta}} afferent fibres<br></div>",
                        "<img src=\"paste-b00dffe6f2f58c1ab8a50b3b588f5904bb60bad2.jpg\">"
                    ],
                    "guid": "mwl682iT.l",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What does NSAID stand for?{{c1::Non Steroidal Anti Inflammatory Drugs}}<div><br></div><div>Weaker or stronger than opiates?&nbsp;{{c1::weaker}}</div>",
                        ""
                    ],
                    "guid": "JF^l:!k4P9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give two other beneficial actions of NSAIDs&nbsp;{{c1::Anti-inflammatory\nAnti-thrombotic\nAnti-pyretic\nAnti-cancer (}}(4)",
                        ""
                    ],
                    "guid": "xUkwJBxp4z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "This One's hard&nbsp;<div>Do it or don't, but like its here if you want it</div><div><br></div><div>Acetic Acid NSAIDs</div><div>{{c1::Diclofenac</div><div>Etodolac</div><div>Indomethacin</div><div>Sulindac</div><div>Tolmetin}} (5)</div><div><br></div><div>Fenamate NSAIDs</div><div>{{c1::Meclofenamate</div><div>Meclofenamic Acid}} (2)</div><div><br></div><div>Naphthylalkanone</div><div>{{c1::Nabumetone}} (1)</div><div><br></div><div>Oxicam</div><div>{{c1::Piroxicam</div><div>Meloxicam}} (2)</div><div><br></div><div>Propionic Acid</div><div>{{c1::Fenoprofen</div><div>Flurbiprofen</div><div>Ibuprofen</div><div>Ketoprfen</div><div>Naproxen</div><div>Oxaproxen}} (6)</div><div><br></div><div>Salicylate</div><div>{{c1::Aspirin</div><div>Diflunisal}} (2)</div><div><br></div><div>Choline Magnesium Trisalicylate</div><div>{{c1::Salsalate}} (1)</div><div><br><div><br></div></div>",
                        ""
                    ],
                    "guid": "OCu]C5UQ2t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "NSAIDs inhibit&nbsp;{{c1::Cycloxygenase}} (COX)<div><br></div><div>COX-1 has&nbsp;{{c1::Homeostatic}} Functions</div><div>Give 2 examples of this function,{{c1::fxn on GI tract, Renal Tract, Platelet finction and Macrophage differentiation}} (4)</div><div><br></div><div>COX-2 has {{c1::inflammatory&nbsp;}} functions</div><div>Specifically the production of&nbsp;{{c1::prostaglandins}}</div><div><br></div><div>Traditional NSAIDs block&nbsp;{{c1::both}} COX channels</div><div>COX-2 inhibitors are&nbsp;{{c1::too big}} so cannot be used on COX-1 channels</div>",
                        "<img src=\"paste-2c6d1a0e917bf340f56af66d6997d02564bdbbac.jpg\">"
                    ],
                    "guid": "g:!K/vs[<O",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give three advantages of Prostaglandin inhibition,<div>{{c1::Analgesia</div><div>Antipyresis</div><div>Anti-inflammatory</div><div>Antithrombotic</div><div>Closure of ductus arteriosus}} (5)<br></div><div><br></div><div>Give three disadvantage of prostaglandin inhibition,</div><div>{{c1::Gastric mucosal damage</div><div>Bleeding,due to platelet problems</div><div>Limitations of renal blood flow</div><div>Prolongation of labour</div><div>Asthma and anaphylactoid reactions in susceptible individuals}} (5)<br></div><div><br></div><div> Prostaglandins themselves do not cause pain but they\npotentiate the pain producing effects of\nother inflammatory mediators such as\n{{c1::5-HT}} and {{c1::Bradykinin}}<br></div>",
                        ""
                    ],
                    "guid": "hGvgeD&r5d",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Other Benefits of NSAIDs apart from Analgesia.<div><b>ANTIPYRESIS&nbsp;</b></div><div> NSAIDs {{c1::reduce}} body temperature in {{c1::fever}} but do\nnot cause {{c1::hypothermia}}&nbsp;</div><div> Fever during infection is produced through the\ngeneration of pyrogen {{c1::ILs}}, {{c1::TNF}}, {{c1::Interferons&nbsp;}}</div><div> Induction of PG in {{c1::hypothalamus}} raises body\ntemperature</div><div><br></div><div><b>Anti-inflammatory action&nbsp;</b></div><div> The most important mechanism of anti-inflammatory action of NSAIDs is {{c1::inhibition\nof PGs at the site of injury&nbsp;}}</div><div><br></div><div> The anti-inflammatory potency of\ncompounds corresponds to their potency\nto inhibit {{c1::COX}}&nbsp;<br></div><div><br></div><div><b>Actions in dysmenorrhoea&nbsp;</b></div><div> Role of PG in dysmenorrhoea has been clearly\ndemonstrated\n The levels of {{c1::PGF2alpha}}(specific pg) are raised in\ndysmenorrhoeic women&nbsp;</div><div> NSAIDs lower uterine PG levels and afford\nsignificant relief in {{c1::60-70}} % of patients&nbsp;</div><div> The ancillary symptoms of dysmenorrhoea such\nas {{c1::headache}}, {{c1::backache}} and {{c1::nausea}} are also\nrelieved<br></div><div><br></div><div>What is Dysmenorrhoea?&nbsp;{{c1::period pains}}</div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "J.t.,co-C0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Aspirin&nbsp;<div>{{c1::Acetylsalicylic}} acid&nbsp;</div><div>Analgesic&nbsp;</div><div>Anti-{{c1::pyretic}}&nbsp;</div><div>Anti-{{c1::inflammatory}}&nbsp;</div><div>Inhibits {{c1::platelet aggregation}}&nbsp;</div><div>causes irreversible inactivation of {{c1::COX-1&nbsp;}}</div><div>Oral, {{c1::rapid}} absorption, 75 % metabolism in\nliver&nbsp;</div><div>Half life = {{c1::4}} hours</div>",
                        ""
                    ],
                    "guid": "7{RT1c~.B",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Bad Effects of NSAIDs<div><br></div><div><b>Antiplatelet action</b>&nbsp;</div><div> NSAIDs inhibit the pro-aggregatory {{c1::TXA2&nbsp;}}</div><div> Bleeding time is {{c1::prolonged&nbsp;}}</div><div> Aspirin is highly active, acetylates {{c1::platelet\nCOX}} irreversibly&nbsp;</div><div> Small doses are able to exert\n{{c1::antithrombotic}} effect for {{c1::several days}} (how long)<br></div><div><br></div><div><b>Gastric mucosal damage</b><br></div><div>Defieciency of Prostaglandins decreases the amount of&nbsp;{{c1::mucus}} and&nbsp;{{c1::HCO3-}} so gastric mucosal damage happens<br></div><div><br></div><div>Give two effects of Gastric mucosal damage of NSAIDs</div><div>{{c1::Gastric pain, mucosal erosion, ulceration and\nblood loss}}<br></div><div><br></div><div>Two ways to counteract this</div><div>1.&nbsp;{{c1::Acid secretion}} inhibition by using {{c1::PPIs or H2RA}}</div><div><br></div><div>2.&nbsp;{{c1::PG}} analogues, such as&nbsp;{{c1::misoprostol}}</div><div><br></div><div><b>Renal Effects</b></div><div>Do healthy individuals have to worry about the renal ADRs of NSAIDs? {{c1::nah man}}</div><div><br></div><div>What conditions would make someone at risk for the renal ADRs of NSAIDs?</div><div>{{c1::CHF,\nhypovolemia, hepatic cirrhosis and renal\ndisease}}<br></div><div><br></div><div>The effects are due to inhibition of&nbsp;{{c1::Prostaglandins}} synthesis</div><div><br></div><div><b>Normal ADRs at Analgesic doses:</b></div><div><b><br></b></div><div>-{{c1::nausea, vomiting and epigastric distress}}(3) (relating to GI tract)<br></div><div><br></div><div>-Blood loss in stool</div><div><br></div><div>-{{c1::rash, worse asthma, fixed drug eruptions}} (3) (relating to hypersensitivity)</div><div><b><br></b></div><div><b>Salicylism</b><br></div><div>{{c1::Anti-inflammatory}} doses cause a\nsyndrome called as salicylism&nbsp;</div><div> Dizziness, {{c1::tinnitus}}, vertigo, {{c1::reversible}}\nimpairment of hearing&nbsp;</div><div> Mental confusion and {{c1::hyper}}ventilation can\noccur<b><br></b></div><div><br></div><div><b>Acute salicylate poisoning</b></div><div>More common in kids or adults?</div><div>{{c1::kids}}<br></div><div><br></div><div>What is the adult fatal dose?&nbsp;{{c1::15-30g}}</div><div><br></div><div>Is it an effect of ASP?</div><div><br></div><div>dehydration,&nbsp;</div><div>vomiting,</div><div>diarrhoea</div><div>electrolyte disturbances,&nbsp;</div><div>frequent urination,</div><div>restlessness and\ndelirium, hallucinations,</div><div>chest pain</div><div>convulsions&nbsp;&nbsp;</div><div>coma<br></div><div>{{c1::everything except diarrhoea, chest pain and frequent urination}}<br></div><div><br></div><div>Death is due to {{c1::respiratory failure}} and\n{{c1::cardiovascular collapse}}<br></div>",
                        ""
                    ],
                    "guid": "dk:[0+l:9f",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Precautions and CI&nbsp;<div> Contraindicated in hypersensitive and {{c1::peptic\nulcers&nbsp;}}</div><div> Chronic {{c1::liver disease }}</div><div> Aspirin should be stopped {{c1::1 week}} before\nsurgery&nbsp;</div><div> During pregnancy may cause premature\nclosure of {{c1::ductus arteriosus&nbsp;}}</div><div> Administration during pregnancy also may\ncause {{c1::low birth weight}} babies&nbsp;</div><div> Should be avoided in {{c1::breast feeding}} women</div>",
                        ""
                    ],
                    "guid": "NRa+Fmna4i",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Is it a non-specific COX inhibitor or a COX-2 specific?<div>Rofecoxib<br></div><div>Ibuprofen&nbsp;</div><div>Celecoxib<br></div><div>Diclofenac&nbsp;</div><div>Etoricoxib<br></div><div>Indomethacin&nbsp;</div><div>Valdecoxib<br></div><div>Mephenamic acid&nbsp;</div><div>Piroxicam&nbsp;</div><div>Ketorolac<br></div><div><br></div><div>{{c1::Celecoxib\n Etoricoxib&nbsp;Rofecoxib&nbsp;Valdecoxib are all COX-2 }}<br></div>",
                        ""
                    ],
                    "guid": "gjDA=<HD:N",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Paracetemol<div>&nbsp;•{{c1::Weak}} inhibitor of COX-1 and COX-2&nbsp;</div><div>•Analgesic&nbsp;</div><div>•Anti-{{c1::pyretic&nbsp;}}</div><div>•{{c1::Very weak}} anti-inflammatory effects&nbsp;</div><div>•Lacks gastrointestinal side effects&nbsp;</div><div>•Metabolized in {{c1::liver}}, half life = {{c1::2-4}}\nhours&nbsp;</div><div>•Hepatotoxic in very high doses</div>",
                        ""
                    ],
                    "guid": "QHnZk[Ac*V",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Advantages of COX-2 Specific Analgesics?<div>Even at {{c1::high doses}} they have less effect\non the {{c1::gastric mucosa&nbsp;}}</div><div> {{c1::Tolerability}} is better than the older NSAIDs&nbsp;</div><div> Longer duration of action (half-life {{c1::11-13}}\nhrs&nbsp;<br></div>",
                        ""
                    ],
                    "guid": "E)-|.WNH!}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        " Rofecoxib was withdrawn due to its\nassociation with higher cardiovascular\nincidents:<div><br></div><div>Increase {{c1::BP}}\nIncreased {{c1::risk of MI}}\n{{c1::Thromboembolism}}<br></div>",
                        ""
                    ],
                    "guid": "z6hL=[|;@T",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13671026-948a-11eb-a4ed-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-679c4995006fba3d8c59324008eb0184a1599db4.jpg",
                "paste-70e8c6027bb30a08b10dcce76ec56a063aa16298.jpg"
            ],
            "name": "03/20 OPioids",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Natural opium alkaloids: {{c1::Morphine,\ncodeine}} (2)<div>Semisynthetic opiates:\n{{c1::diacetylmorphine (Heroin)}} (1)</div><div>Synthetic opiates: {{c1::Pethidine, fentanyl,\ntramadol, methadone and\ndextropropoxyphene}}(5)</div>",
                        ""
                    ],
                    "guid": "pwkA?4)aUh",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "All opioid receptors are&nbsp;{{c1::g-protein coupled}} receptors<div><br></div><div>{{c1::mu}} receptors are responsible for most analgesic effects opioids as well as some additional affects<br></div><div><br></div><div>{{c1::delta}} receptors are more important in the\nperiphery<br></div><div><br></div><div>{{c1::kappa}}receptors are responsible for analgesia\nat the spinal level<br></div>",
                        ""
                    ],
                    "guid": "I=?mFISepe",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Endogenous opioid peptides</b>&nbsp;<div><br></div><div> These are peptides with opiate like pharmacological effects&nbsp;</div><div><br></div><div> There are four types of EOPs&nbsp;</div><div>{{c1::<div>1. Enkephalin&nbsp;</div><div>2. Dynorphin&nbsp;</div><div>3. Endorphin&nbsp;</div><div>4. Endomorphin</div>}}<br></div>",
                        ""
                    ],
                    "guid": "sH.f6D_|Uq",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Pain modulation: Descending inhibitory pathway</b><div><b><br></b></div><div>Opioids can act on the&nbsp;{{c1::periaquaductal grey matter}}, the {{c1::medulla}}, or spinal cord to activate the Desc. Inhib. pathway.</div>",
                        "<img src=\"paste-70e8c6027bb30a08b10dcce76ec56a063aa16298.jpg\"><div><img src=\"paste-679c4995006fba3d8c59324008eb0184a1599db4.jpg\"><br></div>"
                    ],
                    "guid": "Oha@,HY~dv",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CNS Effects of Morphine:</b><div><b><br></b></div><div>{{c1::<div>Analgesia<b><br></b></div><div><br></div><div>Euphoria<br></div><div><br></div><div>Sedation<br></div><div><br></div><div>Respiratory Depression</div>}}(4)<br></div><div><br></div><div><br></div><div><br></div><div>Some questions,</div><div>Does morphine effect the sensory or emotional components of pain?{{c1::both}}</div><div><br></div><div>T/F&nbsp;</div><div>There is severe amnesia associated with morphine use{{c1::f}}</div><div>The respiratory center in the brain is acted on by morphine{{c1::t}}</div><div>Patients on morphine frequently feel a floating sensation{{c1::t}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "DpACU2-L$8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Non-CNS actions of Opioids:</b><div><b><br></b></div><div>-Anti-tussive:&nbsp;{{c1::cough suppression}}</div><div>{{c1::codeine}} is very effective in this action<br></div><div><br></div><div>-{{c1::constriction}} of pupils</div><div><br></div><div>-{{c1::truncal}} rigidity:&nbsp;{{c1::intensification of tone in large trunk muscle}}</div><div>Can interfere with&nbsp;{{c1::ventilation}}</div><div>Usually due to high doses of lipid&nbsp;{{c1::soluble}} opioids like&nbsp;{{c1::fentanyl, sulfentanil}}(2)</div><div><br></div><div>-{{c1::Nausea and vomiting}}(learned about this in drugs and disease)</div><div>Due to&nbsp;Opioid receptors that are present in the {{c1::CTZ}}</div><div><br></div><div>-Vaso{{c1::dilation}}</div><div>Due to both depression of\n{{c1::vasomotor}} center and due to release of\n{{c1::histamine}}<br></div><div>This can cause Bradycardia, but does the heart stay bradycardiac? And why?&nbsp;{{c1::vasodilation and bradycardia lead to hypotension which causes reflex tachycardia , so heart actually becomes tachycardiac}}</div><div><br></div><div>-Constipation</div><div>Due to {{c1::Spasm}} of {{c1::pyloric}} and {{c1::ileocaecal}} sphincters and a&nbsp;{{c1::decrease}}&nbsp;in all intestinal secretions</div><div>What does this mean for opioid addicts?{{c1::its never easy to take a poo}}</div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        "Release of histamine can be due to allergic affect"
                    ],
                    "guid": "Fp-%XEYT_m",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>MORPHINE</b><div>Oral absorption of Morphine is unreliable, why?{{c1::high\nfirst pass metabolism&nbsp;}}</div><div>T/F and if false give corrct answer</div><div>Morphine is widely distributed&nbsp;{{c1::t}}<br></div><div>Enters the brain within minutes {{c1::f v slowly}}</div><div>Does not enter placental barrier{{c1::f yes and quickly}}</div><div>Morphine-4-glycosulfide is the active metabolite{{c1::f Morphine-6-glucuronide}}</div><div>Most morphine is excreted in 24 hrs{{c1::t}}<b><br></b></div>",
                        ""
                    ],
                    "guid": "vfE`O:tOq!",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "ADRs of Morphine<div> {{c1::Sedation, mental clouding, lethargy&nbsp;}}(CNS 3)</div><div> {{c1::Vomiting }}(GIT1)</div><div> {{c1::Urinary retention, constipation&nbsp;}}(Excretion 2)</div><div> Idiosyncracy and allergy</div>",
                        ""
                    ],
                    "guid": "j&zfBqH$fm",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>MORPHINE POISONING:</b><div>acute lethal dose of humans is {{c1::250}} mg<b><br></b></div><div>{{c1::50}} mgs produces\nsevere toxicity<br></div><div><br></div><div><b>Treatment</b></div><div>-Respiratory support&nbsp;</div><div>-Maintenance of {{c1::BP}}</div><div>-Gastric lavage: {{c1::stomach pumping}}</div><div>-Specific antidote-&nbsp;</div><div>Name:{{c1::Naloxone}}&nbsp;</div><div>Dose: {{c1::0.4-0.8}} mg every 2-3 minutes until respiration picks up</div><div>Administration:&nbsp;{{c1::IV}}</div>",
                        ""
                    ],
                    "guid": "C[5<Y=C)Ay",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Morphine Addiction:</b><div>High degree of {{c1::tolerance}} and dependence is\nnoted with morphine<b><br></b></div><div>Addicts can tolerate morphine in {{c1::grams}}(unit of measurement)<br></div><div>Morphine produces both {{c1::physiological}} and\n{{c1::psychological}} dependence<br></div><div><br></div><div>Manifestations of withdrawal are:</div><div>lacrymation:&nbsp;{{c1::crying}}</div><div>sweating,</div><div>&nbsp;yawning,</div><div>&nbsp;anxiety,&nbsp;</div><div>fear,&nbsp;</div><div>restlessness,&nbsp;</div><div>goose flesh:&nbsp;{{c1::permanent goosebumps}}</div><div>mydriasis, :{{c1::<span style=\"color: rgb(32, 33, 36);\">unusual dilation or widening of the pupils</span>}}</div><div>tremor,&nbsp;</div><div>insomnia,&nbsp;</div><div>abdominal colic, :{{c1::<b>abdominal</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;pain characterized by sudden onset and cessation</span>}}</div><div>diarrhea,</div><div>&nbsp;dehydration&nbsp;</div><div>rise in BP</div>",
                        ""
                    ],
                    "guid": "lDbKIKYd]-",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>{{c1::Fentanyl-}}&nbsp;</div><div>80-100 times more potent\nthan morphine&nbsp;</div><div> Short duration of action&nbsp;</div><div> IV, IT, transdermal&nbsp;</div><div> Used in anaesthesia with droperidol<br></div><div><br></div><div><br></div><div><br></div><div>{{c1::Heroin&nbsp;}}<br></div><div> It is {{c1::diacetylmorphine}}&nbsp;</div><div> 3 times more potent than morphine&nbsp;</div><div> More lipid soluble and so enters brain rapidly&nbsp;</div><div> More euphorient and has high addiction liability&nbsp;</div><div> Has less prominent sedative and emetic effect<br></div><div><br></div><div><br></div><div>{{c1::Pethidine (Meperidine)&nbsp;}}</div><div> Was synthesized as an atropine\nsubstitute in 1939&nbsp;</div><div> Chemically unrelated to morphine but has\nsimilar actions&nbsp;</div><div> Has a very good analgesic action&nbsp;</div><div> Poor cough suppressant action&nbsp;</div><div> Given i.m. and onset of action is very rapid&nbsp;</div><div> Used for postoperative pain relief and\nduring labour<br></div><div><br></div><div><br></div><div><br></div><div>{{c1::Codeine&nbsp;}}<br></div><div> It is {{c1::methyl morphine}}, occurs naturally in\nopium and is partly converted into\nmorphine</div><div> It is less potent than morphine&nbsp;</div><div> Selective cough suppressant&nbsp;</div><div> Has good oral bioavailability</div>",
                        ""
                    ],
                    "guid": "E>BI:VwS=_",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Pethidine: ADR&nbsp;<div> Overdose of pethidine causes many excitatory\neffects&nbsp;</div><div>Tremors,&nbsp;</div><div>mydriasis:&nbsp;{{c1::unusual dilation of pupils}}</div><div>hyperreflexia:{{c1::<span style=\"color: rgb(32, 33, 36);\">overactive or overresponsive reflexes</span>}}</div><div>delirium,&nbsp;</div><div>myoclonus:{{c1::sudden muscle spasm}}</div><div>convulsions.&nbsp;</div><div><br></div><div> This is due to accumulation of its metabolite\n{{c1::norpethidine}}</div>",
                        ""
                    ],
                    "guid": "b:{eR)yOqH",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Other opioid analgesics&nbsp;<div> Tramadol&nbsp;</div><div> Tapentadol&nbsp;</div><div> Buprenorphine</div><div>&nbsp; Meptazinol</div><div>Oxycodone&nbsp;</div><div> Hydrocodone wasn't really sure how to go about this one</div><div>{{c1::g}}<br></div>",
                        ""
                    ],
                    "guid": "H))gw%e7oQ",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Adjuvant Analgesics</b>&nbsp;<div> Defined as {{c1::drugs with other indications\nthat may be analgesic in specific\ncircumstances}}&nbsp;</div><div> Numerous drugs in diverse classes&nbsp;</div><div> Multipurpose or specific for {{c1::neuropathic}}\npain<br></div><div><br></div><div>Antidepressant Adjuvant Analgesics:{{c1::amitriptyline, desipramine,\nnortriptyline, duloxetine,\nvenlafaxine, paroxetine}}(6)</div><div><br></div><div>Alpha-2 adrenergic agonists:{{c1::tizanidine, clonidine}}<br></div><div><br></div><div>Corticosteroids:{{c1::prednisone,\ndexamethasone}}(2)<br></div><div><br></div><div>Good anti-covulsants:{{c1::gabapentin, pregabalin,}}(2)</div><div><br></div><div>Reasonable Anti-convulsants:{{c1::valproate, lamotrigine\nphenytoin, carbamazepine,\nclonazepam, topiramate,\ntiagabine, levetiracetam\noxcarbazepine,}}(10)</div><div><br></div><div>Local anesthetics: {{c1::mexiletine, tocainide}}<br></div>",
                        ""
                    ],
                    "guid": "LRIr<W4gjs",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "1367fa01-948a-11eb-a584-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [],
            "mid": 1602236504918,
            "name": "03/21 Dympna Pain",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "If a patient comes into to you with intense pain, what would your initial route of administration be?&nbsp;{{c1::continous subcutaneous infusion, because you know exactly how much will be absorbed}}<div><br></div><div>How long should oxynorm and morphine work for?{{c1::4-6 hours}}</div><div><br></div><div>Ask patient if opioids are working and for how long</div><div><br></div><div>What extra drugs would you give to patients on opioids?{{c1::anti-emetic and laxatives}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "AV?vi@i0E+",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give 4 drugs used for the treatment of cancer pain in ireland<div>{{c1::ketamine, methadone, NSAIDs, Steroids, Paracetamol, Tapentadol}}(6)<br></div><div><br></div><div>Cancer pain can be both&nbsp;{{c1::psychological and physiological}}</div><div><br></div><div>It is important to find the source of pain</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "Lc$:po.JUo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "If a pateint on opioids gets full relief for 2 hours what is there perfect dose",
                        "Double that",
                        ""
                    ],
                    "guid": "pH/iA.{JSt",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How common is it to be allergic to opioids?",
                        "Incredibly rare",
                        ""
                    ],
                    "guid": "n=(!E3$;Q/",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is a rescue drug?",
                        "Drug you take as needed if normal pain relief isn't enough",
                        ""
                    ],
                    "guid": "CT>@F32i/a",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What drug has no metabolites, is excretdby the GI tract, and has a neuropathic NMDA fxn?",
                        "Methadone",
                        ""
                    ],
                    "guid": "iy}/Xl*H9D",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cancer Pain:</b><div><div>Treatment is;</div>\n<div><span style=\"font-weight: bold;\">Individual</span></div>\n<div>Constantly reviewed</div>\n<div>Titrated safely</div></div><div><br></div><div><br></div>{{c1::55}}% of all cancer patients have pain<div>{{c1::66}}% of patients with advanced metastatic cancer have pain</div><div><br></div><div>Drugs used in cancer pain,{{c1::Ketamine</div>\n<div>Methadone</div>\n<div>NSAIDs</div>\n<div>Steroids</div>\n<div>Paracetamol</div>\n<div>Tapentadol}}(6)</div>",
                        ""
                    ],
                    "guid": "AnZ]$HBHYS",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13685abc-948a-11eb-91c2-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-40535901d48a17ed27ec950248dfc3c040ea181d.jpg",
                "paste-e6b57c55602ea7f904bfdc18833c43f9a816e5d2.jpg"
            ],
            "name": "03/22 Local Anaesthetics",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>What class of anaesthesia?</b></div><div><br></div><div>{{c1::• General Anaesthesia}}: loss of sensory perception of the entire body<br></div><div><br></div>{{c1::Local Anaesthesia}}: loss of sensory\nperception over a small area of the body&nbsp;<div><br></div><div>{{c1::• Regional Anaesthesia:}}: loss of sensation over\na specific region of the body (e.g. lower trunk)&nbsp;</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "qidy}FE&XV",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Local Anesthetics (History)</b>&nbsp;<div><br></div><div>• Local anaesthetics - {{c1::reversibly}}&nbsp;block conduction along\nnerve fibers&nbsp;</div><div><br></div><div>•Can produce anaesthesia w/o loss of {{c1::consciousness}}.&nbsp;</div><div><br></div><div>•In the beginning there was {{c1::cocaine •}}</div><div><br></div><div>{{c1::Procaine}} - the first synthetic ester LA (1905)&nbsp;</div><div><br></div><div>{{c1::•Lidocaine}} - the first “amide” LA (1943)</div>",
                        ""
                    ],
                    "guid": "D~hg1A5}OD",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Amide or Ester?</div>– Cocaine<div>– Bupivacaine&nbsp;</div><div>– Mepivacaine&nbsp;</div><div>– Ropivacaine&nbsp;<div>– Procaine&nbsp;</div><div>– Benzocaine&nbsp;</div><div>– Tetracaine&nbsp;</div><div>– Lidocaine&nbsp;</div><div>{{c1::all with two i's are amides}}<br></div></div><div><br></div><div>All local anasthetics have a&nbsp;{{c1::lipophillic}}and&nbsp;{{c1::hydrophillic}} portions, joined by either a ester or amide linkage</div><div><br></div><div>What LA isn't ionic at body pH?&nbsp;{{c1::benzocaine}}</div>",
                        "<img src=\"paste-e6b57c55602ea7f904bfdc18833c43f9a816e5d2.jpg\">"
                    ],
                    "guid": "C:JH3MXSPu",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Answer long action, short action, surface action and whether they're esters or amides<div><br></div><div>Lidocaine</div><div>Xylocaine&nbsp;{{c1::m,a}}</div><div><br></div><div>procaine</div><div>novocaine{{c1::sh,e}}</div><div><br></div><div>benzocaine</div><div>cocaine{{c1::su,e}}</div><div><br></div><div>tetracaine{{c1::l ,e}}</div><div><br></div><div>bupivacaine</div><div>ropivacaine{{c1::l,a}}</div>",
                        ""
                    ],
                    "guid": "j=n;txrN,G",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Esters - hydrolyzed by plasma (&amp; liver)\n{{c1::pseudocholinesterase}}&nbsp;<div>– {{c1::P-aminobenzoic acid}} (PABA) can cause\nallergic rxns (relatively rare)&nbsp;</div><div><br></div><div>• Amides - hepatic metabolism&nbsp;</div><div>– Liver damage. &amp; {{c1::decreased}} hepatic blood flow, {{c1::increased}} toxicity</div>",
                        ""
                    ],
                    "guid": "tD_;@ItRw,",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T/F<div>The LA hydrophobic pathway involves access of nerve sodium channels from nerve cell cytoplasm&nbsp;{{c1::false, thats hydrophillic, hydrophobic is within cell membrane}}</div><div>Extracellular acidosis decreases LA effect{{c1::true}}</div><div>Hydrophillicity increases potency and duration of action{{c1::false, hydrophobicity}}</div><div>Bupivacaine&gt;lidocaine&gt;procaine in terms of potency{{c1::true}}</div><div><br></div><div>Explain Use/Frequency Block{{c1::LA is more effective when nerve is firing rapidly, so more pain makes LA work better}}</div>",
                        "<img src=\"paste-40535901d48a17ed27ec950248dfc3c040ea181d.jpg\">"
                    ],
                    "guid": "x+vk;g]C.K",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "LAs block conduction in which order:<div><br></div><div>nonmyelinated axons{{c1::2}}<br></div><div>Small myelinated axons{{c1::1}}<br></div><div>large myelinated\naxons{{c1::3}}<br></div><div><br></div><div><br></div><div>Order of sensory function block<br></div><div><br></div><div>• {{c1::1.}} pain&nbsp;</div><div>• {{c1::2.}} cold&nbsp;</div><div>• {{c1::3.}} warmth</div><div>• {{c1::4.}} touch</div><div>• {{c1::5.}} deep pressure&nbsp;</div><div>• {{c1::6.}} motor<br></div>",
                        ""
                    ],
                    "guid": "tIX1_)q,%q",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "• Numbness of {{c1::tongue}} &amp; {{c1::mouth}}&nbsp;<div>• <font color=\"#aa0000\">Behavioral &amp; sensory disturbances\n– ringing in ears, metallic taste, tingling\nsensations&nbsp;</font></div><div>• Seizures ({{c1::tonic clonic}}(type))&nbsp;</div><div>• Depression / Loss of {{c1::Consciousness&nbsp;}}</div><div>• {{c1::Respiratory}} Failure&nbsp;</div><div>• Arrhythmias*,hypotension, CV Collapse&nbsp;</div>",
                        ""
                    ],
                    "guid": "ze?8|Tf;wG",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "1368f581-948a-11eb-96ae-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-08e3eedd068308b54f2fcd399067951507c37afd.jpg",
                "paste-1d622ba9751021e17c01f31249d21a1b9575db38.jpg",
                "paste-3ad9601b849df4ce928d087ba84b4d80814e25f0.jpg"
            ],
            "mid": 1602236504918,
            "name": "03/23 General Anaesthetics",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "General Anaesthesia:{{c1::the loss of response to\n&amp; perception of all external stimuli}}<div><br></div><div>Components of General Anaesthesia:\n{{c1::</div><div>• Unconsciousness</div><div>&nbsp;• Analgesia (most GAs are poor analgesics)&nbsp;</div><div>• Attenuation of autonomic responses to painful stimuli&nbsp;</div><div>• Amnesia</div><div>&nbsp;• Immobility (neuromuscular relaxation)}}(5)<br></div><div><br></div><div>Phases of General Anaesthesia&nbsp;</div><div>Induction: {{c1::putting the patient to sleep}}&nbsp;</div><div>Maintenance: {{c1::keeping the patient asleep&nbsp;}}</div><div>Emergence: {{c1::waking the patient up}}<br></div><div><br></div><div>T/F<br>Only drugs with a very specific structure can be a general anaesthetic?{{c1::General anaesthesia\ncan be caused by a\nremarkable number\nof structurally\ndiverse molecules}}</div><div><br></div><div>Briefly what does the Meyer-Overton rule mean?{{c1::The correlation of anaesthetic potency with\nlipid solubility provides a means of predicting\nanaesthetic potency. This correlation has\ntraditionally been interpreted as meaning that\nprimary anaesthetic action sites are lipid portions of\nnerve membranes.}}</div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "C{UhjWN@3p",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The old theory has something to do with lipid bylayers and miracles<div><br></div><div>BUT NOW.... THE MODERN UNDERSTANDING:</div><div><br></div><div>1. Enhanced GABA effect on {{c1::GABAA}} Receptors&nbsp;</div><div>Drugs that do this:</div><div>{{c1::– Inhaled anaesthetics - Etomidate\n– Barbiturates - Propofol\n– Benzodiazepines&nbsp;}}(5)</div><div><br></div><div>2. Block {{c1::nicotinic}} receptor subtypes (analgesia)\n–&nbsp;</div><div>Drugs that do this:Moderate to high concs of {{c1::inhaled anaesthetics&nbsp;}}</div><div><br></div><div>3. Activate {{c1::K+}} channels (hyperpolarize Vm)\n–&nbsp;</div><div>Drugs that do this:</div><div>{{c1:: Nitrous oxide, ketamine, xenon}}(3)<br></div><div><br></div><div>4. Inhibit {{c1::NMDA}} (glutamate) receptors\n–&nbsp;</div><div>{{c1::Nitrous oxide, ketamine, sevoflurane, xenon, high dose\nbarbiturates&nbsp;}}(5)</div><div><br></div><div>5. Inhibit {{c1::synaptic}} proteins&nbsp;</div><div>({{c1::decrease}} NT release)(amnesia)&nbsp;</div><div><br></div><div>6. Enhance {{c1::glycine}} effect on {{c1::glycine}} Receptor’s (immobility)<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "f!-n_b=WSf",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Barbiturates &amp; Benzodiazepines MOA:&nbsp;&nbsp;<div>1) Both bind to {{c1::GABAA}} receptors, at different sites&nbsp;</div><div>• Both cause increase {{c1::Cl}}-influx in presence of GABA</div><div>• Benzodiazepine binding can be blocked by {{c1::flumazenil&nbsp;}}</div><div><br></div><div>2) Barbituates at high doses - are also {{c1::GABA}} mimetic,\nblock {{c1::Na}} channels &amp; {{c1::NMDA}}/glutamate Rs</div><div><br></div><div>T/F</div><div>Barbituates can never send a person beyond the anasthetic state{{c1::f, thats benzos, barbituates can go all the way to coma}}</div>",
                        ""
                    ],
                    "guid": "pbH!gPh7qV",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Parenteral Anaesthetics (Intravenous)&nbsp;<div>– Barbiturates ({{c1::Thiopental* &amp; Methohexital}}(2))&nbsp;</div><div>– Benzodiazepines ({{c1::Midazolam}}(1))&nbsp;</div><div>– Opioids ({{c1::Morphine &amp; Fentanyl}}(2))&nbsp;</div><div>– {{c1::Propofol*&nbsp;}}</div><div>– {{c1::Etomidate}}</div><div><br></div><div>Give two anaesthetics used mainly for induction{{c1::thiopental and propofol}}</div><div><br></div><div><b>Inhaled Anaesthetics&nbsp;</b></div><div>• Easily vaporized liquid {{c1::halogenated}}\nhydrocarbons&nbsp;</div><div>• Administered as gases<br></div><div><br></div><div>Partial pressure or “tension” in inspired air is a\nmeasure of their concentration&nbsp;</div><div>• The speed of induction of anaesthesia depends on:&nbsp;</div><div>&nbsp;{{c1:: -Inspired gas partial pressure (GA concentration)&nbsp;</div><div>– Ventilation rate&nbsp;</div><div>– GA solubility (less soluble GAs equilibrate more\nquickly with blood &amp; into tissues such as the brain) }}(3)<br></div><div><br></div><div>Are inhaled or IV General anaesthetics more common?</div><div>{{c1::IV}}<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "h3{Lgpb`.u",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Classic Stages of Anaesthesia:</b><div><div><br></div><div>&nbsp;• Stage 1: {{c1::Analgesia}}\n– decreased awareness of pain, amnesia&nbsp;</div><div><br></div><div>&nbsp;• Stage 2: {{c1::Disinhibition}}\n– delirium &amp; excitation, enhanced reflexes,\nretching, incontinence, irregular respiration</div><div><br></div><div>&nbsp;• Stage 3: {{c1::Surgical Anaesthesia}}\n– unconscious, no pain reflexes, regular\nrespiration, BP is maintained</div><div><br></div><div>&nbsp;• Stage 4: {{c1::Medullary Depression}}\n– respiratory &amp; CV depression requiring\nventilation &amp; pharmacological support</div></div><div><br></div><div>This is the drug&nbsp;{{c1::ether}}</div>",
                        ""
                    ],
                    "guid": "w$~hLx`z4?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What type up of anasthetic exerts its volume quicker?<div>Highly soluble or Low soluble&nbsp;{{c1::low}}</div><div><br></div><div>Blood:Gas coeffecient is&nbsp;{{c1::proportional}} to rate of which anaesthesia exerts its volume</div><div><br></div><div>Ventilation rate is {{c1::proportional}} to rate of which anaesthesia exerts its volume</div>",
                        "<img src=\"paste-08e3eedd068308b54f2fcd399067951507c37afd.jpg\"><div><img src=\"paste-3ad9601b849df4ce928d087ba84b4d80814e25f0.jpg\"><br></div><div><img src=\"paste-1d622ba9751021e17c01f31249d21a1b9575db38.jpg\"><br></div>"
                    ],
                    "guid": "m=ot/>Q9({",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Minimum Alveolar Concentration: {{c1::The alveolar anaesthetic concentration\nrequired to eliminate the motor response to a\npainful stimulus in 50% of patients}}<div><br></div><div>A measure of GA {{c1::potency}}<br></div><div>It’s <font color=\"#aa0000\">“a population average”</font><br></div><div><br></div><div>When several GAs are mixed, their MAC\nvalues are {{c1::additive}}<br></div><div>What does this mean clinically?{{c1::nitrous oxide is\ncommonly mixed w/ other anesthetics}}</div><div><br></div><div>MAC%</div><div>Nitrous Oxide {{c1::&gt;100&nbsp;}}</div><div>Halothane {{c1::0.75}}&nbsp;</div><div>Methoxyflurane {{c1::0.16}}<br></div><div><br></div><div>MAC values are very useful:&nbsp;</div><div>•Allow easy {{c1::comparison}} of anaesthetics&nbsp;</div><div>•Easily {{c1::measured&nbsp;}}</div><div>•Important clinical endpoints&nbsp;</div><div>•Consistent and reproducible<br></div>",
                        ""
                    ],
                    "guid": "I+$A=aIj}V",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Elimination&nbsp;</b><div><br></div><div>&nbsp;• Anaesthesia is most commonly terminated by {{c1::redistribution\nof drug from brain to the blood &amp; out through the lungs}}.</div><div><br></div><div>&nbsp;• The rate of recovery from anaesthesia for GAs with low\nblood:gas PCs is {{c1::faster}} than for highly soluble Gas.</div><div><br></div><div>&nbsp;- Time is $$ in the O.R. &amp; recovery room&nbsp;</div><div><br></div><div>Blood:Gas PCoeff&nbsp;</div><div>Halothane {{c1::2.30&nbsp;}}</div><div>Desflurane {{c1::0.42&nbsp;}}</div><div>Sevoflurane {{c1::0.69}}</div><div><br></div><div>&nbsp;• {{c1::Halothane}} &amp; {{c1::methoxyflurane}} undergo hepatic metabolism\n&amp; can cause {{c1::liver}} toxicity</div><div><br></div><div>•Margin of safety very small&nbsp;</div><div>•TI: {{c1::2-4}}</div><div>&nbsp;•dose that produces circulatory failure may be {{c1::2-4X}} that for anesthesia&nbsp;</div><div>•Most dangerous drugs in use<br></div>",
                        ""
                    ],
                    "guid": "L*`+0Vt,zt",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>NMJ Blockers</b><div>•Drug names: {{c1::Succinylcholine}}, {{c1::Pancuronium}}&nbsp;</div><div>• Used to:\n– relax skeletal muscle\n– facilitate intubation**\n– ensure immobility&nbsp;</div><div>• Effects of Pancuronium can be reversed\nby {{c1::neostigmine*}} &amp; {{c1::glycopyrrolate*}}\nduring post-op period</div>",
                        ""
                    ],
                    "guid": "gb7?P:r63%",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13696a73-948a-11eb-93ff-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-13ce0d8ee78adde84df5cabb9cfb31a786e3a24d.jpg",
                "paste-1c60af787d2cc4ed5d4c683acdaf1d1c6810e8be.jpg",
                "paste-4cf616574eb517bd77dca52115982aabe88067ec.jpg",
                "paste-6226ed517b45b8fa32c4c64dc3ed4fb35f6b8d56.jpg",
                "paste-8b6d95ecdf67ae73a02cc2839b3562024aea5f69.jpg",
                "paste-9a233c952032603f4deaed9320c063eaa8224660.jpg",
                "paste-9c70b49f9bfd143789a2c862bbc2f4031c108701.jpg",
                "paste-a852427b74fe84afe8c863f5a48baf7259d78220.jpg",
                "paste-ae0cbbe8139587244ef8f7e8088f91c0029e40a6.jpg",
                "paste-bcab73c4ac083b2e719a76abd4ef0462b98e5ac9.jpg",
                "paste-c48f0b3405c8ca1878ea2b2328090a5099e2c0c6.jpg",
                "paste-cb4c48e204b2f3e767d981a521ba30f62722cd47.jpg",
                "paste-d8bf984b8aa087d3fc7388f7faa643ac41256bbf.jpg",
                "paste-d9090d41dbdb18c7150469ffc8d41ecaec4d9765.jpg",
                "paste-fac2fbe1870d7749967b0f81892f2380b39658e9.jpg"
            ],
            "name": "03/29 Dennedy Diabetes 1",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "DIABETES MELLITUS:{{c1::“Transient or permanent disease state of chronic hyperglycaemia characterised\nby insulin deficiency or insulin resistance or a combination of both.”}}<div><br></div><div>What are the type of drugs/treatment one would use for insulin deficiency?</div><div>{{c1::insulin, insulin secretagogues}}(2)<br></div><div><br></div><div>What type of drugs/treatment one would use for insulin resistance?</div><div>{{c1::insulin sensitizers}}<br></div><div>&nbsp;</div><div>type 1 diabetes is an {{c1::autoimmune}} mediated condition<br></div><div><br></div><div>What genetic defects will cause diabetes?&nbsp;</div><div>{{c1::GENETIC DEFECTS IN BETA CELL FUNCTION&nbsp;</div><div>GENETIC DEFECTS IN INSULIN ACTION}}(2)</div><div><br></div><div>Endocrinopathies that cause diabetes?{{c1::cushings and acromegally}}(2) What type?&nbsp;{{c1::insulin resistant}}</div><div><br></div><div>Exocrine pancreas diseases that cause diabetes?{{c1::chronic pancreatitis, alcoholism and cystic fibrosis}}(3) What type?&nbsp;{{c1::insulin deficient}}</div><div><br></div><div>The chronic administration of what type of drug may cause diabetes?&nbsp;{{c1::corticosteroids}}</div><div><br></div><div>When is a woman likely to get diabetes?{{c1::when pregnant}}</div>",
                        ""
                    ],
                    "guid": "pqT6YI-K4N",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Type 1 diabetes is always insulin&nbsp;{{c1::deficient}}<div>Type 2 diabetes is always insulin&nbsp;{{c1::resistant}}</div><div><br></div><div>T/F&nbsp;</div><div>Type 2 diabetes can be both insulin deficient and resistant&nbsp;{{c1::t}}</div><div>Why?{{c1::as disease progresses insulin making stuff goes to shit}}</div><div><br></div><div>A patient presents with slow onset chronic insulin deficiency, type 1 or type 2?</div><div>{{c1::Type 1}}<br></div><div>What is the name of this condition?</div><div>{{c1::latent autoimmune diabetes of Adulthood (LADA)}}<br></div><div><br></div><div>What mutations are monogenic diabetes associated with?{{c1::germ line mutations}}</div><div><br></div><div>Is gestational diabetes type 1 or type 2?{{c1::usually type 2 but can be type 1}}</div><div>Is maturity onset diabetes of the young type 1 or 2&nbsp;{{c1::2}}</div><div><br></div><div>How would one get secondary diabetes mellitus?{{c1::from another disease such as an endocrinopathy or a pancreas problem}}.</div>",
                        "<img src=\"paste-8b6d95ecdf67ae73a02cc2839b3562024aea5f69.jpg\">"
                    ],
                    "guid": "Q?;Z8me<j{",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the three parameters you look at when dagnosing diabetes?<div>{{c1::FASTING GLUCOSE&nbsp;</div><div>POST-PRANDIAL GLUCOSE&nbsp;</div><div>HBA1C(glycosylated haemoglobin)}}(3)</div><div><br></div><div>What would you do to determine the aetiology of the diabetes?</div><div>{{c1::PROPER CLINICAL &amp; DRUG HISTORY&nbsp;</div><div>CLINICAL EXAMINATION&nbsp;</div><div>CALCULATION OF INSULIN RESISTANCE&nbsp;</div><div>AUTO-ANTIBODY TESTING</div><div>&nbsp;SPECIFIC GENETIC TESTING&nbsp;</div><div>SPECIFIC EVALUATION FOR ENDOCRINOPATHY}}(6)<br></div><div><br></div><div>Specific genetic testing should have been one of those, but you only do it if you suspect a specific type of diabetes, which one?{{c1::MODY}}</div><div><br></div>",
                        "HBA1c= how much Hb has a glucose moiety attached to it<div>post prandial= after eating</div><div><img src=\"paste-9c70b49f9bfd143789a2c862bbc2f4031c108701.jpg\"><br></div><div><br></div><div><br></div>"
                    ],
                    "guid": "y0:_NgIN(`",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Insulin:<div>{{c1::Peptide}} hormone</div><div>Synthesised, packaged and released from\n{{c1::pancreatic islets - β-cells}}.</div><div>Glucose Dependent Secretion<br></div><div><br></div><div>As it is a peptide hormone it cannot be&nbsp;{{c1::orally}} administered</div><div><br></div><div>Endogenous insulin is released into&nbsp;{{c1::portal}} circulation</div><div>Synthetic insulin is released into&nbsp;{{c1::systemic}} circulation</div><div><br></div><div>Proinsulin consists of an a,b and c chain</div><div>In insulin {{c1::a}} and {{c1::b}} chains are connected through&nbsp;{{c1::s=s}}bonds and the&nbsp;{{c1::c}} chain is cleaved</div><div><br></div><div>Therefore, what is a good indicator that patient taking synthetic insulin is starting to make their own insulin again?{{c1::the c chain}}</div>",
                        "<img src=\"paste-c48f0b3405c8ca1878ea2b2328090a5099e2c0c6.jpg\">"
                    ],
                    "guid": "D#qYM!r]Ia",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Endogenous Insulin Secretion:</b><div>Secreted into {{c1::portal circulation}}<b><br></b></div><div>{{c1::60}}% undergoes hepatic 1st pass metabolism<br></div><div><br></div><div>Step 1: Glucose enter&nbsp;{{c1::pancreatic}} cell through&nbsp;{{c1::GLUT 2}} channels.</div><div><br></div><div>Step 2: Glucose is broken down to&nbsp;{{c1::Glucose-6-Phosphate}} by {{c1::glucokinase}}(enzyme)</div><div><br></div><div>Step 3: ATP is formed through metabolism</div><div><br></div><div>Step 4: ATP opens&nbsp;{{c1::potassium}} channels</div><div><br></div><div>Step 5: The depolarization of the cell caused by the opening of&nbsp;{{c1::k}} channels, opens&nbsp;{{c1::Calcium}} channels.</div><div><br></div><div>Step 6: The influx of&nbsp;{{c1::calcium}} causes insulin to be released</div><div><br></div><div>In brief:</div><div>{{c1::Glucose}} stimulates the release of insulin.&nbsp;</div><div>{{c1::Glucagon}} inhibits its release.&nbsp;</div><div>Counter-regulatory hormones modulate the function of insulin<br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-13ce0d8ee78adde84df5cabb9cfb31a786e3a24d.jpg\"><div><img src=\"paste-d9090d41dbdb18c7150469ffc8d41ecaec4d9765.jpg\"><br></div>"
                    ],
                    "guid": "vmAeo7U.t1",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The insulin receptor:<div><br></div><div>TWO SUBUNITS&nbsp;</div><div>Alpha - {{c1::Binds Insulin&nbsp;}}</div><div>Beta - {{c1::Tyrosine Kinase}}<br></div><div><br></div><div>Bound together by&nbsp;{{c1::disulfate}} bonds</div><div><br></div><div>Phosphorylation cascade is triggered and 4 things happen</div><div><br></div><div>{{c1::Liberation GLUT 4</div><div>Glycogen Synthesis (Glycogen Synthase)&nbsp;</div><div>TG Synthesis (Acetyl CoA Carboxylase, LPL)&nbsp;</div><div>Inhibits lipolysis}}<br></div>",
                        "<img src=\"paste-cb4c48e204b2f3e767d981a521ba30f62722cd47.jpg\">"
                    ],
                    "guid": "f[CB|I;W:>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>INSULIN RELEASE PATTERNS</b><div><br></div><div>CONSTANT BASAL RELEASE OF INSULIN:<b><br></b></div><div>Inhibits hepatic {{c1::gluconeogenesis&nbsp;}}</div><div>Prevents excessive {{c1::lipid}} breakdown<br></div><div>{{c1::prevents}}&nbsp;glycogenolysis<br></div><div>Prevents {{c1::Ketosis}}<br></div><div><br></div><div>INCREASED RATES OF INSULIN RELEASE IN RESPONSE TO\nCHO / GLUCOSE i.e. after eating</div><div><br></div><div>Promotes {{c1::glucose utilization&nbsp;}}</div><div>Promotes {{c1::glycogenesis}}<br></div>",
                        "<img src=\"paste-bcab73c4ac083b2e719a76abd4ef0462b98e5ac9.jpg\">"
                    ],
                    "guid": "eX,c<+g>{t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THERAPY OF DIABETES MELLITUS&nbsp;<div><br></div><div>AIMS OF THERAPY&nbsp;</div><div>1. Restore physiological patterns of insulin release or increase insulin release ({{c1::if insulin deficient}})</div><div>2. Restore sensitivity of target organs to insulin action&nbsp;</div><div>3. Replace insulin where it is completely deficient.. What type of diabetes would this occur in?{{c1::all type 1, pancreatic type 2}}</div><div>4. Reduce glucose by non-insulin dependent mechanisms, what two ways can you do this?{{c1::prevent uptake from GIT, piss it out more}}</div><div><br></div><div>HOW IS THIS ACHIEVED?&nbsp;</div><div>1. Insulin {{c1::secretagogues}} or incretin agents… (type 1)</div><div>2. Insulin {{c1::sensitising}} agents… (type 2)</div><div>3. Insulin in the form of long acting and short-acting insulin or CSII.&nbsp;</div><div>4. Inhibit absorption from GI tract or promote excretion from kidney..</div>",
                        ""
                    ],
                    "guid": "qAps@Uo6$#",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TYPE 1 DIABETES MELLITUS MEANS {{c1::COMPLETE}} INSULIN {{c1::DEFICIENCY}}<div><br></div><div>What sort of therapy should type 1 diabetes be treated with?</div><div>{{c1::insulin therapy}}<br></div><div>How long should the patient be treated for?</div><div>{{c1::for life}}<br></div><div><br></div><div>DRIVEN BY AN AUTO-IMMUNE PROCESS&nbsp;</div><div>-{{c1::Anti-Glutamic Acid Decarboxylase (GAD)}} antibodies&nbsp;</div><div>-Associated with abnormalities of {{c1::HLA-DR3/DR4}}<br></div><div><br></div><div>When do patients generally get diagnosed?</div><div>{{c1::teens or twenties}}</div><div><br></div><div>Biggest complication of Type 1 Diabetes is:</div><div>Diabetic {{c1::ketoacidosis (DKA)}}&nbsp;</div><div><br></div><div>symptoms of which include</div><div>-Weight Loss, why?&nbsp;{{c1::body can't store and use glucose so breaks down fat}}</div><div>-Osmotic Symptoms, give two?&nbsp;{{c1::polydipsia, polyuria }}</div><div>-Dehydrated, why?{{c1::you piss glucose, has a severe diuretic effect}}</div><div>-Acidotic, why?&nbsp;{{c1::ketones are acidic}}</div><div>-Ketosis, why?{{c1::body can't use glucose, so has to use ketones}}<br></div>",
                        ""
                    ],
                    "guid": "QEGOWu82JH",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Insulin Therapy:</b><div><br></div><div>{{c1::Recombinant}} human insulin preparations are used</div><div><br></div><div>WHEN IS IT GIVEN?&nbsp;</div><div>To every patient with {{c1::type 1}} diabetes..&nbsp;</div><div>To most patients with {{c1::secondary}} diabetes..&nbsp;</div><div>To many patients with type {{c1::2}} diabetes..<br></div><div><br></div><div>T/F</div><div>Is given orally&nbsp;{{c1::f, given parenterally}}</div><div>No post prandial doses needed as basal dose is long acting{{c1::f, that's not how insulin works, see endogenous insulin slide for more}}</div><div>Can be administered by patient themselves&nbsp;{{c1::t}}</div>",
                        "<img src=\"paste-1c60af787d2cc4ed5d4c683acdaf1d1c6810e8be.jpg\">"
                    ],
                    "guid": "v1qY_P#d(g",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Does endogenous insulin or injected insulin last longer in the body?<div>{{c1::injected}}<br></div><div>Why?</div><div>{{c1::goes into systemic circulation rather than portal, so no fpm}}<br></div><div><br></div><div>Describe basal-bolus insulin dosage</div><div>{{c1::one or two basal long acting insulin injections, as well as further bolus short acting insulin injections at mealtimes to compensate for raised CHO&nbsp;</div><div><img src=\"paste-a852427b74fe84afe8c863f5a48baf7259d78220.jpg\">}}<br></div><div>What does the basal dosage inhibit?</div><div>{{c1::glycogenolysis and ketosis}}<br></div><div><br></div><div>Describe mixed insulin dosage</div><div>{{c1::two doses of mixed long and short acting insulin</div><div><img src=\"paste-ae0cbbe8139587244ef8f7e8088f91c0029e40a6.jpg\">}}<br></div><div>What patients might need mixed insulin dosage?</div><div>{{c1::those that are elderly, blind forgetful etc.}}<br></div><div><br></div><div>What is the biggest risk with mixed insulin dosage?<br>{{c1::hypoglycemia}}<br></div>",
                        "disclaimer, its very confusing"
                    ],
                    "guid": "v=K=&[r,&W",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How long did the first human recombinant quick acting insulin to work?<div>{{c1::40 minutes and lasted for 6 hours}}<br></div><div><br></div><div>Give three ultra-quick acting insulin and the amino acids that they replace</div><div>{{c1::Insulin Aspart (Pro28 → Asp)</div><div>&nbsp;Insulin Lispro (Pro 28Lys29 Reversed)</div><div>&nbsp;Insulin Glulisine (Asn3 → Lys)}}<br></div><div><br></div><div>Why are certain amino acids replaced?</div><div>{{c1::to form dimers and prevent hexamer formation in the body, easier to be absorbed}}<br></div><div><br></div><div>Fast absorption - {{c1::20}} minutes&nbsp;</div><div>Peak Concentration - {{c1::40}} minutes&nbsp;</div><div>Duration of action - {{c1::2-3}} Hours<br></div><div><br></div><div>What is special about fiasp, the new insulin aspart?</div><div>{{c1::absorbtion in 5 minutes, can even be taken post prandially}}<br></div>",
                        ""
                    ],
                    "guid": "u;q]`L1t)P",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The three peakless, long acting insulins are as follows, how are they be long acting rather than short acting?<div><br></div><div>Insulin Glargine - {{c1::Altered pH - Prolonged absorption&nbsp;}}<br></div><div>Insulin Detemir - {{c1::Albumin Bound - Longer serum t1/2&nbsp;}}</div><div>Insulin Degludec - {{c1::Zn Bound Hexamers then Phenol Bound - ↓ Solubility}}<br></div><div><br></div><div>What is th emost commonly used one?&nbsp;{{c1::degludec}}</div><div><br></div><div>What is their duration of action?&nbsp;{{c1::18 - 36 HOUR DURATION}}</div><div><br></div><div>You would only use intermediate acting insulins in difficult rare cases, give an example of an intermediate acting insulin.</div><div>{{c1::NPH Insulin - Zn Bound ↓ Solubility}}<br></div><div>What is its duration of action?{{c1::10 - 12 HOUR}}</div><div>What is the big risk acssociated with it?&nbsp;{{c1::RISK OF NOCTURNAL HYPOGLYCAEMIA}}</div>",
                        "<img src=\"paste-d8bf984b8aa087d3fc7388f7faa643ac41256bbf.jpg\">"
                    ],
                    "guid": "IsGIj1p(^$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>PROBLEMS WITH INSULIN THERAPY</b><div>{{c1::PARENTERAL}} ADMINISTRATION ROUTE ONLY&nbsp;</div><div><br></div><div>LIPODYSTROPHY :{{c1::<span style=\"color: rgb(32, 33, 36);\">lump or small dent in the skin that forms when a person performs injections repeatedly in the same spot</span>}}</div><div>LIPOHYPERTROPHY :{{c1::<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span><span style=\"color: rgb(32, 33, 36);\">lump under the skin caused by accumulation of extra fat at the site of many subcutaneous injections of insulin</span>}}</div><div><br></div><div>INSULIN ANTIBODIES - INFREQUENT WITH RECOMBINANT INSULINS..&nbsp;</div><div><br></div><div>THERAPY MUST BE CONSTANTLY MONITORED&nbsp;</div><div>Measurement of {{c1::capillary glucose}} - Painful&nbsp;</div><div>Monitoring of {{c1::HbA1c&nbsp;}}</div><div><br></div><div>DOSING IS MEAL DEPENDENT AND DEPENDENT ON PHYSIOLOGIC / PATHOLOGIC STATE\nHYPOGLYCAEMIA&nbsp;</div><div><br></div><div>⇧ APPETITE AND WEIGHT GAIN..<b><br></b></div>",
                        ""
                    ],
                    "guid": "jNCu:e#>*&",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Type 2 starts out as insulin&nbsp;{{c1::resistance}}<div>And progresses to insulin&nbsp;{{c1::deficiency}}</div><div><br></div><div>Type 2 diabetes is&nbsp;{{c1::progressive}} and patients&nbsp;{{c1::gain}} weight</div><div><br></div><div>What microvascular complications will diabetes cause?</div><div>{{c1::neuropathy, nephropathy and retinopathy}}<br></div><div><br></div><div>What macrovascular complications will diabetes cause?</div><div>{{c1::cvd }}<br></div><div><br></div><div>What level of HbA1c is needed for risk of microvascular complications to be reduced?&nbsp;{{c1::6}} %</div><div><br></div><div>T/F<br></div><div>Treatment of type 1 geberally stays the same{{c1::t}}</div><div>Treatment of type 2 generally stays the same{{c1::f}}</div><div><br></div><div>What were the three initial therapies for type 2 diabetes?</div><div>{{c1::Metformin&nbsp;</div><div>Sulphonylurea&nbsp;</div><div>Insulin}}<br></div><div><br></div><div>Why isn't insulin the best treatment for type 2 diabetes?</div><div>{{c1::it cuases weight gain and type 2 diabetres is driven by weight gain}}<br></div>",
                        ""
                    ],
                    "guid": "HM`d2@qC|@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>Insulin Sensitisers:</b></div><div><br></div>What is the best insulin sensitisers?<div>{{c1::weight loss and excercise}}<br></div><div><br></div><div>Pharmaceuticals</div><div>&nbsp;</div><div>{{c1::BIGUANIDES / METFORMIN}}<br></div><div>Targets the mitochondrial respiratory chain and Increases Insulin Receptor TK activity<br></div><div><br></div><div>Advantages:&nbsp;<br></div><div>orally available</div><div>&nbsp;well tolerated</div><div>weight stable</div><div><br></div><div>Disadvantages:<br></div><div>Renal Excretion&nbsp;</div><div>Lactic Acidosis&nbsp;</div><div>GI Symptoms<br></div><div><br></div><div>{{c1::THIAZOLIDINEDIONES}}<br></div><div>Activate PPARγ<br></div><div><br></div><div>Advantages:</div><div>orally available</div><div>reduce HbA1c-0.5-0.8%</div><div><br></div><div>Disadvantages:</div><div>CVS effects</div><div>Fluid retention</div><div>Weight gain (1-2 kg)</div><div><br></div><div><br></div><div><br></div><div>SOME QUESTIONS</div><div>1. Drug 1,&nbsp;Acts through {{c1::OCT-1 / AMPK}} ➞ {{c1::de}}crease Hepatic Gluconeogenesis</div><div><br></div><div>2. Explain how lactic acidosis by using drug 1 could occur.{{c1::if its renally excreted and patient has renal failure then its kept in the body so lactic acidosis occurs}}</div><div><br></div><div>3.&nbsp;PPARγ moa</div><div>-{{c1::Nuclear Orphan}} Receptor&nbsp;</div><div>-Modulates insulin sensitivity through GLUT-{{c1::1}} &amp; GLUT-{{c1::4&nbsp;}}</div><div>-Stimulates {{c1::TAG}} storage in organs through {{c1::AGTL}}&nbsp;</div><div>-Governs first step of {{c1::adipo}}genesis&nbsp;</div><div>-Inhibits Hepatic {{c1::Gluconeo}}genesis<br></div><div><br></div><div>4. What is the specific receptor target of drug 1?{{c1::no one knows}}</div><div><br></div><div>5. Why would drug 2 be contraindicted in a patient with heart failure?{{c1::fluid retention}}</div><div><br></div><div>6. Which is the most commonly used drug for type 2 diabetes{{c1::BIGUANIDES / METFORMIN}}</div><div><br></div><div>7. Give 2 examples of drug 2.{{c1::rosiglitazone, pioglitazone}}</div>",
                        ""
                    ],
                    "guid": "KLvK_)N#,3",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>SULPHONYLUREAS: Insulin&nbsp;</b>{{c1::secretagogues}}<div><br></div><div>Safe and well tolerated oral agents '</div><div>Facilitate closure of {{c1::K-ATP}} channel<br></div><div>{{c1::de}}crease HbA1c ~ {{c1::1.5}}%&nbsp;</div><div>Weight gain&nbsp;</div><div>Significant risk of {{c1::hypoglycaemia}}…<br></div><div><br></div><div>Can it be used for both type 1 and 2&nbsp;{{c1::no just type 2}}</div><div>Why?</div><div>{{c1::needs functioning beta-cells for it to work}}<br></div><div><br></div><div>Pharmacokinetics&nbsp;</div><div>Metabolised in liver ({{c1::P450}} enymes)&nbsp;</div><div>Excreted in liver and kidneys&nbsp;</div><div>Duration of action {{c1::12 - 24&nbsp;}}hours<br></div><div><br></div><div>First Generation:</div><div>&nbsp;{{c1::Tolbutamide &amp; Chlorpropamide}}&nbsp;</div><div>Second Generation:</div><div>&nbsp;{{c1::Glibenclamide &amp; Glipizide}}&nbsp;</div><div>Third Generation: {{c1::Gliclazide}}<br></div><div><br></div><div>Give three drugs that will increase sulphonylureas affect and three that will reduce it</div>",
                        "<img src=\"paste-fac2fbe1870d7749967b0f81892f2380b39658e9.jpg\"><div><img src=\"paste-6226ed517b45b8fa32c4c64dc3ed4fb35f6b8d56.jpg\"><br><div><br></div></div>"
                    ],
                    "guid": "bkw1XCX]dS",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Describe the incretin effect&nbsp;{{c1::release of insuilin is 3x greater with oral glucose than iv glucose}}<div><br></div><div>Incretin Hormones</div><div><br></div><div>GLP-1&nbsp;{{c1::glucagon like peptide 1}}</div><div>Released from&nbsp;{{c1::Terminal Ileum}}</div><div><font color=\"#aa0000\">Post-translational Processing\nPro-Glucagon</font><br></div><div>Degraded by {{c1::DPP-IV}}&nbsp;</div><div>Ubiquitously Expressed on&nbsp;{{c1::White blood cells}}</div><div>T1/2 - 1.5 minutes<font color=\"#aa0000\"><br></font></div><div><font color=\"#aa0000\">Released for a number of hours after eating</font></div><div><font color=\"#aa0000\"><br></font></div><div>{{c1::Lower}} post-prandial glucose&nbsp;<font color=\"#aa0000\"><br></font></div><div>{{c1::Low}} risk of hypoglycaemia<br></div><div>{{c1::high}} release of c-peptide, so what?&nbsp;{{c1::c-peptide good marker for endogenous insulin production}}<br></div><div>Causes weight&nbsp;{{c1::loss}}</div><div><br></div><div>Is it class&nbsp;{{c1::yes}}</div><div><br></div><div>So what was the issue?{{c1::too short acting}}</div><div><br></div><div><br></div>",
                        "<img src=\"paste-4cf616574eb517bd77dca52115982aabe88067ec.jpg\"><div><img src=\"paste-9a233c952032603f4deaed9320c063eaa8224660.jpg\"><br></div>"
                    ],
                    "guid": "tSp~-wi)hP",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>HOW TO MAKE GLP-1 last longer</b><div><b><br></b></div><div>1. Use synthetic forms of GLP-1 that block degradation of DPP-4</div><div><br></div><div>such as&nbsp;</div><div>{{c1::liraglutide}}- Which has a glutamate chain that blocks DPP-4<br></div><div>{{c1::Exenatide}}- which only has to administered twice daily and is taken from the saliva of the gila monster<br></div><div><br></div><div>2.DPP IV ANTAGONISTS</div><div>Name:{{c1::gliptins}}</div><div>{{c1::Competitive}} Inhibitors of DPP-IV&nbsp;</div><div>Increase physiological GLP-1&nbsp;</div><div>{{c1::De}}crease HbA1c ~ {{c1::1}}%&nbsp;</div><div>{{c1::Orally}} available (admin)</div><div>Well tolerated&nbsp;</div><div>Weight {{c1::neutral}}<br></div><div><br></div><div>3. GLP-1 AGONISTS&nbsp;</div><div>Name:{{c1::GLUTIDES&nbsp;}}</div><div>Structural analogues of {{c1::GLP-1&nbsp;}}</div><div>{{c1::Parenterally}} administered&nbsp;</div><div>{{c1::De}}crease HbA1c ~ {{c1::1.5 - 2}}%&nbsp;</div><div>&nbsp;weight&nbsp;{{c1::loss}}&nbsp;</div><div>Inhibit gastric emptying&nbsp;</div><div>Safe in moderate renal failure&nbsp;</div><div><br></div><div>BUT….\nNausea and diarrhoea&nbsp;</div><div>Risk of {{c1::pancreatitis&nbsp;}}</div><div>Associated with ↑ {{c1::calcitonin}} and MTC<br></div>",
                        ""
                    ],
                    "guid": "GPowX@;g,]",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "136a60c3-948a-11eb-8937-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-173124d048694d62b56ded7842cdafb2d11f52b5.jpg",
                "paste-29d7b2bf6647150ea310f0b3cf3c9e458bdf5aa5.jpg",
                "paste-6005b30343c5d711d94084341a125c78856527f9.jpg",
                "paste-7e39aa3b2025a53ce535128ca71ca96b5ee3ea1a.jpg",
                "paste-88f589626b17529944256fc225965adede3da880.jpg",
                "paste-8a470cdc241eeb396ac413f959be600cb61a560f.jpg",
                "paste-a594fa8b9e2446775d2e29f6aa56455e4e5a346e.jpg"
            ],
            "name": "03/30 Dennedy Thyroid",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "The thyroid has right and left lobes, and an&nbsp;{{c1::isthmus}} that connects them<div>Sometimes has a {{c1::Pyramidal}} Lobe that is a&nbsp; Remnant of the {{c1::Thyroglossal}} Duct<br></div><div><br></div><div>In the thyroid there are four&nbsp;{{c1::parathyroid}} glands which contains&nbsp;{{c1::parathyroid}} hormone and is responsible for&nbsp;{{c1::calcium}} metabolism</div><div><br></div><div><br></div><div><img src=\"paste-8a470cdc241eeb396ac413f959be600cb61a560f.jpg\"><br></div>",
                        "<img src=\"paste-29d7b2bf6647150ea310f0b3cf3c9e458bdf5aa5.jpg\">"
                    ],
                    "guid": "L/fr1_M+#0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Thyroid Glamd Physiology and control<div><br></div><div>1. Hypothalamus releases&nbsp;{{c1::tyrotropin releasing hormone}} which causes the&nbsp;{{c1::anterior pituatary}} gland to release {{c1::thyroid stimulating}} hormone.</div><div><br></div><div>2. This hormone acts on a G{{c1::s}} coupled receptor in the thyroid</div><div><br></div><div>3. Two pathways are stimulated</div><div>&nbsp;-Adenylate cyclase--{{c1::cAMP}} which does what?&nbsp;{{c1::upregulation of transcription factor for thyroid hormone to be synthesized}}</div><div><br></div><div>-PLC--{{c1::DAG/IP3}} which does what?&nbsp;{{c1::increases intracellular calcium which stimulates release of thyoid hormone}}</div><div><br></div><div><br></div><div>What are the two types of thyroid hormone?{{c1::T4 amd T3}}</div><div>Which is the abundant one&nbsp;{{c1::T4}}</div><div>Which is the active one&nbsp;{{c1::T3}}&nbsp;</div><div>WHat converts one to the other{{c1::Di and Dii}}</div><div>So which one do we give therapeutically?{{c1::T4 becuase body is used to it}}</div><div><br></div><div><br></div><div>What sort of hormones are thyrtoid hormone?&nbsp;{{c1::nuclear hormones}}</div><div><br></div><div>EFFECTS (5)</div><div>{{c1::<div>Oxygen Consumption&nbsp;</div><div>Thermogenesis&nbsp;</div><div>CHO, Fat, Protein Metabolism&nbsp;</div><div>Growth / Differentiation&nbsp;</div><div>Modulation hormonal action</div>}}<br></div><div><br></div>",
                        "<img src=\"paste-173124d048694d62b56ded7842cdafb2d11f52b5.jpg\"><div>T4 and T3 shut off this process</div>"
                    ],
                    "guid": "u>U^}Img&>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THYROID HORMONE SYNTHESIS&nbsp;<div>MAIN SYNTHETIC STEPS&nbsp;</div><div>put in correct order and whether its cAMP or PLC mediated</div><div><br></div><div>Oxidation of iodine and iodination of tyrosine residues&nbsp;{{c1::3cAMP}}<br></div><div>Plasma Iodide Uptake and Concentration&nbsp;{{c1::1 cAMP}}</div><div>Proteolysis of thyroglobulin to release T3 and T4&nbsp;{{c1::5 PLC}}<br></div><div>Thyroglobulin Synthesis&nbsp;{{c1::2 cAMP}}</div><div>Secretion of thyroid hormone&nbsp;{{c1:: 6 PLC}}</div><div>Coupling of iodotyrosines to make T3 and T4&nbsp;{{c1::4 cAMP}}</div><div><br></div><div>Occurs within the {{c1::follicular}} cells - cuboidal / columnar epithelial cells surrounding\nthe colloid-containing follicle<br></div>",
                        ""
                    ],
                    "guid": "csh*;{.U&4",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THYROID HORMONE SYNTHESIS IN DEPTH<div><br></div><div>TSHR is stimulated which causes upregulation of cAMP, how does this lead to iodide collecting in the colloid?</div><div>{{c1::cAMP stimulates Na+-I- symporter, which brings in iodide first to the follicular cell and then to the colloid and Na-K atpase pumps back out sodium so that it can be used again for the symporter}}<br></div><div><br></div><div>cAMP also stimulates release of&nbsp;thyroglobulin from the&nbsp;{{c1::ER and Golgi}} into the colloid.</div><div><br></div><div>The&nbsp;</div>",
                        ""
                    ],
                    "guid": "OJ|oso=U#F",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T4 - {{c1::80}}% OF SECRETED THYROID HORMONE<div><br></div><div><font color=\"#aa0000\">BUT…..\nT3 BINDS WITH HIGH AFFINITY TO THYROID HORMONE RECEPTOR</font><br></div><div><br></div><div>DE-IODINATION (HIGHLY EFFICIENT PROCESS)<br></div><div><br></div><div>Done by&nbsp;{{c1::5’-deiodinases}} - Family of selenoproteins</div><div><br></div><div>D1-{{c1::80}}% circulating T3</div><div><br></div><div>Expressed in {{c1::Liver, Kidney, Thyroid Gland}}(3)</div><div>Inhibited by {{c1::PTU, Amiodarone, Glucocorticoids}}(3)</div><div><br></div><div>D2 - Tissue Specific Role - Lower affinity than D{{c1::1}}&nbsp;</div><div><br></div><div>Expressed in {{c1::Cardiac/Skeletal Muscle, Brain, Pituitary}}(3)<br></div><div><br></div><div>D3 - Produces inactive reverse T3 (rT3)&nbsp;</div><div>Expressed in {{c1::Placenta, Skin, Uterus, Brain, Inflammed Tissue}}(5)<br></div><div><br></div><div>What happens in&nbsp;THYROTOXICOSIS&nbsp;{{c1::D1 and 2 decrease}}</div><div>What happens in&nbsp;HYPOTHYROIDISM&nbsp;{{c1::D1 and 2 increase}}</div><div>What happens in illness and pregnancy&nbsp;{{c1::D3 increases}}</div>",
                        ""
                    ],
                    "guid": "cvQ^TyW1&P",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>THYROID HORMONE TRANSPORTATION IN BLOOD&nbsp;</b></div><div>HIGHLY PROTEIN BOUND:<br></div><div>STRONG NON-COVALENT BONDS WITH PLASMA PROTEINS<br></div><div><br></div><div>T4 BOUND WITH {{c1::HIGHER}} AVIDITY THAN T3<br></div><div>{{c1::0.03}}% T4 UNBOUND &amp; {{c1::0.3}}% T3 UNBOUND<br></div><div><br></div><div>Is bound or unbound more biologically active? {{c1::unbound}}</div><div><br></div><div>THREE MAIN PROTEINS:<br></div><div><br></div><div>{{c1::Thyroxine-Binding Globulin (TBG)}}:</div><div>Binds a single T4 with high avidity\nBiological levels of T4 highly influenced by circulating TBG&nbsp;</div><div><br></div><div>{{c1::Transthyreitin}}:</div><div>Higher concentration but lower affinity&nbsp;</div><div>Found in patients with ATTR</div><div><br></div><div>{{c1::Albumin}}:</div><div>Low Affinity Binding<br></div><div>It's the one you're thinking of</div>",
                        ""
                    ],
                    "guid": "wLGkf|`Z;e",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give three drug and two systemic factors that increase thebinding of thyroids to the proteins",
                        "<img src=\"paste-88f589626b17529944256fc225965adede3da880.jpg\">"
                    ],
                    "guid": "Hph@s(iM7e",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T4 ELIMINATION&nbsp;<div>Occurs slowly with T1/2 circa {{c1::8}} days&nbsp;</div><div>T1/2 reduced to {{c1::3}} days in thyrotoxicosis&nbsp;</div><div>T1/2 increased to {{c1::9}} days in hypothyroidism&nbsp;</div><div><br></div><div>T3 ELIMINATION&nbsp;</div><div>Occurs quickly with T1/2 circa 1 day\nDue predominantly to {{c1::reduced protein binding}}</div><div><br></div><div>NON-DEIODINATIVE DEGRADATION&nbsp;</div><div>Occurs within the {{c1::liver&nbsp;}}</div><div>{{c1::Conjugates}} excreted in bile<br></div>",
                        "<img src=\"paste-a594fa8b9e2446775d2e29f6aa56455e4e5a346e.jpg\">"
                    ],
                    "guid": "jp%x$p~ic_",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "NUCLEAR RECEPTOR<div>T3 Dimerises with {{c1::RXR}} and binds to {{c1::Thyroxine Response Element}}<br></div><div><br></div><div>THYROID RECEPTOR SUBTYPES<br></div><div>TRβ2 expressed in&nbsp;{{c1::HYPOTHALAMUS &amp; PITUITARY}}<br></div><div>TRβ1 expressed in&nbsp;{{c1::BRAIN, LIVER &amp; KIDNEY}}<br></div><div>TRα1 expressed in&nbsp;{{c1::CARDIAC AND SKELETAL MUSCLE}}<br></div><div><br></div><div>RESISTANCE TO THYROID RECEPTOR BETA AND ALPHA CAN OCCUR<br></div>",
                        "<img src=\"paste-6005b30343c5d711d94084341a125c78856527f9.jpg\">"
                    ],
                    "guid": "C1l$S~-t%2",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Etiology of Thyrotoxicosis</b><div><br><div>Definitions</div><div>Graves’ Thyrotoxicosis&nbsp;&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span><span style=\"color: rgb(32, 33, 36);\">immune system disorder that results in the overproduction of thyroid hormones</span>}}</div><div>Toxic Adenoma&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">This occurs when a single nodule (or lump) grows on the thyroid gland causing it to become enlarged and produce excess thyroid hormones.</span>}}</div><div>Toxic Multinodular Goitre&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">one or more nodules (typically benign growths) in the thyroid gland that make thyroid hormone without responding to the signal to keep thyroid hormone balanced.</span>}}</div><div>Inflammatory thyroiditis&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">swelling (</span><b>inflammation</b><span style=\"color: rgb(32, 33, 36);\">) of the&nbsp;</span><b>thyroid</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;gland. It causes either unusually high or low levels of&nbsp;</span><b>thyroid</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;hormones in the blood</span>}}</div><div>Hashitoxicosis\nFactitious /\nOver-replaced LT4&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span><span style=\"color: rgb(32, 33, 36);\">transient hyperthyroidism caused by inflammation associated with Hashimoto's thyroiditis disturbing the thyroid follicles, resulting in excess release of thyroid hormone.</span>}}</div><div>Drug Induced&nbsp;</div><div>Post-partum Thyroiditis{{c1::post pregnancy}}<br></div><div><br></div><div>All of these are caused by too much free t4 and too little TSH</div><div>But there is one thyrotoxicosis that is caused by an increase in both?&nbsp;{{c1::TSHoma}}</div><div><br></div><div><br></div><div><br></div><div><br></div></div>",
                        ""
                    ],
                    "guid": "pG^s-)8S~z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "HYPOTHYROIDISM ETIOLOGY&nbsp;<div><br></div><div>{{c1::<div>Autoimmune Thyroiditis&nbsp;</div><div>Post-RAI Rx&nbsp;</div><div>Post-Thyroidectomy&nbsp;</div><div>Inflammatory Thyroiditis&nbsp;</div><div>Haemmorrhage /\nInfiltration&nbsp;</div><div>Under-replacement\nIodine Deficiency&nbsp;</div><div>Pituitary hypothyroidism&nbsp;</div><div>Thyroid Hormone Resistance&nbsp;</div><div>Post-partum Thyroiditis</div>}}(4/9)<br></div><div><br></div>",
                        ""
                    ],
                    "guid": "gTAM11X8^M",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>HYPOTHYROIDISM</b><div><b><br></b></div><div>CLINICAL FEATURES:<b><br></b></div><div>{{c1::Cold}} intolerance&nbsp;</div><div>{{c1::Brady}}cardia&nbsp;</div><div>Constipation&nbsp;</div><div>Weight {{c1::Gain}}&nbsp;</div><div>Poor Concentration&nbsp;</div><div>{{c1::Lethargy&nbsp;}}(less energy)</div><div>{{c1::Decreased}} Appetite&nbsp;</div><div>{{c1::Myxoedema}}(heart)&nbsp;</div><div>Peripheral Oedema, does it pit?&nbsp;{{c1::no}}</div><div>{{c1::Dry}} Skin / Hair<br></div><div><br></div><div>PRINCIPAL CAUSES&nbsp;</div><div>{{c1::Autoimmune Thyroiditis&nbsp;</div><div>Radioiodine Therapy / Surgery&nbsp;</div><div>Pituitary Hypothyroidism}}(3)<br></div><div><br></div><div>TREATMENT</div><div><font color=\"#aa0000\">&nbsp;THYROID HORMONE REPLACEMENT</font><br></div><div><font color=\"#aa0000\"><br></font></div><div>Oral T4&nbsp;</div><div>drug name:&nbsp;{{c1::LEVO-THYROXINE}}</div><div>{{c1::Long}} T1/2</div><div>{{c1::&nbsp;Once daily}} dosage<br></div><div><br></div><div>What can you not take with oral T4?{{c1::anything with calcium and anything that interferes with stomach acid}}</div><div><br></div><div>When would you give Oral T3?&nbsp;{{c1::when patient is in myxoedema coma}}</div><div><br></div><div>What do they give now to patients undergoing radioiodine therepay for thyroid cancer?&nbsp;{{c1::Recombinant TSH}}</div>",
                        ""
                    ],
                    "guid": "Ao;+TQJd)Z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THYROTOXICOSIS\nCLINICAL FEATURES&nbsp;<div>{{c1::Heat}} intolerance&nbsp;</div><div>{{c1::Tachy}}cardia / Atrial Fibrillation&nbsp;</div><div>Diarrhoea&nbsp;</div><div>Weight {{c1::Loss}}&nbsp;</div><div>Tremor&nbsp;</div><div>Anxiety / Agitation&nbsp;</div><div>{{c1::Increased}} Appetite&nbsp;</div><div>Thyroid Storm, mortality?{{c1::75%}}<div>High-output {{c1::HF}}<br></div><div><br></div><div><br></div><div>&nbsp;TREATMENT\nBASED ON UNDERLYING CAUSE…\nOPTIONS: {{c1::</div><div>Thioureylenes&nbsp;</div><div>Radioiodine / 131I&nbsp;</div><div>Potassium Iodide / Lugol’s Iodine&nbsp;</div><div>Thyroidectomy&nbsp;</div>}}(4)</div><div><br></div><div>PRINCIPAL CAUSES&nbsp;</div><div>{{c1::<div>Graves’ Thyrotoxicosis&nbsp;</div><div>Toxic Adenoma&nbsp;</div><div>Toxic Multinodular Goitre&nbsp;</div><div>Thyroiditis&nbsp;</div><div>Amiodarone</div>}}(5)<br></div><div><br></div>",
                        ""
                    ],
                    "guid": "jJD3olk!>2",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Grave's Disease or Autoimmune Thyrotoxicosis</b><div><br></div><div>Driven by&nbsp;{{c1::tyrotropin}} receptor antibodies (CTLA, HLA-DR3)</div><div><br></div><div>{{c1::Young}} age of onset - Incidence Women : Men is {{c1::9}}:1<br></div><div><br></div><div>Can go into remission but relapses in &gt; {{c1::50}}%<br></div><div><br></div><div><br></div><div>What happens to the eyes in Grave's Disease?</div><div>{{c1::opthalmopathy, bulging eyeballs. TRAb stimulate adipocytes and fibroblast in the orbit to store fat in the muscles so eyes bulge and opthalmoplegia can occur}}<br></div><div><br></div><div>What problems do these cause?{{c1::patient soemtimes lose their eyes and they can't close them at night. }}</div><div><br></div><div>How would you treat it?&nbsp;{{c1::hydrosteroids, orbital decompression, and hyaluronic acid to moisten eyes}}</div><div><br></div><div>What sort of Goitre do you get with Grave's&nbsp;{{c1::smooth}}</div><div><br></div><div>There are two ways to treat Grave's</div><div><br></div><div>Just Thioureylenes:{{c1::Start at high dose thioureylene and reduce over time to maintain euthyroid state\nRequires 18 months therapy}}</div><div><br></div><div>Combination with LT4:{{c1::Start at high dose thioureylene until euthyroid\nThen continue at high-dose, but add LT4 and titrate the LT4 to maintain euthyroid state\nRequires 12 months therapy}}<br></div>",
                        "<img src=\"paste-7e39aa3b2025a53ce535128ca71ca96b5ee3ea1a.jpg\">"
                    ],
                    "guid": "h,V!ml~a|}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "GUESS THE THIOURYLENE<div><br></div><div><br></div><div>{{c1::CARBIMAZOLE}}<br></div><div>Plasma half life 4-6 hours</div><div>Vd 40L</div><div>metabolism decreased in liver failure&nbsp;</div><div>No plasma protein binding</div><div>Admin once or twice daily</div><div>Low placental and breast milk levels</div><div>Not used during first trimester of pregnancy, why?{{c1::associated with poor skin development}}</div><div><br></div><div>{{c1::Propylthiouracil}}<br></div><div>Plasma protein binding 75%</div><div>Plasma half life 75 minutes&nbsp;</div><div>Vd 20L</div><div>Admin 1-4 times daily</div><div>low placental and breast milk levels</div><div>Advantagious affects in thyroid storm</div><div><br></div><div>WHich is more commonly used?{{c1::Carbimazole}}</div><div>Where are both concentrsted?{{c1::thyroid}}</div><div><br></div><div><br></div><div>Adverse Effects:</div><div>Agranulocytosis ({{c1::0.2}}%)&nbsp;</div><div>{{c1::In}}creased Liver Blood Tests&nbsp;</div><div>Rash&nbsp;</div><div>Hair {{c1::Loss&nbsp;}}</div><div>Skin {{c1::Pigmentation&nbsp;}}</div><div>Headache<br></div><div><br></div><div>Inhibition of {{c1::NIS (sodium iodine syporter}}&nbsp; &nbsp; &nbsp;&nbsp;</div><div>Inhibition of the enzyme&nbsp;{{c1::TPO}}</div><div>Immunoregulatory Effect reduces production of&nbsp;{{c1::TRAb}} - Additional benefit in Graves’ Disease<br></div><div><br></div><div>PTU inhibits D{{c1::1}} but not D{{c1::2}}</div><div><br></div><div>What should you treat the symptoms of thyrotoxicosis with while waiting for thioureylenes to take effect?</div><div>{{c1::beta-adrenoceptors antagonists}}<br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "j|s|L@i<JM",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>TOXIC ADENOMA / TOXIC MULTINODULAR GOITRE:</b>{{c1::SINGLE OR MULTIPLE HYPER FUNCTIONING THYROID NODULES}}<div><br></div><div>They supersede normal {{c1::pituitary}} thyroid regulation</div><div><br></div><div>{{c1::Older}} age of onset<br></div><div>Often presents with {{c1::AFib}} and {{c1::stroke}} or {{c1::Osteoporosis}}<br></div><div><br></div><div>RESPONDS TO THIOUREYLENE THERAPY AT RELATIVELY LOW DOSE&nbsp;<br></div><div>So why don't they use it?</div><div>{{c1::relapse as soon as they come off it}}<br></div><div><br></div><div>So what do we do instead?</div><div>{{c1::SURGERY OR RADIOIODINE THERAPY}}<br></div>",
                        ""
                    ],
                    "guid": "M(S4#V{~/3",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "RADIOIODINE THERAPY<div><br></div><div>When do you use it?{{c1::GRAVES’ RELAPSE OR IN TA / TMNG}}</div><div><br></div><div><font color=\"#aa0000\">131I - Emits β and γ radiation </font>Was possibly going to make this a cloze, but we're not chemists<br></div><div><br></div><div>Destroys {{c1::functioning}} thyroid tissue&nbsp;<br></div><div><br></div><div>Dosage</div><div>{{c1::300}}MBq&nbsp;Higher dose required with PTU<br></div><div>T1/2 ~ {{c1::8}} Days<br></div><div>Therapeutic Effect @ {{c1::8 - 12}} weeks<br></div><div>Need cover with {{c1::thioureylene +/- β blocker}}<br></div><div><br></div><div>PRECAUTIONS / CONTRAINDICATIONS<br></div><div>{{c1::Pregnancy}}</div><div>Thyroid eye disease, why?&nbsp;{{c1::Increased levels of TRAb}}</div><div><font color=\"#aa0000\">For mild case of thyroid eye disease you can pre treat with steroids to put it into remission for duration of treatment</font></div><div><br></div><div>Contact with children&nbsp;</div><div>&lt; 5yo: {{c1::No prolonged close contact for 3 weeks}}&nbsp;</div><div>&gt; 5yo: {{c1::No prolonged close contact for 10 days}}&nbsp;</div><div>&lt; 2yo: {{c1::No contact for 7 days}}<br></div><div><br></div><div>COMPLICATIONS&nbsp;</div><div>Radiation {{c1::thyroiditis}}</div><div>Worsening or emergence {{c1::opthalmopathy}}&nbsp;</div><div>Post-RAI hypothyroidism: does this happen more whilst treating TA/TMNG or Graves?{{c1::Graves}}, why?{{c1::In Graves all of thyroid is active, In TA/TMNG only affected nodules are actually actuve as they shut down the rest}}<br></div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "KK*R1ObtwY",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Lugol's Iodine</b><div><br></div><div>When do you use it?{{c1::When patient is in umar na haimléise and needs a thyroidectomy, this will tide them over}}</div><div><br></div><div>How does it work?{{c1::Collects in colloid, doesn't become thyorid hormone so large collection of iodine so TSH receptor and sodium-iodide symporter stops, basically thyroid fxn stops}}</div><div><br></div><div>What is this effect called?{{c1::Wolff-chaikoff effect}}</div><div>Dosed @ {{c1::150}}mg / day as tincture<br></div><div>Produces a temporary effect for ~ {{c1::2}} weeks only<br></div><div><br></div><div>What happens if surgery doesn't happen before effect wears off?</div><div>{{c1::resistant hyperthyroidism, thyroid storm}}<br></div><div><font color=\"#aa0000\">This is called Jod Basedow effect</font></div><div>What can you do for patient in this situation?</div><div>{{c1::β-blocker to treat adrenergic symptoms but other than that, pray}}<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "nVYV@D=p]8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>AMIODARONE</b>&nbsp;<div>Class III anti {{c1::arrhythmic}} used in treatment of {{c1::supra ventricular and ventricular\narrhythmias}}</div><div><br></div><div>37% iodine by weight so may cause&nbsp;{{c1::Jod Basedow effect}}<br></div><div><br></div><div>{{c1::In}}crease D3 and {{c1::de}}crease D1, so what forms of thyroid hormone are increased?&nbsp;{{c1::T4 and rT3}} and T{{c1::3}} is decreased.&nbsp;</div><div>This is good as sometimes too much T{{c1::3}} can cause the&nbsp;{{c1::arrythmias}}</div><div>But this might be confusing for doctors, why?{{c1::may prescribe thyroid hormone as levels are low}}</div><div><br></div><div>Accelerates onset of hypothyroidism in {{c1::autoimmune thyroiditis}}<br></div><div><br></div><div>AMIODARONE INDUCED THYROTOXICOSIS&nbsp;</div><div><br></div><div>Type 1</div><div>Severe treatment resistant thyrotoxicosis due to {{c1::Jod Basedow}} Effect&nbsp;</div><div>{{c1::Premorbid nodular}} gland&nbsp;</div><div><br></div><div>Type 2&nbsp;</div><div>Amiodarone-induced thyroiditis - Direct toxic effect of amiodarone on {{c1::follicular}} cells&nbsp;</div><div>Transient effect<br></div>",
                        ""
                    ],
                    "guid": "m-+&Btlh[V",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "PREGNANCY\nHYPOTHYROIDISM&nbsp;<div><br></div><div>Higher binding globulins and higher D{{c1::3}} from placenta&nbsp;</div><div><br></div><div>Requirement for higher doses of LT4\nIncrease dose by ~ {{c1::30}}%&nbsp;</div><div><br></div><div>In women with Graves’ rendered hypothyroid by surgery or RAI\nNeed to check TRAb in 1st trimester and 30 weeks\nRisk of neonatal thyrotoxicosis (transient)..&nbsp;</div><div><br></div><div>{{c1::Radioiodine}} absolutely contraindicated&nbsp;</div><div><br></div><div>TRY TO AVOID PREGNANCY UNTIL EUTHYROID&nbsp;</div><div><br></div><div>Should not become pregnant for {{c1::6}} months after radio iodine&nbsp;</div><div><br></div><div>If resistant, severe thyrotoxicosis, aim for surgery in 2nd trimester&nbsp;</div><div>Can treat with lowest dose PTU which keeps FT4 in Upper Ref Range&nbsp;</div><div><br></div><div>{{c1::Thioureylenes}} cross placenta - can cause fetal goitre&nbsp;</div><div><br></div><div>Carbimazole may cause {{c1::aplasia cutis}}</div>",
                        ""
                    ],
                    "guid": "hkA,s95k~W",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "a06c53f6-aded-11eb-9c11-c0b5d703b09e",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-3b5f158b2569c79b27806b461e3ef003d594ff15.jpg",
                "paste-3e6c9a284fab6fd61d3bd1215948c94a42b28489.jpg",
                "paste-41f68bab2081883e337bcfdd2d8b71a58816fad0.jpg",
                "paste-463f1acca5bb9df1b664fa8b62c5e20d91f363cb.jpg",
                "paste-4947a505cdb3bc72b16ab720b427c358d84716e5.jpg",
                "paste-4debe0ca50ff3936b59b38a482af3b25934a7f93.jpg",
                "paste-7acbe03151acae6d1de29e662025b18da25bc6c1.jpg",
                "paste-81d836a9e6b50fed8d799ee0da4dc44243202fc6.jpg",
                "paste-93524eaf72b55a0ab5d9b90d9c0e923d3d5423de.jpg",
                "paste-ddaed92bf508097186fe142dac3319db774793b7.jpg",
                "paste-eb1944483516658ae1f84d9f5aebc61131ce3f76.jpg",
                "paste-ed9b58b93c7df8af6df6a4333a576d9e5ca27244.jpg",
                "paste-f08017a090816ff4c3201ea836a571e54675a9a8.jpg"
            ],
            "name": "04/15 Dennedy Adrenal",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Where do the adrenal glands sit?{{c1::on top of the kidneys}}<div><img src=\"paste-ed9b58b93c7df8af6df6a4333a576d9e5ca27244.jpg\"><br></div><div>Point to the adrenal glands</div>",
                        "small lines either side of the spine"
                    ],
                    "guid": "i47OpSOh]]",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Adrenal Glands</b><div><b><br></b></div><div>The adrenal gland is divided in to the cortex and the medulla&nbsp;</div><div>What is the main function of the cortex?{{c1::production of steroid hormones}}</div><div>What is the main function of the medulla?{{c1::catecholamines}}<br></div><div><br></div><div><br></div><div>Say where each part of the cortex lies (e.g. middle cortex) and what it produces:</div><div><br></div><div>Fasciculata:{{c1::middle cortex, glucocorticoids}}</div><div><br></div><div>Glomerulosa:{{c1::outer cortex, mineralocorticoids}}</div><div><br></div><div>Reticularis:{{c1::inner cortex, sex hormones}}</div><div><br></div><div>Out of all the products produced by the adrenals, what is the most abundant in the body?{{c1::sex hormones}}</div><div><br></div><div>Why, specifically talking about the adrenals, is it the least clinically significant?{{c1::the proportion of sex hormone made by the adrenals is a lot less than what is made by the gonads}}</div><div><br></div><div><br></div><div>The release of the products of the glomerulosa are regulated by the&nbsp;{{c1::RAAS}}</div><div><br></div><div>The release of the products of the Fasciculata are regulated by the&nbsp;{{c1::ACTH from pituatary}}</div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-3b5f158b2569c79b27806b461e3ef003d594ff15.jpg\">"
                    ],
                    "guid": "NxGDN?:A</",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>STEROIDOGENESIS</b><div><b><br></b></div><div>What is the rate limiting step for steroidogenesis?{{c1::The movement of cholestrol from the outer mitochondrial membrane to the inner mitochondrial membrane}}</div><div><br></div><div>What is this step regulated by?{{c1::StAR}}</div><div><br></div><div><font color=\"#aa0000\">Enzymes used for steroidogenesis are zone specific</font>, what does this mean?{{c1::what ever part of the cortex the steroid is being produced, that is the only place the enzyme will be expressed}}</div>",
                        "<img src=\"paste-81d836a9e6b50fed8d799ee0da4dc44243202fc6.jpg\"><div>Talk to Joe</div>"
                    ],
                    "guid": "xBp?sXTk~;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>HYPOTHALAMIC PITUITARY ADRENAL AXIS</b><div><b><br></b></div><div>What hormone does the hypothalamus release in this system and what part of the hypothalamus releases it?</div><div>{{c1::CRH, supraoptic nuclei}}<br></div><div><br></div><div>What hormone is released by the pituatary gland in response to the hypothalamic hormone?&nbsp;{{c1::ACTH}}</div><div><br></div><div>What pattern does there release follow?{{c1::pulsatile e.g. higher amplitude/frequency=more hormone}}</div><div><br></div><div>What does the Adrenal gland release?{{c1::cortisol and DHEA}}</div><div><br></div><div><font color=\"#aa0000\">The products of the adrenal gland have a classical diurnal rhythm</font></div><div><b>diurnal rhythms</b><span style=\"color: rgb(32, 33, 36);\">:&nbsp;</span>{{c1::<span style=\"color: rgb(32, 33, 36);\">the circadian&nbsp;</span><b>rhythm</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;synced with day and night</span>}}<font color=\"#aa0000\"><br></font></div><div>So when is the adrenal cortex most active?{{c1::when you normally wake up}}</div><div><br></div><div>Describe the feedback mechanism for the HPA axis</div><div>{{c1::cortisol=negative feedback, amdrogens don't feed back}}<br></div><div><br></div><div>What is a good indicator of HPA axis activity?{{c1::DHEAS (a product of DHEA)}}</div><div>Why?{{c1::longer half life than the rest of the stuff}}</div><div><br></div><div>ACTH deficiency will cause\n{{c1::glucocorticoid}} deficiency and low\n{{c1::androgens}} (in females)<br></div><div><br></div><div>ACTH deficiency has no bearing on\n{{c1::mineralocorticoids}}<br></div><div><br></div><div><br></div><div><font color=\"#aa0000\"><br></font></div>",
                        "<img src=\"paste-ddaed92bf508097186fe142dac3319db774793b7.jpg\">"
                    ],
                    "guid": "b_pTRs`#e6",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CONTROL OF MINERALOCORTICOIDS:</b><div><b><br></b></div><div><font color=\"#aa0000\">Mineralocorticoid levels are influenced but not controlled by ACTH levels</font>, why?&nbsp;{{c1::ACTH controls StAR protein which is involved in letting cholestrol crossing the mitochondrial membrane}}</div><div><br></div><div><font color=\"#aa0000\">Mineralocorticoid levels are controlled by the RAAS</font></div><div>You should know what this is by now so give us a basic rundown</div><div>{{c1::<img src=\"paste-f08017a090816ff4c3201ea836a571e54675a9a8.jpg\">}}</div><div><br></div><div>What other things can inhibit the release of renin that stops this whole system?{{c1::Calcium, potassium, sodium and catecholamins}}</div>",
                        ""
                    ],
                    "guid": "qrKsyMV_=9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>ACTH</b><div><b><br></b></div><div>ACTH is one of 4 products of {{c1::pro-opiomelanocortin (POMC)}} which is synthesized in the hypothalamus<b><br></b></div><div><br></div><div>What are the other 3 products?&nbsp;{{c1::gamma-MSH, gamma-LPH, beta-endorphin}}</div><div><br></div><div>ACTH binds to&nbsp;{{c1::MC2}}R &amp; {{c1::MC1}}R&nbsp;</div><div><br></div><div>These are {{c1::Gs}} coupled GPCR and cause {{c1::cAMP-PKA}} phosphorylation</div><div><br></div><div>Which receptor is bound with more affinity?&nbsp;{{c1::MC2R}}</div><div><br></div><div>Two phased response&nbsp;</div><div>Phase 1: StAR activation, which&nbsp;{{c1::moves the cholestrol through the mitochondrial membrane }}</div><div>Phase 2: Transcription of CYP11B1 which&nbsp;{{c1::is enzyme that makes cortisol}}<br></div>",
                        ""
                    ],
                    "guid": "z_a|t{c/b1",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Glucocorticoids</b><div><b><br></b></div><div>{{c1::Diurnal}} rhythm and stressors effect glucorticoid release at the&nbsp;{{c1::hypothalamic level}}</div><div><br></div><div>Stressors include&nbsp;{{c1::(hypoglycaemia,\nhypotension,\nfever, trauma,\nsurgery}}3/5</div><div><br></div><div>What can effect glucocorticoid release at the pituatary level?</div><div>{{c1::ADH, Cytokines}}<br></div><div><br></div><div>Cortisol release triggered an increase in 4 metabolic functions, what are they?{{c1::Gluconeogenesis\nGlycogenolysis\nProteolysis\nLipolysis}}</div><div><br></div><div>Cortisol effects the CVS, in what ways?&nbsp;{{c1::increase in Myocardial contractility ,Cardiac output, Catecholamine pressor\neffect}}</div><div><br></div><div>Glucocorticoids such as cortisol also have a significant&nbsp;{{c1::immunosupressive }} effect</div><div><br></div><div><br></div><div><b>GLUCOCORTICOID MOA</b></div><div><b><br></b></div><div>Glucocorticoids are steroid hormones, so how do they get into the cell?&nbsp;{{c1::Bound to corticoid-binding globulin}}</div><div><b><br></b></div><div><font color=\"#aa0000\">Once inside the cell the steroid binds to the glucocorticoid response element and relocates to the nucleus where it can effect transcription</font></div><div><font color=\"#aa0000\"><br></font></div><div>Why doesn't the glucocorticoid response element enter the nucleus when unbound to a steroid?{{c1::the element is bound to heat shock proteins 70 and 90}}</div><div><br></div><div><br></div>",
                        "<img src=\"paste-7acbe03151acae6d1de29e662025b18da25bc6c1.jpg\">"
                    ],
                    "guid": "K3~=gUQL)l",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Cortisol has the same affinity for the mineralocorticoid receptor as&nbsp;{{c1::aldosterone}}<div><br></div><div>However cortisol inctivated by constitutive expression of {{c1::11βHSD Type 2}} which is expressed at the mineralocorticoid receptor, it turns cortisol into its inactive form, {{c1::cortisone}}</div><div><br></div><div>This system can be overloaded by:</div><div>{{c1::cushings}} syndrome</div><div>high doses of {{c1::hydrocortisone}}</div><div>Syndrome of Apparent Mineralocorticoid Excess<br></div><div>Drugs:{{c1::Carbenoxalone, Glycerrhinic Acid}} (2)</div>",
                        "<img src=\"paste-93524eaf72b55a0ab5d9b90d9c0e923d3d5423de.jpg\">"
                    ],
                    "guid": "H}Nsv.YlYk",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What three glucocorticoids have no effect on the mineralocorticoid receptor?{{c1::<img src=\"paste-463f1acca5bb9df1b664fa8b62c5e20d91f363cb.jpg\">}}",
                        ""
                    ],
                    "guid": "t%vBT/wt$U",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What changes would you make to the glucocorticoid backbone to increase glucocorticoid r activity, but completely diminish mineralocorticoid r activity?{{c1::g}}",
                        "<img src=\"paste-3e6c9a284fab6fd61d3bd1215948c94a42b28489.jpg\">"
                    ],
                    "guid": "C;9>|lzH>7",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>PHARMACOLOGIC USE OF GLUCOCORTICOIDS</b><div><br></div><div><font color=\"#aa0000\">At high-dose (supraphysiologic) they are anti-inflammatory / immunosuppressive</font><b><br></b></div><div><br></div><div>Used in {{c1::inflammatory}} conditions both systemically and topically<br></div><div><br></div><div>Immunosuppressive post-{{c1::transplantation - avoid rejection}}<br></div><div><br></div><div>Long-term use - Causes Iatrogenic Cushing’s Syndrome&nbsp;</div><div>Symptoms</div><div>{{c1::Thin Skin / Bruising\nHypertension\nOsteoporosis\nProximal Myopathies\nDrug-Indices Diabetes Mellitus / Insulin Resistance\nOpportunistic Infections}}4/6<br></div><div><br></div><div>What happens when you take a patient who had been taking glucocorticoids long-term off them?</div><div>{{c1::Secondary Adrenal Insufficiency}}<br></div>",
                        ""
                    ],
                    "guid": "c.]&M|01Je",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>GLUCOCORTICOID DEFICIENCY</b><div><b><br></b></div><div><b>1. </b>ACTH deficiency- due to {{c1::anterior pituitary}} or {{c1::hypothalamic}} dysfunction</div><div><br></div><div><b>2.</b>Atrophy due to chronic exogenous {{c1::glucocorticoid}} excess</div><div><br></div><div>What part of the adrenal cortex do these 2 conditions affect?</div><div>{{c1::Destruction of the zonae fasciculata and reticularis only}}<br></div><div><br></div><div>So what will need to be replaced?{{c1::only glucocorticoid}}</div><div><br></div><div>{{c1::Addison’s Disease}} is Complete autoimmune destruction of the adrenal cortex<br></div><div><br></div><div>So what will need to be replaced?{{c1::both glucocorticoid and mineralocorticoid}}</div>",
                        ""
                    ],
                    "guid": "BlO97a+qXi",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Replacement GLucocorticoid</b><div><b><br></b></div><div>Attempt to mimic physiologic {{c1::diurnal}} rhythm.(very difficult to do this)<b><br></b></div><div>Use {{c1::hydrocortisone}}, why? - {{c1::identical properties to cortisol}}<br></div><div><br></div><div>Must give at higher dose or parenterally during times of {{c1::illness}} or {{c1::high stress}}<br></div><div><br></div><div>Very important to give parenterally if patient has&nbsp;{{c1::vomiting}}</div>",
                        "<img src=\"paste-4debe0ca50ff3936b59b38a482af3b25934a7f93.jpg\">"
                    ],
                    "guid": "v`f}>z.mlx",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CUSHING’S DISEASE / SYNDROME</b><div>Cushing’s Disease: {{c1::Caused by Pituitary ACTH excess&nbsp;}}</div><div>Ectopic ACTH: {{c1::Most commonly from SCC Lung&nbsp;}}</div><div>Cushing’s Syndrome: {{c1::Autonomous Adrenal Tumours / Nodules&nbsp;}}</div><div>Adrenal CRF Secretion: {{c1::Bilateral Pigmented Nodular Hyperplasia (ARMC5)}}<b><br></b></div><div>Exogenous Glucocorticoid Excess<b><br></b></div><div><b><br></b></div><div><b>What is the treatment of choice?</b></div><div>{{c1::surgery}}<b><br></b></div><div><br></div><div>Cushing’s Disease: {{c1::Hypophysectomy or Bilateral Adrenalectomy&nbsp;}}</div><div>Ectopic ACTH: {{c1::Removal of Primary Tumour or Bilateral Adrenalectomy&nbsp;}}</div><div>Cushing’s Syndrome: {{c1::Adrenalectomy}}<br></div><div><br></div><div>How would you treat a patient who cannot undergo surgery?</div><div>{{c1::STEROIDOGENESIS INHIBITORS OR ADRENOLYTIC AGENTS}}<br></div>",
                        ""
                    ],
                    "guid": "O56vHfY4}@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><br></div><div><br></div><div><br></div><div><br></div><div>{{c1::KETOCONAZOLE}}<br></div><div>Less used therapeutically&nbsp;</div><div>Inhibits CYP17 and at higher doses CYP11A1&nbsp;</div><div>Powerful inhibitor of steroidogenesis&nbsp;</div><div>Also anti-fungal agent but given at higher doses to inhibit steroidogenesis<br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div>{{c1::METYRAPONE}}<br></div><div>Principally used agent therapeutically&nbsp;<br></div><div>Inhibits CYP11B1 - ACTH sensitive enzyme&nbsp;</div><div>Glucocorticoid inhibition of ACTH removed with build-up of precursors&nbsp;</div><div>Includes 11_DOC (Strong MR activity) and aldosterone…&nbsp;</div><div>Can also increase production of adrenal androgens..</div><div>&nbsp;Hence usually used for primary adrenal lesions or exceptionally in ectopic\nACTH</div>",
                        ""
                    ],
                    "guid": "iO#D>^[P^A",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Mineralocorticoid Excess</b><div>SEVERAL FORMS\n{{c1::Primary Aldosteronism / Conn’s Syndrome\nGlucocorticoid Excess\nDrug Induced / Liquorice\nSyndrome of Apparent Mineralocorticoid Excess\nGlucocorticoid Remediable Hyperaldosteronism\nPseudoaldosteronism / Liddle’s Syndrome}}3/6<b><br></b></div><div><br></div><div>What symptoms are all categorized by?&nbsp;{{c1::hypertension and spontaneous or drug induced hypokalaemia}}</div><div><br></div>",
                        ""
                    ],
                    "guid": "L__~P@6:~-",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>The Somatic Mutation theory</b><div><b><br></b></div><div>Essentially cancer is a result of many {{c1::mutations }} over time working together to change the&nbsp;{{c1::function}} of the cell, in many cancer patient there is also mutations within the&nbsp;{{c1::DNA repair mechanisms}} of the cell.</div><div><br></div><div><div>Cancer causes the\n{{c1::proliferation}} of cells where and when they should not</div>\n<div>Cancers\nare “clonal”, meaning: {{c1::arising from a single aberrant cell}}</div>\n<div><font color=\"#aa0000\">This\ndoes not mean that tumours are a homogeneous population of cells</font></div>\n<div>The\ngenomes of cancer cells are {{c1::unstable}}</div>\n<div>As\ntumour cells proliferate, they acquire more {{c1::mutations}}</div>\nTumour “{{c1::evolves}}” as its environment\nimposes selective pressures<br></div><div><br></div><div>Why is cancer among the older population at a higher rate thna the younger population?&nbsp;{{c1::Because the mutations aise from divisions, the more divisions you undergo the bigger chance of cancer}}</div>",
                        ""
                    ],
                    "guid": "BzRdkpzzFB",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Cancer is a&nbsp;{{c1::multi-stage}} process<div><br></div><div>It can take many&nbsp;{{c1::years}} and multiple&nbsp;{{c1::mutations}} for malignancy to tkae place</div>",
                        "<img src=\"paste-eb1944483516658ae1f84d9f5aebc61131ce3f76.jpg\">"
                    ],
                    "guid": "Luy+C2,io8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><div>Current\nmodels suggest that genome instability must result in {{c1::mutations that subvert particular cellular processes in order for a cancer to develop}}</div></div><div><br></div><div><br></div>Progression\nfrom normality to {{c1::malignancy}} requires the <font color=\"#aa0000\">acquisition</font> of various different <font color=\"#aa0000\">capabilities</font> or\n<font color=\"#aa0000\">characteristics</font> that <font color=\"#aa0000\">cooperate</font> to cause cancer.&nbsp;<div><br></div><div>While no one change is\nsufficient to cause cancer, these changes are necessary for malignant\n{{c1::transformation}} and also for maintenance of the {{c1::malignant state}}.&nbsp;</div><div><br></div><div>So what capabilities/characteristics that cancer requires are targeted by anti-cancer drugs?{{c1::ideally all of them}}</div>",
                        "<img src=\"paste-41f68bab2081883e337bcfdd2d8b71a58816fad0.jpg\">"
                    ],
                    "guid": "NH+2]]Vs6L",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-4947a505cdb3bc72b16ab720b427c358d84716e5.jpg\"><div>Blue=nurture</div><div>Green=Nature</div>",
                        ""
                    ],
                    "guid": "jQuY,=KQ^W",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the three goals of cancer chemotherapy?<div><br></div><div>1.&nbsp;{{c1::cure}}:{{c1::kill cancer cells, enter complete remission}}</div><div><br></div><div>2. {{c1::Control}}:{{c1::Prolong remissionDecrease rate\nof relapse}}</div><div><br></div><div>3.{{c1::Palliate}}:{{c1::Relieve symptomsImprove quality of life}}</div><div><br></div>",
                        ""
                    ],
                    "guid": "LxnhV|l]x9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "a06d6c21-aded-11eb-a5f2-c0b5d703b09e",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-030213664e93ca85c90f0ed2d8026d92d19d9b8a.jpg",
                "paste-064b50d61be5f1495d847aca29537c77273b4291.jpg",
                "paste-0feaef695d7912003fe26823765ca1a941a6d65e.jpg",
                "paste-10734b273154eb4e97a8ee9430cfc0f9594d3683.jpg",
                "paste-169c070abf4feb79b3b542a986bea030fa62ef20.jpg",
                "paste-2a44e1a30365281bcadd175abf47f2f778c62081.jpg",
                "paste-30e42cf60f37ca63573d254d1481a5dd10f7f155.jpg",
                "paste-3274d80e8aca22c9f25308fbf7d2045c534000d0.jpg",
                "paste-341a32e835a8a97d53f7b414b9763f2ff72daad4.jpg",
                "paste-34e5ff10f3f03c0a8f35eec17db8a0187c38ca6a.jpg",
                "paste-36fde18e28477e182975518705f3e65fd3594f0d.jpg",
                "paste-372f47f53491c4d96ebdebb5b7fb5d83397c5247.jpg",
                "paste-3cc3b5eefa27151400d5d7f53861fb00ff0a0f99.jpg",
                "paste-4143c0738aa48da26c90da853a4b15eb909a80d4.jpg",
                "paste-417c2f701d53d3c024499d79bbc80907ce526abd.jpg",
                "paste-42f9894f449b3fbfdce25ab1ac31886b291c3db4.jpg",
                "paste-43b2eff959ecf31338fba1b0f59644c1809484db.jpg",
                "paste-44071cd56c495a4450d2e02ef1692dbc98979c6a.jpg",
                "paste-44e97009dd6d5df389555c135bfa0804c3f0743c.jpg",
                "paste-45fb862cea3f3321acaa8d54db740d78afd8b8c8.jpg",
                "paste-46d7b6eabe396216aab2d8a64182e9f2fcfda762.jpg",
                "paste-514eda490250291d9b0416b37c1deb060e5e211c.jpg",
                "paste-54092d59d7f77ab4065a69789847351b5f139257.jpg",
                "paste-566cf6c0b0605f6416ec46019c81132675b7f7fb.jpg",
                "paste-66ff69edf891ded010870a1bec45efdfe1b68352.jpg",
                "paste-6c6d0051ad2844d9cc27ae13e81de3f4991c9997.jpg",
                "paste-70efff2decc62e26c540c3ada5f597d22b5ddccf.jpg",
                "paste-758998a2099dfa471c476d3a0c23c722df9b1395.jpg",
                "paste-8cdd4d995da2419b0e984c4526cf52a03afab6ed.jpg",
                "paste-96ec4dff56499d172d43a4e2c4e72d204472c9df.jpg",
                "paste-a5bcfd992e5143b2b8db58cd6db7e568871f2259.jpg",
                "paste-a60d159962ee2a4b9f55caa2f170db434e150412.jpg",
                "paste-a87f7b70d927deb77be1f282d92de839a5ecd641.jpg",
                "paste-bbd7a6353ea4874c110ed0076dc010cd3173d42d.jpg",
                "paste-c588b2cc0e12cc63432631be48c3cdf650c5f318.jpg",
                "paste-c99ef6d49733965a70f2c775665867d6418c31ef.jpg",
                "paste-d161b8b99793a744ef727763b53e9763b8d28758.jpg",
                "paste-d442b9b15b34e0e10a7db6e5e22524ff0632b62c.jpg",
                "paste-da0fa0cdbaa8e9a2ce41175ac20c896dc70fbcf2.jpg",
                "paste-de727d573c1e74d0ecfad3e3dfc08bd2f15e661f.jpg",
                "paste-e4643b4845a14969c03918d708152133fc8f86fc.jpg",
                "paste-e6307fbfc7de9c47210570b90903bcb50bd4e2aa.jpg",
                "paste-e7c1cfd6b4121e5866e2fe423389ffdbfac5d32f.jpg",
                "paste-eb98d33f190de9f29c8e906b71fb561906ddb1f9.jpg",
                "paste-f142627652f1adc5e2e5dcf7e1fead9e391558a1.jpg",
                "paste-f4699a631948a53912abfb3fe5b5f7bbe1b758a1.jpg",
                "paste-fb09d81c7da2c82c99355d46e616bed7be54c0e9.jpg",
                "paste-ff02b30f5bfc2e4a15f1c32f384d5a2c20934cc4.jpg"
            ],
            "name": "04/16-27 Fearnhead Cancer",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the two most common cnacers?{{c1::Prostate and Breast}}<div><br></div><div>What cancers causes the most deaths?&nbsp;{{c1::lung and bronchus}}</div>",
                        "<img src=\"paste-e6307fbfc7de9c47210570b90903bcb50bd4e2aa.jpg\">"
                    ],
                    "guid": "p=fwW&`#iD",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Etiology of Cancer:</b><div><b><br></b></div><div>Somatic mutation theory:{{c1::accumulation of particular mutations acting in concert allows disregulation of cell behaviour, malignancy. These mutations are acquired over time as cells divide.}}</div><div><br></div><div>A mutation that contributes to cancers by causing accumulatio of more genetic damage would be a mutation of what?{{c1::DNA damage repair mechanisms}}</div><div><br></div><div>Cancer, in essence, is the&nbsp;{{c1::proliferation}} of cells where and when they should not</div><div><br></div><div>Cancers are clonal, what does this mean?&nbsp;{{c1::they arise from a single abherrent cell}}</div><div><br></div><div>Would this mean all cancer cells in a cancer are the same (homogenous)?</div><div>{{c1::no}}<br></div><div><br></div><div>Why?{{c1::the genomes of the cancer cell sare unstable and as the cancer progresses, it acquires more mutations}}</div><div><br></div><div><br></div><div>Most cancers take years to develop and they have stages</div>",
                        "<img src=\"paste-d161b8b99793a744ef727763b53e9763b8d28758.jpg\">"
                    ],
                    "guid": "g=-&IclI7M",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T/F<div><br></div><div>In order for a normal cell to become malignant, only one change is needed{{c1::false, many characteristics and adaptations are needed, and they all need to work in tandem}}</div><div><br></div><div>What were the original 6 characteristics that a cnacer cell needed (Hanahan and Weinberg)?{{c1::<img src=\"paste-fb09d81c7da2c82c99355d46e616bed7be54c0e9.jpg\">}}</div><div><br></div><div>So then relating to new anti-cancer therapies, what should we target?{{c1::any of these characteristics}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "PyoTO3MP9[",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the three goals of cancer therapy?<div><br></div><div>{{c1::cure}}:{{c1::kill cancer cells, complete remission}}<br></div><div>{{c1::control}}:&nbsp;{{c1::prolong remission, decrease rate of relapse}}<br></div><div>{{c1::palliate}}:{{c1::relieve symptoms and improve quality of life}}<br></div><div><br></div><div>What are the three criteria by which anti-cancer drugs select a malignant cell?{{c1::Cell behaviour (e.g. cell proliferation)</div>• Molecular markers that identify tumours<br>• Molecular changes that confer tumour<br><div>behaviour}}</div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "Ir=<,&v0h.",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cytotoxic drugs</b><div><b><br></b></div><div>-They typically react with cellular {{c1::macromolecules}} and damage them&nbsp;<b><br></b></div><div><br></div><div>-Act on normal and cancerous cells that are {{c1::proliferating}} (limited selectivity)</div><div><br></div><div>-Were identified because they kill cells</div><div><br></div><div>What non-cancer cells are at risk of being killed by cytotoxic drugs?</div><div>{{c1::rapidly proliferating cells, such as GIT, stem cells or bone marrow cells}}<br></div><div><br></div><div><b>Targeted Drugs</b></div><div>They have a pharmacological mode of action i.e.{{c1::have an affinity for a target (enzyme,receptor,microtubule)}}</div><div><br></div><div>Act on specific {{c1::molecular}} targets that are associated with cancer<br></div><div><br></div><div><font color=\"#aa0000\">Are deliberately chosen or designed to interact with their target</font><br></div>",
                        ""
                    ],
                    "guid": "zRy&MYKa$S",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-f142627652f1adc5e2e5dcf7e1fead9e391558a1.jpg\"><div>Talk to Joe{{c1::h}}</div>",
                        ""
                    ],
                    "guid": "Fr%Ex>X&hl",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CYTOTOXIC CHEMOTHERAPY</b><div><b><br></b></div><div>Selectivity through targeting {{c1::rapidly proliferating cells}}<b><br></b></div><div><br></div><div><font color=\"#aa0000\">Some therapies target specific phases, some do not</font><br></div><div><font color=\"#aa0000\"><br></font></div><div>Name 3 S-phase specific cytotoxic drugs<br>{{c1::Doxorubicin<br>Etoposide<br>5-FloraUracil}}<font color=\"#aa0000\"><br></font></div><div><br></div><div>Name 3 M-phase (mitosis) specific cytotoxic drugs</div><div>{{c1::Vincristine<br>Vinblastine<br>Taxol}}<br></div><div><br></div><div>What is their mechanism of action?{{c1::they poison microtubules}}</div><div><br></div><div>Name 2 Cytotoxic drugs that act in all phases</div><div>{{c1::Cisplatin</div><div>Cyclophosphamide}}<br></div><div>Why do they act in all phases?</div><div>{{c1::they damage the cell by reacting with the DNA}}<br></div><div><br></div><div>Give an example of an ANTI-METABOLITE cytotoxic drug{{c1::5-Fluorouracil}}</div><div><br></div><div>Give 3 examples of cytotoxic drugs that are naturally occurring products{{c1::Vincristine</div>– Etoposide<br><div>– Doxorubicin}}</div>",
                        ""
                    ],
                    "guid": "FpYF(0JSh,",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>ALKYLATING AGENTS</b><div><br></div><div><font color=\"#aa0000\">Alkylating Agents are a sub-group of Cytotoxic Drugs</font></div><div><font color=\"#aa0000\"><br></font></div><div><font color=\"#aa0000\"><b>TYPE/ DRUG NAME/ DISEASE</b></font></div><div><br></div><div>e.g. Nitrogen Mustards/ Cyclophosphamide/ Many Malignancies</div><div><br></div><div>{{c1::Ethyleneimines and methylmelamines}} /{{c1::Altretamine}}/ Ovarian cancer</div><div><br></div><div>Methylhydrazines/ {{c1::Procarbazine}}/&nbsp;{{c1::Hodgkin’s disease}}<br></div><div><br></div><div>{{c1::Nitrosoureas}}/ Carmustine/ {{c1::Hodgkin’s disease, non Hodgkin’s lymphoma, brain, melanoma}}<br><br></div><div>{{c1::Triazenes}}/ {{c1::Dacarbazine}}/ Malignant melanoma<br><br></div><div>Platinum compounds/ {{c1::Cisplatin}}/ {{c1::Many malignancies}}<br></div>",
                        ""
                    ],
                    "guid": "PGqQVT3RYj",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>NITROGEN MUSTARDS</b><div><b><br></b></div><div><b><font color=\"#aa0000\">NITROGEN MUSTARDS ARE A SUB-TYPE of ALKYLATING AGENTS</font></b></div><div><br></div><div>What are nitrogen mustards MOA?</div><div>{{c1::they alkylate(react) with various substances in the cell, but specifically the N7 position on Guanine}}<br></div><div><br></div><div>DRUG NAME/ DISEASE IT CURES</div><div><br></div><div>e.g. Cyclophosphamide/ Broad application</div><div><br></div><div>Mechlorethamine/ {{c1::Hodgkin’s disease; non Hodgkin’s lymphoma}}<br><br></div><div><br></div><div>{{c1::Chlorambucil}}/ Chronic lymphocytic lymphoma<br><br>{{c1::Melphalan}}/ Multiple myeloma, ovarian and breast<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "l[dUI<:T*@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CYCLOPHOSPHAMIDE</b><div><b><br></b></div><div><img src=\"paste-c588b2cc0e12cc63432631be48c3cdf650c5f318.jpg\"><br></div><div>This is cyclophosphamide, what a good little boy he is, but what part is important for it to react with and kill cancer cells (or any cell for that matter, he's cytotoxic, he doesn't care who he murders)?</div><div>{{c1::those chlorine leaving groups on the end}}<br></div><div><br></div><div>What part of him lets you know he's a nitrogen mustard?</div><div>{{c1::that little nitrogen in the middle there}}<br></div><div><br></div><div>Cyclophosphamide&nbsp;Alkylates proteins, give 4 parts of a protein it can alkylate,{{c1::</div><div>Amino groups</div>– Carboxyl groups<br>– Sulphydryl<br>– Imidazole groups}}<div><br></div><div>What is the most pharmacologically relevant thing it reacts with?</div><div>{{c1::Alkylation of N7 of</div><div>guanine}}<br></div><div><br></div><div>Would cyclophosphamide be more or less reactive if it was monofunctional (one chlorine leaving group){{c1::much fucking less&nbsp;<img src=\"paste-0feaef695d7912003fe26823765ca1a941a6d65e.jpg\">}}</div><div><br></div><div>Why?{{c1::Bifunctional mustards</div>crosslink molecules<br>• DNA crosslinks<br><br>• Intra-strand and inter-<br><div>strand crosslinks}}</div>",
                        "BIS-2-chloroethylamino group is<br>essential for drug activity<br>Chloro atom provides maximum<br><br>activity"
                    ],
                    "guid": "H::?>qY~{$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-6c6d0051ad2844d9cc27ae13e81de3f4991c9997.jpg\"><div>Which is the most reactive?</div><div>{{c1::mechlorethamine}}<br></div><div><br></div><div>Why?{{c1::the more complex the r-group is the less reactive, mechlorethamine has the simplest r-group}}</div><div><br></div><div>What is the least reactive?{{c1::cyclophosphamide}}</div><div>Why?{{c1::most complex r-group, in fact tis actually a pro-drug}}</div><div><br></div><div>So presumably what we want is the most reactive?</div><div>{{c1::braitheann sé, mustards are cytotoxic drugs, if its really reactive, it is going to destroy all cells in its path, cnacer or non cancer}}<br></div><div><br></div><div>Drug/ Route of Administration/ Plasma T1/2</div><div><br></div><div>e.g.Chlorambucil/ Oral/ 90 m</div><div><br></div><div>Mechlorethamine/ {{c1::Iv (not im or sc)}}/ {{c1::1 m}}<br>Melphalan/ {{c1::Oral}}/ {{c1::90 m}}<br>Cyclophosphamide/ {{c1::Oral or iv}}/ {{c1::7 h}}<br></div><div><br></div><div>What is the acute side effect they all cause?{{c1::nausea and vomiting}}</div><div><br></div><div>Meclorethamine also causes :</div><div>Vesicant, which is&nbsp;{{c1::blistering}}, why?{{c1::it is so reactive it literally burns through the body}}</div><div>Phlebitis, which is&nbsp;{{c1::inflammation of a vein}}, why?{{c1::again really damages anything it goes through}}</div><div>Local reaction</div><div><br></div><div>What is the chronic side effect they all cause&nbsp;{{c1::bone marrow depreciation, sort of alopecia}}</div><div>Why?{{c1::they're all cytotoxic, so they're going to effect rapidly proliferating cells}}</div><div><br></div><div>What has the most chronic side effects?&nbsp;{{c1::cyclophosphamide}}</div><div>We'll get to what they are, dw Joe</div><div><br></div><div><br></div>",
                        "<img src=\"paste-4143c0738aa48da26c90da853a4b15eb909a80d4.jpg\">"
                    ],
                    "guid": "j+C{tsoP)z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cyclophosphamide metabolism</b><div><b><br></b></div><div><img src=\"paste-2a44e1a30365281bcadd175abf47f2f778c62081.jpg\"><b><br></b></div><div>This step happens in the liver, what enzyme makes it happen?{{c1::Hepatic cyt P450}}</div><div><br></div><div>4-hydroxy-cyclophosphamide is then non-enzymatically converted into one of two products, one is aldophosphamide whichis furthering the metabolic process, what is the other product?{{c1::4-keto-cyclophosphamide}}</div><div><br></div><div>What is the significance of this?&nbsp;{{c1::just a non-toxic metabolite}}</div><div><br></div><div>Aldophosphamide is converted non-enzymatically into <font color=\"#aa0000\">phosphoramide</font> which is the <font color=\"#aa0000\">first toxic metabolite of cyclophosphamide.</font></div><div><br></div><div>Aldophosphamide can also undergo an enzyme mediated reaction</div><div>What is the enzyme?{{c1::Aldehyde dehydrogenase}}</div><div>What is the product? {{c1::Carboxyphosphamide}}</div><div>What is the significance of this?{{c1::a detoxification mechanism, its great in liver cells, as it means liver is protected, but we DO NOT want this to happen in a cancer cell}}</div><div><br></div><div>What does phosphoramide break down into? {{c1::Nornitrogen mustarad and acrolein}}(2)</div><div><br></div><div>Which is the functional metabolite in a cancer cell?</div><div>{{c1::nornitrogen mustard, alkylates DNA and kills cell}}<br></div><div><br></div><div>What does the other metabolite do?</div><div>{{c1::Its just really reactive, we try to excrete it as quick as possible from the bladder, causes most of side effects}}</div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-45fb862cea3f3321acaa8d54db740d78afd8b8c8.jpg\">"
                    ],
                    "guid": "sA.d}/`[7h",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>MORE CYCLOPHOSPHAMIDE</b><div><b><br></b></div><div>Normal tissues such as liver may be protected from<br>cyclophosphamide by high levels of {{c1::– Aldehyde dehydrogenase}} and {{c1::– Glutathione and Glutathione transferases}}<b><br></b></div><div><br></div><div>What does each detoxify?</div><div>{{c1::Aldehyde dehydrogenase detoxifies Aldo- phosphamide}}</div><div>{{c1::Glutathione and Glutathione transferases detoxify Nornitrogen</div><div>mustard}}</div><div><br></div><div>So how might a cancer cell evolve to become immune to cyclophosphamide?{{c1::develop high levels of Aldehyde dehydrogenase and&nbsp;&nbsp;Glutathione and Glutathione transferases}}</div><div><br></div><div><b>Controlling the side effects of cyclophosphamide</b></div><div><b><br></b></div><div><i>Control ACROLEIN and you control the side effects</i>.</div><div><br></div><div>Haemorrhagic Cystitis:<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span>{{c1::<span style=\"color: rgb(32, 33, 36);\">inflammation of the bladder defined by lower urinary tract symptoms that include dysuria, hematuria, and&nbsp;</span><b>hemorrhage</b>}}</div><div><br></div><div>You reduce acrolein toxicity by,</div><div>-Increased&nbsp;{{c1::fluid}} intake, why?&nbsp;{{c1::piss more, less time for acrolein to accumulate}}</div><div>-Administer&nbsp;{{c1::n-acetyl-cysteine}} or&nbsp;{{c1::Mesna}} why?&nbsp;{{c1::both have thiol groups and accumulate in bladder so acrolein will react with them instead of bladder epithelium }}</div>",
                        "<div><img src=\"paste-44071cd56c495a4450d2e02ef1692dbc98979c6a.jpg\"><br></div><img src=\"paste-f4699a631948a53912abfb3fe5b5f7bbe1b758a1.jpg\">"
                    ],
                    "guid": "Od#Bs/Z>oj",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Antimetabolites</b><div><b><br></b></div><div><font color=\"#aa0000\">Antimetabolites are a sub-group of cytotoxic drugs.</font></div><div><font color=\"#aa0000\"><br></font></div><div><div>-Interfere\nwith production of {{c1::nucleic acids}}</div>\n<div>-Inhibit\nproduction of deoxyribonucleoside {{c1::tri}}phosphates</div>\n<div>-Others\nmimic purines or pyrimidines and inhibit {{c1::nucleotide}} synthesis</div></div><div><img src=\"paste-42f9894f449b3fbfdce25ab1ac31886b291c3db4.jpg\"><font color=\"#aa0000\"><br></font></div><div>{{c1::<img src=\"paste-de727d573c1e74d0ecfad3e3dfc08bd2f15e661f.jpg\">}}</div><div><br></div><div>What is Methotrexate's MoA?{{c1::It's a competitive anolog of folic acid, and can bind to the enzyme dihydrofolate reductase and inhibit it, sice DHFR is needed to make DNA, DNA production is inhibited}}</div><div><br></div><div>What is 5-Fluorouracil's MoA?&nbsp;{{c1::mimics uridine and uracil containing monophosphates, so binds and poisons the enzyme thymidylate synthase}}</div><div><br></div><div>What is the MoA for purine analogs?{{c1::They are incorporated into the DNA, and the lesions destroy the cell}}</div><div><br></div><div>What are two complications that can arise from Antimetabolite treatment?{{c1::dose limiting toxicities and emergence of drug resistance}}</div><div><br></div><div>Give an example of a complication associated with 5-Flourouracil.</div><div>{{c1::amplification of thymidylate synthase, so 5-FU has less of an effect}}<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "GXC~AfS/5{",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Microtubule Poisons</b><div><b><br></b></div><div>T/F&nbsp;</div><div>Microtubule poisons are cytotoxic drugs&nbsp;{{c1::t}}</div><div>Microtubule poisons are fully synthetic&nbsp;{{c1::f}}</div><div><br></div><div><img src=\"paste-10734b273154eb4e97a8ee9430cfc0f9594d3683.jpg\"><br></div><div>What drug is this, and what is it isolated from?</div><div>{{c1::vincritine, periwinkle}}<br></div><div><br></div><div><img src=\"paste-70efff2decc62e26c540c3ada5f597d22b5ddccf.jpg\"><br></div><div>What drug is this, and what is it isolated from?<br></div><div>{{c1::paclitaxel, American Yew}}<br></div><div><br></div><div>What drugs destabilise microtubules?</div><div>{{c1::Vincristine, vinblastine}}</div><div><br></div><div>What drugs stabilise microtubules (thus not letting cell progress in mitosis)?{{c1::Paclitaxel}}</div><div><br></div><div>What is the dose limiting toxicity with microtubule poisons?</div><div>{{c1::neuropathy/neurotoxicity}}<br></div><div><br></div><div>What is the mechanism behind this?</div><div>{{c1::microtubules required for axonal transport, transports nutriens, organelles etc., breka that and the cell bodies of the neurons and functionality of the synapse breaks down}}</div>",
                        ""
                    ],
                    "guid": "IRfQ~]<zcm",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cyclophosphamide</b><div><b><br></b></div><div><b><font color=\"#aa0000\">Is an Alkylating Agent</font></b></div><div><b><font color=\"#aa0000\">Is a Nitrogen Mustard</font></b></div><div><b><font color=\"#aa0000\"><br></font></b></div><div>Route of administration:&nbsp;{{c1::oral or IV}}</div><div>Plasma Half life:&nbsp;{{c1::7hours}}</div><div>Acute Side effects:&nbsp;{{c1::nausea, vomiting}}</div><div>Delayed Side effects: {{c1::Bone marrow depr., haemorrhagic cystitis,&nbsp;alopecia, neurotox, water retention }}</div><div><br></div><div><img src=\"paste-417c2f701d53d3c024499d79bbc80907ce526abd.jpg\"><br></div><div>Point to the R-group</div><div>What is the significance of the R-group?{{c1::more complex the R-group, slower mustard is to react}}</div><div><br></div><div>What is the functional part of cyclophosphamide?</div><div>{{c1::BIS-2-chloroethylamino group i.e. the chlorine nitrogen and H}}<br></div><div><br></div><div>What parts of proteins do nitrogen mustards Alkylate?</div><div>{{c1::Amino groups</div>– Carboxyl groups<br>– Sulphydryl<br><div>– Imidazole groups}}<br></div><div><br></div><div>But what is the most important reaction that Nitrogen Mustards facilitate?{{c1::Alkyklation of the N7 of guanine forming a monoalkylation\nadduct, which damages DNA}}</div><div><br></div><div>Is Cyclophosphamide a monofunctional or a bifunctional mustard?{{c1::bifunctional}}</div><div><br></div><div>Why?{{c1::two Cl molecules}}</div><div><br></div><div>Is this more or less reactive then the other option?</div><div>{{c1::Much more}}<br></div><div><br></div><div>Why?{{c1::Since it has two chlorine molecules, it can crosslink molecules specifically DNA and it enables Intra-strand and inter-</div><div>strand crosslinks}}</div><div><br></div><div><b>CYCLOPHOSPHAMIDE METABOLISM</b></div><div><b><br></b></div><div><font color=\"#aa0000\">Cyclophosphamide is actually a prodrug</font></div><div><br></div><div>It is first acted upon by cytochrome p450 in the&nbsp;{{c1::liver}}</div><div><br></div><div>Which break it down into 2 products which are in equilibriam with each other</div><div><br></div><div><img src=\"paste-169c070abf4feb79b3b542a986bea030fa62ef20.jpg\"><br></div><div><br></div><div>Product 1 gets broken down into a non-reactive substance</div><div>What is product 1 and what is its non reactive substance</div><div><br></div><div>Product 2 can be broken down by an eznyme into a non reactive substance as well</div><div>{{c1::<img src=\"paste-e4643b4845a14969c03918d708152133fc8f86fc.jpg\">}}</div><div><br></div><div>How does product 2 become the functional nornitrogen?</div><div>{{c1::<img src=\"paste-36fde18e28477e182975518705f3e65fd3594f0d.jpg\">}}</div><div><br></div><div>Tissues can be protected from&nbsp;cyclophosphamide by high levels of</div><div>{{c1::Aldehyde dehydrogenase}}<br></div><div>{{c1::Glutathione and Glutathione transferases}}<br></div><div><br></div><div>Describe each&nbsp;</div><div><br></div><div>{{c1::Aldehyde dehydrogenase detoxifies Aldophosphamide to Carboxyphosphamide}}</div><div><br></div><div>{{c1::Glutathione-S-transferases enable a reaction between glutathione and nornitrogen mustard which inactiates it }}<br></div><div><br></div><div>What cells have naturally high levels of each?</div><div>{{c1::Liver}}</div><div><br></div><div>What is the incredibly toxic by-product of cyclophosphamide?</div><div>{{c1::Acrolein}}<br></div><div><br></div><div>What is the main side effect caused by this by-product?</div><div>{{c1::Haemorrhagic cystitis}}<br></div><div><br></div><div>How does this side effect come about?</div><div>{{c1::acrolein accumulates in the bladder and reacts with the epithelium}}<br></div><div><br></div><div>What are the two ways to treat this condition, and describe the mechanism of treatment?</div><div>{{c1::Increase fluid intake, keeps everything moving in the bladder, less chance of accumulation}}<br></div><div><br></div><div>{{c1::NAC or Mesna, both accumulate in bladder and both have thiol groups, which means that Acrolein reacts with them instead of bladder epithelium}}<br></div>",
                        ""
                    ],
                    "guid": "kWU?:JD&z?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>The Rest of The Nitrogen Mustards</b><div>Chronic lymphocytic lymphoma<b><br></b></div><div><br></div><div>Drug Name:{{c1::Melphalan}}<b><br></b></div><div>Used to treat: Multiple myeloma, ovarian and breast</div><div>Route of Administration: Oral</div><div>Acute Side effects: mild nausea</div><div>Delayed Side effects: Bone marrow depr.</div><div>Plasma half Life: 90 min</div><div>Molecular Structure:<img src=\"paste-eb98d33f190de9f29c8e906b71fb561906ddb1f9.jpg\"></div><div><br></div><div><br></div><div><div>Drug Name:{{c1::Mechlorethamine}}<b><br></b></div><div>Used to treat: Hodgkin’s disease; non Hodgkin’s lymphoma</div><div>Route of Administration: IV</div><div>Acute Side effects: Vesicant,severe nausea, vomiting, phlebitis, local reaction</div><div>Delayed Side effects: Bone marrow depr., amenorrhea</div><div>Plasma Half life: 1min</div><div>Molecular Structure:<img src=\"paste-064b50d61be5f1495d847aca29537c77273b4291.jpg\"></div></div><div><br></div><div><div><br></div><div>Drug Name:{{c1::Chlorambucil}}<b><br></b></div><div>Used to treat: Chronic lymphocytic lymphoma</div><div>Route of Administration: Oral</div><div>Acute Side effects: nausea, vomiting</div><div>Delayed Side effects: Bone marrow depr.</div><div>Plasma Half Life: 90min</div><div>Molecular Structure:<img src=\"paste-d442b9b15b34e0e10a7db6e5e22524ff0632b62c.jpg\"></div></div><div><br></div><div><br></div><div>Which is most reactive and why?</div><div>{{c1::Meclorethamine, simplest structure}}<br></div><div><br></div><div>Is this a good thing?{{c1::Not really, it just kills all cells in it's path, has most side effects and shortest half life}}</div><div><br></div><div>Why do all have bone marrow depr. as a delayed side effect?{{c1::Nitrogen mustards target rapidly proliferating cells, and bone marrow cells do be rapidly proliferating}}</div><div><br></div><div>What is the main long term affect of cytotoxic drugs?</div><div>{{c1::hogher risk of cancer int he future}}<br></div>",
                        ""
                    ],
                    "guid": "wTuWSSj7:Z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CISPLATIN</b><div><b><br></b></div><div><font color=\"#aa0000\">Is a type of Alkylating agent</font></div><div><font color=\"#aa0000\">Is a type of platinum compound</font></div><div><font color=\"#aa0000\"><br></font></div><div>Cisplatin\nenter cells either by transporters, such as {{c1::CTR1}}, or by {{c1::passive diffusion}}<font color=\"#aa0000\"><br></font></div><div><br></div><div>Once inside cells, it is hydrolyzed by the addition of {{c1::water}} molecules to form\na chemically reactive {{c1::aqua}} species<br></div><div><br></div><div>What can this react with</div><div>{{c1::DNA\nand with other cellular nucleophilic\ngroups, such as the thiol groups in cysteine or methionine amino acids or\nwith the&nbsp; tripeptide glutathione.}}(4)</div><div><br></div><div>How does the active Cis-platin damage the DNA?</div><div>{{c1::Binds to N7 of Guanine, and due to its bifunctionality it can cross link molecules as well }}<br></div><div><br></div><div>Would trans-platin be more or less reactive?</div><div>{{c1::Less}}<br></div><div><br></div><div>Why?</div><div>{{c1::the trans form is\nmore reactive, meaning it does not reach the DNA before it has reacted with a\ntarget and/or because the trans conformation limits crosslinking in DNA.}}</div><div><br></div><div>What are the two ways cisplatin is ejected from the cell?</div><div>{{c1::through\nthe copper exporters ATP7A and ATP7B}}</div><div>{{c1::glutathione\nS-conjugate export GS-X pump}}</div><div><br></div><div>How would a cell become resistant to cisplatin?</div><div>{{c1::Higher levels of glutathione S-conjugate}}<br></div><div><br></div><div><div>Cisplatin\ntaken up by an organic cation transporter expressed on {{c1::renal tubular}} cells</div>\n<div>Generation\nof {{c1::ROS}} causes cisplatin induced {{c1::nephotoxicty}}</div></div>",
                        "<img src=\"paste-8cdd4d995da2419b0e984c4526cf52a03afab6ed.jpg\"><div><img src=\"paste-54092d59d7f77ab4065a69789847351b5f139257.jpg\"><br><div><br></div></div>"
                    ],
                    "guid": "MuF!47zTOD",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>THE PURINE ANALOGS</b><div><b><br></b></div><div><i>SUB-GROUP OF ANTI-METABOLITES</i></div><div><i><br></i></div><div>Drug Name:{{c1::Mercaptopurine}}</div><div>Used to treat: ALL, AML</div><div><br></div><div>Drug Name:&nbsp;{{c1::Fludarabine}}</div><div>Used to treat: CLL</div><div><br></div><div>What is their MoA?</div><div>{{c1::Incorporated into DNA and the lesions cause DNA damage}}<br></div>",
                        ""
                    ],
                    "guid": "ekiP5Bv;xK",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>FOLIC ACID ANALOGS</b><div><br></div><div><i>SUB-GROUP OF ANTI-METABOLITES</i></div><div><i><br></i></div><div><u>Methotrexate</u></div><div><br></div><div>Used to treat:&nbsp;{{c1::ALL, breast, head and neck, lung, bladder}}</div><div><br></div><div>MoA:&nbsp;{{c1::Competitive Analog of Folic Acid, so can bind to enzyme dihydrofolate reductase and inhibits it, and DHFR is needed for DNA synthesis, so it effectively inhibits DNA synthesis}}</div><div><br></div><div><u>Raltitrexed</u></div><div><u><br></u></div><div>Used to treat:&nbsp;{{c1::Colon}}</div><div><br></div><div>MoA: {{c1::Thymidylate synthase is an enzyme needed to convert dUMP to dTMP and then to dTTP which is is needed for DNA repair, raltitrexed binds to TS at CH2THF site and inhibits it, so a DNA repair mechanism is inhibited&nbsp;}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "B|b<%K{U-S",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>5-FLUORURACIL</b><div><b><br></b></div><div><i>A PYRIMIDINE ANOLOG</i></div><div><i>AN ANTI-METABOLITE</i></div><div><i><br></i></div><div>Used to treat: {{c1::Breast, <u><b><i>colon</i></b></u>, stomach, head and neck</div>\n<div>AML, ALL, non Hodgkin’s lymphoma}}</div><div><br></div><div>5-Fluorouracil has <u>3</u>&nbsp;mechanisms of action</div><div><br></div><div>1. Being converted to&nbsp;{{c1::FUTP}} which is taken up by&nbsp;{{c1::RNA}} and the lesions it causes, causes serious damage to the cells</div><div><br></div><div>2.Being converted to&nbsp;{{c1::FdUTP}} which is taken up by&nbsp;{{c1::DNA}} and the lesions it causes, causes serious damage to the cells</div><div><br></div><div>3. Being converted to&nbsp;{{c1::FdUMP}} which binds to and inhibits the enzyme {{c1::Thymidylate Sulfate}} which inhibits&nbsp;{{c1::DNA}} repair mechanism</div><div><br></div><div>The full conversions are here&nbsp;{{c1::<img src=\"paste-ff02b30f5bfc2e4a15f1c32f384d5a2c20934cc4.jpg\">}}</div><div><br></div><div>How is 5-flourouracil metabolised?</div><div>{{c1::5-FU is broken down by (DPD)-mediated conversion of 5-FU\nto dihydrofluorouracil\n(DHFU)}}</div><div><br></div><div>Where does this metabolism happen?&nbsp;{{c1::the liver}}</div><div>How much is metabolised through fps?&nbsp;{{c1::80}}%</div><div><br></div><div>How would a cell become resistant to 5-flourouracil?</div><div>{{c1::Upregulation of Thymidylate Synthase so there's too much for the 5-FU to have any real effect}}<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "wVg0(U&t/}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>MICROTUBULE POISONS</b><div><br></div><div><i>MADE FROM NATURAL PRODUCTS</i></div><div><i><br></i></div><div><u>VINCA ALKALOIDS</u></div><div><u><br></u></div><div>Drug Name:&nbsp;{{c1::vinblastine}}</div><div>Used for: Kaposi’s\nsarcoma, Hodgkin’s\ndisease, breast, lung, testicular, others, Acute\nlymphocytic leukemia</div><div><br></div><div>Drug Name: Vincristine</div><div>Used for: acute\nlymphocytic leukemia, neuroblastoma, others</div><div><br></div><div>What plant were both isolated from?{{c1::Catharanthus\nroseus/ Periwinkle}}</div><div><br></div><div>What is the MoA for the Vinca Alkaloids?</div><div>{{c1::They destabilise the microtubules}}</div><div><br></div><div><u>TAXANES</u></div><div><br></div><div>Drug Name: Paclitaxel (Taxol)&nbsp;</div><div>Used For: Ovarain,\nbreast, lung others small cell</div><div><br></div><div>What plant was it originally isolated from?&nbsp;{{c1::American Yew}}</div><div><br></div><div>What is the mechanism for the Taxanes?&nbsp;</div><div>{{c1::they stabilise the microtubules, so they arrest the cell in a certain stage of mitosis}}<br></div><div><br></div><div><br></div><div>T/F</div><div>Microtubule poisons are simple drugs{{c1::false, they're so fucking complicated}}</div><div><br></div><div>What is the dose limiting toxicity for microtubule poisons?</div><div>{{c1::neurotoxicity/neuropathy}}<br></div><div><br></div><div>WHat is the mechanism for this?</div><div>{{c1::microtubules required for axonal transport, material, organelles, proteins, nutrients etc., if you cut that off then synapse and cell body suffers}}</div><div><br></div>{{c1::Vincristine}} causes more severe neuropathy than {{c1::paclitaxel}}.\nVincristine is delivered iv but intrathecal delivery is {{c1::fatal}}.<div>\n<div><br></div><div>Anterograde fast axonal transport\ninhibited potency being vincristine {{c1::&gt;}}\npaclitaxel. </div>\n<div><br></div><div>Paclitaxel does not {{c1::inhibit}} retrograde\nfast axonal transport while vincristine\ndoes.</div></div><div><br></div>",
                        "<img src=\"paste-030213664e93ca85c90f0ed2d8026d92d19d9b8a.jpg\">"
                    ],
                    "guid": "n^<F022.oA",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cellular\nconsequences of treatment with cytotoxic drugs&nbsp;</b><div><b><br></b></div><div><div>•Damage\nto/perturbation&nbsp; of cellular\nmacromolecules</div>\n<div>–{{c1::DNA}}</div>\n<div>–{{c1::Microtubules}}</div>\n<div>•Disruption\nof cellular processes</div>\n<div>–{{c1::Cell\ncycle arrest}}</div>\n<div>•Activation\nof a “checkpoint” and/or stress response and increased cancer cell death</div>\n<div>–Up-regulation\nof {{c1::p53}}</div></div><div><br></div><div>All these designed to cause&nbsp;{{c1::apoptosis}} of the cell</div><div><br></div>",
                        ""
                    ],
                    "guid": "P$?L,6,8@^",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give 3 benefits of drug combination therapy<div><br></div><div><div>•{{c1::Additive\nor synergistic effects}}</div>\n<div>•{{c1::Reduced\nrisk of drug-resistance}}</div>\n<div>•{{c1::Reduced\nconcentration of each drug</div>\n<div>–Limits\nadverse effects}}</div></div>",
                        ""
                    ],
                    "guid": "z<Mok3e1l9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::75}}% of breast cancers are positive for the Oestrogen receptor (ER+).<br><div><br></div><div><font color=\"#aa0000\">Means Tumour is Reliant On ER Signalling to Proliferate and Survive</font></div><div><font color=\"#aa0000\"><br></font></div><div>The oestrogen receptor is initially inactive in the&nbsp;{{c1::cytoplasm}} of the cell.</div><div><br></div><div>What type of oestrogen binds to the oestrogen receptor?</div><div>{{c1::E2, also known as Oestradiol}}<br></div><div><br></div><div>The receptor then&nbsp;{{c1::dimerizes}} and translocates to the&nbsp;{{c1::nucleus}}</div><div><br></div><div>What does it bind in the nucleus?</div><div>{{c1::to\nthe oestrogen response element which is a ligand activated transcription factor, specifically activating\nfunction 1 (AF1) and 2 (AF2)}}</div><div><br></div>",
                        "<img src=\"paste-e7c1cfd6b4121e5866e2fe423389ffdbfac5d32f.jpg\">"
                    ],
                    "guid": "PHARe3JE*]",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>THE DRUGS THAT EFFECT THE OESTROGEN RECPTORS</b><div><b><br></b></div><div><b>The SERMs (SELECTIVE ESTROGEN RECEPTOR MODULATORS)</b></div><div><b><br></b></div><div>MoA:&nbsp;{{c1::partial agonists}} of the ER that interfere with the signalling that make it more likely for&nbsp;{{c1::pro-apoptotic}} signals to be expressed.</div><div><br></div><div>{{c1::tamoxifen}} and&nbsp;{{c1::Toremifene}} are SERMs used for Breast cancer<br></div><div><br></div><div>Clomiphene is used for {{c1::(Female infertility)}}<br></div><div><br></div><div>Bazedoxifene is on Clinical trial for {{c1::osteoporosis)}}</div><div><br></div><div>Ospemifene is on Clinical trial for {{c1::vaginal atrophy &amp; dryness)}}<br></div><div><br></div><div><b>The SERDs (SELECTIVE OESTROGEN RECEPTOR DOWN REGULATORS)</b></div><div><b><br></b></div><div>MoA: Pure ER&nbsp;{{c1::antagonist}} binds to ER and prevents&nbsp;{{c1::dimerization}} and increases ER degradation by use of&nbsp;{{c1::proteases}}</div><div><br></div><div>The ONLY SERD that is approved is {{c1::Fulvestrant}}<br></div><div><br></div><div>Approved for {{c1::post menopausal}} women with ER+ tumours and metastatic tumours {{c1::refractory}} to other anti-<br>oestrogen therapy<br></div><div><br></div><div><b>THE AROMATASE INHIBITORS</b></div><div><br></div><div>Aromatase is a {{c1::cytochrome p450}} enzyme, which converts {{c1::androgens}} into estrogens</div><div><br></div><div>Steroidal Aromatase Inhibitors: {{c1::Formestane, <b>EXEMESTANE</b>}}</div><div>Non-Steroidal Inhibitors: {{c1::Letrozole, ANASTROZOLE}}</div><div><br></div><div><br></div><div><br></div><div>Most of these treatments are used in combination with other treatments</div>",
                        "<img src=\"paste-96ec4dff56499d172d43a4e2c4e72d204472c9df.jpg\"><div><img src=\"paste-a87f7b70d927deb77be1f282d92de839a5ecd641.jpg\"><br></div>"
                    ],
                    "guid": "z^:w~(koCQ",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Prostate Cancer</b><div><b><br></b></div><div>{{c1::80-90}}%\nprostate carcinomas are androgen dependent&nbsp;initially<b><br></b></div><div><br></div><div>Non-steroidal Anti-androgens such as&nbsp;{{c1::Flutamide, Bicalutamide, Nilutamide}}(3) are used to treat this.</div><div><br></div><div>Inhibit androgen-binding to the receptor i.e. is an&nbsp;{{c1::antagonist}}<br></div><div><br></div><div><font color=\"#aa0000\">Unfortunately prostate cancer generally develops beyond androgen dependancy which eventually makes it unresponsive to the Non-steroidal Anti-androgens</font></div>",
                        ""
                    ],
                    "guid": "xva!p<N4^z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How might anti-androgen therapy increase the amount of androgen in the body?<div>{{c1::The feedback loop will no longer have androgens giving it feedback so more will be produced}}<br></div><div><br></div><div>So <b>GnRH agaonists, </b>such as {{c1::</div><div>Leuprolide (Lupron), Goserelin (Zoledex), Triptorelin</div>(Trelstar), Histrelin (Vantas)}}(4) are used.<div><br></div><div>What is their MoA:{{c1::Down-regulates a GPCR involved with the androgen feedback loop}}<br><div><br></div></div>",
                        "<img src=\"paste-bbd7a6353ea4874c110ed0076dc010cd3173d42d.jpg\"><div>I don't know what this means</div>"
                    ],
                    "guid": "tX4?>VQ^Lv",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Glucocorticoid Receptor.</b><div><b><br></b></div><div><font color=\"#aa0000\">Activating the glucocorticoid receptor in some case causes cell death</font></div><div><font color=\"#aa0000\"><br></font></div><div>Dexamethasone and&nbsp;{{c1::prednisone}} are two corticosteroids used in the treatment of&nbsp;{{c1::Acute Lymphoblastic</div><div>Leukemia}}&nbsp;</div><div><br></div><div>What is the MoA?</div><div>{{c1::Binds to the GR, which translocates to the nucleus and binds to the Glucocorticoid response element and either transactivates or represses some genes, which leads to altered gene expression, which leads to cell cycle arrest and apoptosis}}<br></div><div><br></div><div>What are the corticosteroids usually used in combination with for this particular condition?&nbsp;{{c1::vincristine}}</div>",
                        "<img src=\"paste-514eda490250291d9b0416b37c1deb060e5e211c.jpg\">"
                    ],
                    "guid": "`{OjkXHqj",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>All-Trans-Retinoic Acid</b><div><b><br></b></div><div>What is used to treat?&nbsp;{{c1::Acute promyelocytic leukemia}}<br><div><br></div></div><div>How is the MoA of the disease? . {{c1::The PML gene on Chromosome 15 is fused to the RARa gene\non Chromosome 17 to produce a PML-RARa fusion protein that inhibits myelocytic\ndifferentiation.}}{{c1::<img src=\"paste-a5bcfd992e5143b2b8db58cd6db7e568871f2259.jpg\">}}</div><div><br></div><div>So how does&nbsp;<b>All-Trans-Retinoic Acid </b>help with this?</div><div>{{c1::If you give a high enough dose, it will outnumber the faulty gene expression and thus forcing the cancer cell to differentiate}}<br></div>",
                        ""
                    ],
                    "guid": "b`3hBfYOdR",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T/F<div>One activated oncogene is not enough to cause cancer&nbsp;{{c1::t}}</div><div>An activated TSG causes cancer&nbsp;{{c1::f, the opposite}}</div><div>An oncogene needs to be constantly active to cause cancer&nbsp;{{c1::t}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "D|{wSgvp>?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>The Philadelphia Chromosome</b><div><b><br></b></div><div>Caused by a translocation between chromasomes 9 and 22 which causes the oncogenic kinase&nbsp;{{c1::ABL}} to attach to&nbsp;{{c1::BCR}}</div><div>Which causes the tyrosine kinase to be constituitively active.</div><div><br></div><div>This kinase can phosphorylate certain proteins which activates certain oncogenic pathways such as&nbsp;{{c1::Ras, PI3-kinase, Jak-STAT}}(3)</div><div>And certain oncogenic transcription factors such as&nbsp;{{c1::c-Myc, NF-KappaB, Jun}}</div><div><br></div><div>Which causes the condition&nbsp;{{c1::CML, can also cause ALL,\nCNL and AML}}</div><div><br></div><div><br></div>",
                        "<div>•Retrovirus\nused to introduce BCR-ABL in to\nmouse</div>\n<div>•Mice\ndeveloped a CML-like leukemia</div>\n<div>•Mutant\nBCR-ABL (lacking kinase\nactivity) did not induce leukemia</div><div><br></div><div>This is how Imatanib was found</div>"
                    ],
                    "guid": "yZkL%h8,%>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>KINASE THERAPY</b><div><br></div><div>Class of Kinase Inhibitor:Type I<br></div><div><br></div><div>MoA: {{c1::Competes for the substrate and binds in the ATP-binding pocket of the active conformation }}</div><div><br></div><div>Examples of Drugs:{{c1::Bosutinib, Cabozantinib, Ceritinib,</div>Crizotinib, Gefitinib, Pazopanib, Ruxolitinib, Vandetanib}}(8)<div><br></div><div><br></div><div><br></div><div><div>Class of Kinase&nbsp;Inhibitor:Type II<br></div><div><br></div><div>MoA: {{c1::Type II inhibitors bind to the DFG-Asp out protein kinase conformation, which corresponds to an inactive enzyme form}}</div><div><br></div><div>Examples of Drugs: {{c1:: Imatinib, Sorafenib, Axitinib, Nilotinib }}(4)</div></div><div><br></div><div><br></div><div><div>Class of Kinase&nbsp;Inhibitor: Type III (Allosteric Inhibitor)</div><div><br></div><div>MoA: {{c1::Occupy a site next to the ATP-binding pocket so that both ATP and the allosteric inhibitor can bind simultaneously to the protein.}}</div><div><br></div><div>Examples of Drugs:&nbsp;&nbsp;{{c1::Trametinib, GnF2}} (2)</div></div><div><br></div><div><br></div><div><br></div><div><div>Class of Kinase&nbsp;Inhibitor:&nbsp; Type IV (Substrate Directed Inhibitors)</div><div><br></div><div>MoA:&nbsp; {{c1::Undergo a reversible interaction outside the ATP pocket and offer selectivity against targeted kinases}}</div><div><br></div><div>Examples of Drugs:&nbsp; ONO12380</div></div><div>What is&nbsp;ONO12380 used for?</div><div>{{c1::binds\nan allosteric site on BCR-ABL and can be used to treated imatinib\nresistant CML.}}</div><div><br></div><div><br></div><div><br></div><div><div>Class of Kinase&nbsp;Inhibitor: Type V (Covalent Inhibitor)</div><div><br></div><div>MoA:{{c1::Bind covalently (irreversible)to their protein kinase target}}</div><div><br></div><div>Examples of Drugs:&nbsp;{{c1::Afatinib, Ibrutinib, HK1–272}}</div></div><div><br></div><div><div><font color=\"#aa0000\">The discovery that Rous sarcoma virus\nencoded an oncogenic gene that was a tyrosine\nkinase (v-src) first\nimplicated kinases in the pathogenesis of cancer.\nOther human\noncogenes were subsequently found to be kinases. Imatinib\ndemonstrated the efficacy of targeting kinases in\ncancer and triggered a revolution in cancer therapy heralded the era of\n“targeted therapy”.&nbsp;</font></div></div><div><font color=\"#aa0000\"><br></font></div><div>What are the benefits of targeting oncogenic kinases?</div><div>{{c1::increased specificity,\nfewer adverse effects and dose limiting toxicity,\nculminating in &nbsp;and better patient outcomes}}</div><div><br></div><div><b>Different Ways of Targeting Kinases</b></div><div><b><br></b></div><div>Examples of small molecule kinase inhibitors</div><div><br></div><div>Drug Name: Gefitinib</div><div><br></div><div>Class of tyrosine kinase: Type&nbsp;{{c1::I}}</div><div><br></div><div>Targeting what?:&nbsp;{{c1::Epithelial growth factor receptor EGFR}}</div><div><br></div><div>What is it used to treat?&nbsp;{{c1::Lung Cancer (NSCLC)}}</div><div><br></div><div><br></div><div>Drug Name: Vemurafenib&nbsp;</div><div><br></div><div>Targeting What?:{{c1::BRAF}}</div><div><br></div><div>What is it used to treat?{{c1::Melanoma}}<br></div><div><br></div><div><br></div><div>Drug Name: Sorefenib</div><div><br></div><div>Class of Tyrosine Kinase: Type&nbsp;{{c1::II}}</div><div><br></div><div>What is it Used to Treat?&nbsp;{{c1::Hepatocarcinoma}}</div><div><br></div><div>Sorefenib has 3 MoAs, can you describe them?</div><div>1.&nbsp;{{c1::can activate a cell death process called ferroptosis}}</div><div>2.&nbsp;{{c1::Inhibits PDGFR signalling}}</div><div>3.{{c1::Targets MAP kinase pathways}}</div><div><br></div><div>Monoclonal Antibodies have also been used as they can bind to the extracellular domain of\nreceptor tyrosine kinases: such as Cetuximab which binds to the&nbsp;{{c1::EGFR}} in&nbsp;{{c1::Colorectal}} cancer</div><div><br></div><div>And Trastuzumab which binds to&nbsp;{{c1::HER-2 (tyep of EGFR)}} in&nbsp;{{c1::HER-2+ Breast}} cancer</div><div><br></div><div>mAbs can also bind to signalling molecules to prevent it from activating a receptor:</div><div>Such as&nbsp;Bevacizumab, which binds&nbsp;{{c1::VEGF}}, which stops it binding to the&nbsp;{{c1::VEGFR}} which inhibits&nbsp;{{c1::angiogenesis}} in&nbsp;{{c1::renal}} cancer</div>",
                        "<img src=\"paste-758998a2099dfa471c476d3a0c23c722df9b1395.jpg\">"
                    ],
                    "guid": "hUxB_8{c=w",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<font color=\"#aa0000\">BRCA1/2 genes play roles in\nhomologous recombination and contribute to DNA repair after damage.&nbsp;</font><br><div><br></div><div>BRCA1/2 Mutations often lead to breast cancer.&nbsp;</div><div><br></div><div>BRCA1/2 mutated cancer rely on&nbsp;{{c1::base excision repair}} to survive, which is mediated by&nbsp;{{c1::PARP}}. Therefore a treatment for cancers such as this is to inhibit&nbsp;{{c1::PARP}}, which means cancer DNA cannot be repaired, thus leading to cell death.</div><div><br></div><div>An example of a drug like this is&nbsp;{{c1::Olaparib}}</div><div><br></div>",
                        "<img src=\"paste-da0fa0cdbaa8e9a2ce41175ac20c896dc70fbcf2.jpg\">"
                    ],
                    "guid": "pnz;$>9z?[",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>Irinotecan</b><br></div><div><br></div>A drug used to treat {{c1::colorectal}} cancer<br><br><div><br></div><div>• A prodrug activated by a {{c1::carboxylesterase}}to SN-38 which&nbsp;inhibits topoisomerase I<br><br></div><div>• Topoisomerase I is an enzyme that<br>{{c1::plays a role in unwinding DNA}} which<br>is required for DNA replication and<br>transcription<br><br></div><div>• By blocking DNA replication and/or<br>transcription, SN-38 induces<br>apoptosis<br><br></div><div>• SN-38 inactivated by {{c1::glucuronidation}}<br>by {{c1::uridine diphosphate glucoronosyl</div>transferase 1A1 (UGT1A1)}}<div><br></div><div>What is the first dose limiting toxicity of Irinotecan?</div><div>{{c1::Myelo-suppression</div>(bone marrow<br><div>suppression)}}<br></div><div><br></div><div>Why?{{c1::rapidly proliferating cells}}</div><div><br></div><div>What is the second dose limiting toxicity?</div><div>{{c1::Kills gut cells and causes potentially fatal diarrhoea}}<br></div><div><br></div><div>Why?{{c1::Glucuronide is</div>metabolized by gut<br><div>microbes so then its just SN-38 again, and gut cells are rapidly proliferating}}</div>",
                        "<img src=\"paste-c99ef6d49733965a70f2c775665867d6418c31ef.jpg\"><div><img src=\"paste-341a32e835a8a97d53f7b414b9763f2ff72daad4.jpg\"><br></div>"
                    ],
                    "guid": "p6njI@2yZo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Doxorubicin (Adriamycin)</b><div><b><br></b></div><div>An antibiotic derived from {{c1::Streptomyces}}<br><br></div><div>Binds DNA (it is an “intercalating agent”)<br><br>Doxorubicin bound to DNA inhibits {{c1::topoisomerase II}}</div><div><br></div><div>Which does what?<br>{{c1::• DNA synthesis ceases<br>• DNA double&nbsp; strand breaks occur}}<b><br></b></div><div><br></div><div><br></div><div>What is the big old dose limiting toxicity with Doxorubicin?</div><div>{{c1::Acute and chronic Cardiotoxicity</div>– Severe and rapidly progressive congestiveheart failure}}<div><br></div><div>Doxorubicin can be reduced by&nbsp;{{c1::quinone reductase}} to form doxirubicin semiquinone.</div><div><br></div><div>Doxirubicin Semiquinone can react with&nbsp;{{c1::Fe3+}} to generate {{c1::free radicals}}.</div><div>{{c1::<img src=\"paste-3cc3b5eefa27151400d5d7f53861fb00ff0a0f99.jpg\">}}</div><div><br></div><div>Why does it effect cardiac tissue more than others?</div><div>{{c1::–because\nheart has lower levels of superoxide dismutase and catalase</div>\n<div>–Enzymes\nwhich protect against free radicals}}<br></div><div><br></div><div>How to prevent this.</div><div><br></div><div>Co-treatment with iron {{c1::chelators}} such as&nbsp;{{c1::dexrazoxane}} to limit redox cycling<br></div><div>which has been show to reduce cardiotoxicity from</div>{{c1::47}}% to {{c1::6}}%<div><br></div><div>Synthesis of Doxorubicin analogues that retain<br>the DNA interchelating activity of the drug but<br>do not redox cycle<br>– {{c1::Mitoxantrone}}, synthetic doxorubicin-like drug<br><div><br></div></div>",
                        "<img src=\"paste-46d7b6eabe396216aab2d8a64182e9f2fcfda762.jpg\"><div>Subclinical cardiac<br>damage in approx 25% of<br>children treated with<br>moderate doses<br></div>"
                    ],
                    "guid": "gU:qaReibQ",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-372f47f53491c4d96ebdebb5b7fb5d83397c5247.jpg\"><div>{{c1::<img src=\"paste-a60d159962ee2a4b9f55caa2f170db434e150412.jpg\">}}</div>",
                        ""
                    ],
                    "guid": "bX,mhp+_Kp",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Angiogenesis and cancer</b><div><b><br></b></div><div>The supply of oxygen and nutrients to cells limits the size of a tumour to approximately a {{c1::millimetre}}.<b><br></b></div><div><br></div><div>How might a tumour get around this problem?</div><div>{{c1::Tumours\ncan stimulate angiogenesis by releasing angiogenic\nfactors or stimulating nearby normal cells to produce angiogenic\nfactors}}</div><div><br></div><div><font color=\"#aa0000\">Tumours consist of many different types of cancer cells that all have different mutations</font></div><div><br></div><div>What meadiates apoptosis for cells that don't have a good enough O2 or nutrient supply.</div><div>{{c1::Caspase 3,6,7, through proteolytic cleavage of proteins}}<br></div><div><br></div><div>Is there anything the tumour can do to prevent this?</div><div>1.{{c1::angiogenesis}}</div><div>2.{{c1::BCL-2, oncogene that inactivates these caspases}}</div><div><br></div><div>What are some so-called 'angiogenic switches' (changes that causes a tumour to express angiogenic factors)?</div><div>{{c1::oxygen\ndeprivation, although other stimuli such as inflammation, oncogenic mutations\nand mechanical stress may also play a role}}</div><div><br></div><div>What are some angiogenic factors?</div><div>{{c1::angiogenin,\nvascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and\ntransforming growth factor-β (TGF-β)}}(4)</div><div><br></div><div>What is the most prominent angiogenic factor?{{c1::VEGF, found in 60% of cells}}</div><div><br></div><div><br></div><div><b>Targeting Angiogenesis</b></div><div><b><br></b></div><div>Lets take the example of VEGF on the VEGFR to promote angiogenesis.</div><div><br></div><div>There are three ways to inhibit this</div><div><br></div><div><u>Kinase Inhibitor</u></div><div><u><br></u></div><div>Drug Name:&nbsp;{{c1::sorefenib}}</div><div><b><br></b></div><div>MoA:{{c1::Sorefenib inhibits the kinase activity of the\nVEGFR by binding to it}}</div><div><br></div><div><u>mAb</u></div><div><u><br></u></div><div>Drug Name: {{c1::Bevacizumab}}</div><div><br></div><div>MoA:&nbsp;{{c1::Binds VEGF, thus preventing it from binding the VEGFR}}</div><div><br></div><div><u>Recombinant protein<br></u></div><div><br></div><div>Drug Name:{{c1::Aflibercept}}</div><div><br></div><div>MoA: {{c1::Aflibercept is a recombinant protein that is a\nfusion of the ligand binding domain of VEGFR fused to another protein, so it can bind to VEGF, thus stopping the binding&nbsp;}}</div><div><br></div>",
                        "More kinase inhibitors<div>Axitinib<br>• Cabozantinib<br>• Pazopanib<br>• Regorafenib<br>• Sunitinib<br>• Thalidomide<br>• Vandetanib<br></div><div><br></div><div>mAb: ramucirumab</div><div><br></div><div><img src=\"paste-44e97009dd6d5df389555c135bfa0804c3f0743c.jpg\"><br></div>"
                    ],
                    "guid": "hz&rrF6-y&",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Different Ways that mAbs can elicit responses on tumour antigens.</b><div><b><br></b></div><div><b>1.</b>&nbsp;Inhibit signalling</div><div>MoA:{{c1::mAb binds to receptor which inhibits ligand binding}}</div><div>Exmaple:{{c1::Trastuzumab and the HER-2 receptor}}</div><div><br></div><div>2. Antibody dependant cellular cytotoxicity (ADCC)</div><div><br></div><div>MoA:{{c1::mAb binds to tumour antigen and immune\neffector cells, such as macrophages and natural killer (NK) cells, bind to the\nCH3 region of IgG mAbs, immune cells then do a number on the immune cell}}</div><div><br></div><div>3.CDC</div><div><br></div><div>MoA:{{c1::mAb binds to tumour antigen and complement pathway attacks tumour}}</div><div><br></div><div>4. Antibody drug conjugates (ADC)</div><div><br></div><div>MoA:{{c1::mAb bound to very cytotoxic drug, that only activates when mAb attaches to tumour antigen}}</div>",
                        "<img src=\"paste-66ff69edf891ded010870a1bec45efdfe1b68352.jpg\">"
                    ],
                    "guid": "cpiZ9&avQ_",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Antibody-drug conjugates (ADCs)&nbsp;</b><div><b><br></b></div><div>ADCs are made up of three parts</div><div>1.{{c1::antibody}}</div><div>2.{{c1::cytotoxic agent}}</div><div>3.{{c1::linker}}</div><div><br></div><div>ADC binds to antigen on tumour, how does cell die?</div><div>{{c1::ADC brought inside the cell due to endocytosis, lysosomes break linker, andcytotoxic drug goes to town}}<br></div><div><br></div><div>Examples:</div><div>Lapatinib-Capecitabine, what is capecitabine a prodrug of&nbsp;{{c1::5-flourouracil}}</div><div>Trastuzumab-Emtansine, when would you use this drug?{{c1::if treatment for trastuzumab (which is an ADCC) isn't working}}</div><div><br></div><div><img src=\"paste-34e5ff10f3f03c0a8f35eec17db8a0187c38ca6a.jpg\"><br></div>",
                        "<img src=\"paste-30e42cf60f37ca63573d254d1481a5dd10f7f155.jpg\">"
                    ],
                    "guid": "m_{K@+MKq*",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Anti-tumour T-cell responses</b><div><b><br></b></div><div>A t-cell has two ways that a tumour cell cn comunicate with it to not harm it.</div><div><br></div><div>1. CD80;CD86 on the tumour binds to CTLA-4 on t-cell</div><div><br></div><div>Give a drug that inhibits this,&nbsp;{{c1::Ipilimumab}}</div><div><br></div><div>2. PD-1 on T-cells bind to PD-L1 on cancer cells</div><div><br></div><div>What drugs target PD-1 (T-cell)&nbsp;{{c1::Pembrolizumab, Nivolumab}}</div><div>{{c1::Melanoma of the skin, non- small cell lung cancer, kidney cancer, bladder cancer, head and neck cancers, and Hodgkin lymphoma if the tumour is positive for PD-1L}}</div><div><br></div><div>What drugs target PD-L1 (cancer cells)&nbsp;{{c1::Atezolizumab, Avelumab, Durvalumab}}</div><div>{{c1::Bladder cancer, non-small cell</div>lung cancer, and Merkel cell skin<br><div>cancer (Merkel cell carcinoma)}}<br></div>",
                        "<img src=\"paste-566cf6c0b0605f6416ec46019c81132675b7f7fb.jpg\"><div><img src=\"paste-3274d80e8aca22c9f25308fbf7d2045c534000d0.jpg\"><br></div>"
                    ],
                    "guid": "s!>epye_];",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>The Importance of Downstream Stuff (also two new drugs)</b><div><b><br></b></div><div>This is the&nbsp;{{c1::MAPK}} signalling pathway<br><div><b><br></b></div><div><img src=\"paste-43b2eff959ecf31338fba1b0f59644c1809484db.jpg\"><b><br></b></div><div>Anything in red causes a different type, or a few different types of cancer</div><div><br></div><div>But if we target BRAF or MEK (1/2) we can treat all of these cancers</div><div><br></div><div>BRAF is inhibited by&nbsp;{{c1::Vemurafenib}} which is mainly used to treat&nbsp;{{c1::melanoma}}</div></div><div><br></div><div>MEK 1/2 is inhibited by&nbsp;{{c1::Selumetinib}}</div>",
                        ""
                    ],
                    "guid": "z=_nj&fOEr",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Ventoclax:</b><div><b><br></b></div><div>Type of Drug:&nbsp;{{c1::BH3 Mimetic}}</div><div><br></div><div>MoA:{{c1::Inhibits Anti-apoptotic Bcl-2 Proteins}}</div>",
                        ""
                    ],
                    "guid": "C*H<[OWOw@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><br></div>Tazemetostat is a\npotent and selective inhibitor of\nthe {{c1::EZH2 histone methyltransferase}}<div><br></div><div><br></div>",
                        "EZH2\nis overexpressed or mutated in a variety of cancer cells and plays a key role\nin tumor cell\nproliferation. Inhibition of EZH2 specifically prevents the methylation of\nhistone H3 lysine 27 (H3K27),\naltering chromatin conformation and patterns of gene expression patterns, disrupting signalling and\ndecreasing tumour cell proliferation in cancers with&nbsp; EZH2\nmutations"
                    ],
                    "guid": "nra0@`tF8o",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>Selinexor</b><br></div><div><br></div>Selective\ninhibitors of nuclear export are drugs that block {{c1::exportin 1\n(XPO1 or CRM1)}}, a protein involved in transport from the cell nucleus to the\ncytoplasm<div><br></div><div>What does it treat&nbsp;{{c1::Multiple Myeloma}}</div><div>When would you use it?&nbsp;{{c1::A last resort}}</div>",
                        ""
                    ],
                    "guid": "p$RoXC,Ou$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "a06f113b-aded-11eb-8ae2-c0b5d703b09e",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-19c7a6c326242e786b67a57e369eadb2704ad331.jpg",
                "paste-419b245e3c75ea17e642c70f7e0bb6040489e906.jpg",
                "paste-703866f7c963dfe5bbcc4d2c1313c5f9bbf456db.jpg",
                "paste-fd6b73b9ed766f2d1174fee03edb105a78b1f655.jpg"
            ],
            "mid": 1602236504918,
            "name": "05/05 Dennedy Pituatary",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>PITUITARY GLAND</b><div><b><br></b></div><div>Where is it located?{{c1::sella tunica at base of skull between eyes anteriorly}}</div><div><br></div><div>The hypothalamus is continuous with the&nbsp;{{c1::posterior}} pituitary gland</div><div><br></div><div>So what would be the difference in how hypothalamus communicates with either lobe of the pituitary?</div><div>{{c1::post, communicate directly, it is continuous</div><div>Anterior, communicates through hypophyseal portal system}}<br></div><div><br></div><div>The hypothalamus releases&nbsp;{{c1::neuropeptide}} which causes the release of hormones from the ant. pituitary gland. This is normally released in a&nbsp;{{c1::pulsatile/diurnal}} pattern.</div><div><br></div><div>Hormone released by hypothalamus/ hormone reeleased by Ant pituatary/ Hormone released by gland as a result</div><div><br></div><div>GnRH/{{c1::LH+FSH}}/{{c1::Testosterone and estradiol}}</div><div>{{c1::CRF}}/ACTH/{{c1::Cortisol}}<br></div><div>{{c1::TRH}}/{{c1::TSH}}/Thyroid Hormone<br></div><div><br></div><div>And GHRH causes release of&nbsp;{{c1::Growth hormone}}</div><div><br></div><div>{{c1::Dopamine}} causes the tonic inhibition of release of&nbsp;{{c1::prolactin}} from ant pituitary</div><div>{{c1::Somatostatin}} causes the tonic and controlled inhibition of release of&nbsp;{{c1::growth hormone}} from ant pituitary<br></div><div><br></div><div>The posterior pituitary gland releases&nbsp;{{c1::oxytocin and aVP/ADH}}</div>",
                        ""
                    ],
                    "guid": "d{)uSH`3%n",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Pituitary Tumours:</b><div><br></div><div>{{c1::80}}% are non-functioning tumours, how do they effect the pituitary gland?</div><div>{{c1::compress and cause hormonal dysfunction or inhibition of the release of the hormones}}<br></div><div><br></div><div>Functioning tumours:&nbsp;</div><div>ACTH producing tumour causes {{c1::Cushing's disease}}</div><div>GH producing tumour causes&nbsp;{{c1::Acromegaly or pituitary gigantism}}</div><div>Secretory Gonadotropinomas causes&nbsp;{{c1::too much LH and FSH}}</div><div>TSHoma causes&nbsp;{{c1::hyperthyroidism}}</div><div>Prolactinomas ccause&nbsp;{{c1::too much prolactin}}</div>",
                        ""
                    ],
                    "guid": "Q/iSiX;V|X",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>HYPERPROLACTINAEMIA: Excessive Prolactin</b><div><b><br></b></div><div>SOURCES:</div><div><br></div><div>Functional tumours:</div><div>Microprolactinoma causes&nbsp;{{c1::1500-5000}}prolactin levels</div><div>Macroprolactinoma cuases&nbsp;{{c1::&gt;5000}} prolactin levels</div><div><br></div><div>How might a non-functional tumour cause it?</div><div>{{c1::Tumour compresses pituitary stalk, inhibiting dopamine transport to the pituitary}}<br></div><div>What prolactin levels does this cause?{{c1::&gt;1500}}</div><div><br></div><div>Drug Induced:</div><div>Name three drug types that would cause it</div><div>{{c1::dopamine antagonists, anti-psychotics, antiemetics}}<br></div><div>What particular function on a particular receptor would cause it?</div><div>{{c1::inhibition of D2 receptor}}<br></div><div><br></div><div>Name two other causes:</div><div>{{c1::STRESS-INDUCED</div><div>PREGNANCY / BREAST FEEDING}}<br></div><div><br></div><div><br></div><div>The prolactin receptor is a type of&nbsp;{{c1::GH}} receptor, dimerizes when prolactin binds.</div><div><br></div><div>Give two functions of this receptor</div><div>{{c1::trophic effect on breast tissue and production of milk (STAT5) signalling}}<br></div><div>{{c1::Increase in efficient fuel utilisation and glucose coming into cell (Akt)}}<br></div><div><br></div><div>Unfortunately, when there is too much it inhibits the GnRH neuron in the hypothalamus</div><div>What is the outcome of this?</div><div>{{c1::Causes inhibition of GnRH which causes Hypogonadism due to the inhibition of LH and FSH which cuases less testosterone and progesterone}}<br></div><div>{{c1::<img src=\"paste-703866f7c963dfe5bbcc4d2c1313c5f9bbf456db.jpg\">}}</div><div><br></div><div><br></div><div><br></div><div><b>Clinical Problems</b></div><div><b><br></b></div><div>Hypogonadotrophic hypogonadism:<b><br></b></div><div>{{c1::Anovulation / Infertility}}<br></div><div>{{c1::↓ Libido}}<br></div><div>{{c1::Erectile Dysfunction}}in men<br></div><div>{{c1::Osteoporosis due lack of estradiol}} in women<br></div><div><br></div><div>Galactorrhoea:&nbsp;{{c1::production of breast milk in men and women}}<br></div><div><br></div><div>Pressure Effects:</div><div>{{c1::<div>Pituitary Adenoma&nbsp;</div><div>Headache&nbsp;</div><div>Bi-temporal Visual Field\nDefect}}(3)</div></div><div><br></div><div><br></div><div><b>MEDICAL\tMANAGEMENT</b><br></div><div><b><br></b></div><div>Contraceptive pill</div><div>Hormone Replacement therapy, what hormone?&nbsp;{{c1::Dopamine, if you said prolactin you deserve to fail this exam}}</div><div><br></div><div>Very rarely surgical debulking</div><div><br></div><div>Dopamine Agonist therapy:</div><div><br></div><div>Two drugs</div><div>What is their drug class?&nbsp;{{c1::Ergot Alkaloids}}</div><div>What is their 5-HT2A mediated adverse affect thta has to be checked on every 5 years?</div><div>{{c1::right sided valvular disease}}<br></div><div><br></div><div>{{c1::Bromocriptine}}<br></div><div>t1/2 2-8 hours</div><div>3 times a day dosage</div><div>Adverse effects:</div><div>Nausea&nbsp;</div><div>Postural Hypotension&nbsp;</div><div>CNS side effects that end up being severly limiting</div><div>Can be used during pregnancy</div><div><br></div><div>{{c1::Cabergoline}}<br></div><div>4 times more potent</div><div>T1/2 65 hours</div><div>1-2 weekly</div><div>Less side effects and better clinical response</div><div>What is a side effect it has?</div><div>{{c1::Behavioural abnormalities, higher risk taking}}<br></div><div><br></div><div><br></div><div>REDUCED PROLACTIN IN &gt;{{c1::90}}% CASES<br>REDUCED TUMOUR BULK IN &gt;{{c1::70}}% CASES<br></div><div><br></div>",
                        "canstop<br>and<br>bromowiptive I cabergolineinpatients4microprolactinwasduringpregnancy"
                    ],
                    "guid": "x:*Gkw^>S_",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>GROWTH HORMONE</b><div><img src=\"paste-19c7a6c326242e786b67a57e369eadb2704ad331.jpg\"></div><div>Can you guess what factor almost all growth hormones actions are mediated by?{{c1::IGF-1}}</div><div><br></div><div>What is GH signalling pathway mediated by?{{c1::JAK-2}}</div><div><br></div><div>The effects of GH:</div><div><br></div><div>1. In bones:{{c1::increases osteoclastic activity which promotes bone mineralisation and turnover}}</div><div><br></div><div>2. In muscles:{{c1::Muscle growth and differentiation}}</div><div><br></div><div>3.Adipocytes:{{c1::Pre-adipocyte to adipocyte differentiation and fat storage}}</div><div><br></div><div>4.In kidneys:&nbsp;{{c1::Increases Glomerular Filtration Rate}}</div><div><br></div><div>5. Liver has a range of functions</div><div><br></div><div>6. Promotes acral growth and soft tissue expansion</div><div><br></div><div>7. Increases expression of&nbsp;{{c1::glucose transporter}}</div>",
                        "<img src=\"paste-fd6b73b9ed766f2d1174fee03edb105a78b1f655.jpg\">"
                    ],
                    "guid": "Nu}q?C!5Y,",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>GH DEFICIENCY</b><div><b><br></b></div><div>Most common Ant pituitary hormone deficiency</div><div><br></div><div>The treatment is&nbsp;{{c1::rhGH (replacement Growth hormone)}}</div><div>It is administered&nbsp;{{c1::subcutaneously}}</div><div>Circulating T1/2&nbsp;{{c1::20mins}}</div><div>Biological T1/2&nbsp;{{c1::17 hours}}</div><div><br></div><div>Dosage?{{c1::once daily}}</div><div><br></div><div>Do you give it to children?</div><div>{{c1::yes, it is needed for good bone growth and getting to their height}}<br></div><div><br></div><div>DO you give it to adults?</div><div>{{c1::Braitheann sé, if their AGHDA(QoL) score improves then yes,</div><div>if it doesn't after six months then no}}<br></div><div><br></div><div>How do you monitor therapy?{{c1::Monitor therapy with serum IGF-1 concentration}}</div>",
                        "Not administered to patients&nbsp; actively growingtumor or cancer"
                    ],
                    "guid": "N|)Zyh_z6a",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Growth Hormone Excess</b><div><b><br></b></div><div>What are the general effects of too much growth hormone?</div><div>{{c1::Insulin}} resistance<br>Intracranial {{c1::hyper}}tension<br>Arthralgia / myalgia:&nbsp;{{c1::muscle and joint pain}}<br></div><div>{{c1::Carpal tunnel}} syndrome</div><div>Muscle,{{c1::atrophy}}</div><div>Osteoporosis</div><div><br></div><div>And the one that usually eventually kills you,&nbsp;{{c1::dilated cardiomyopathy}}</div><div><br></div><div>What is the physiological difference between pituitary gigantism and accromegaly?{{c1::Gigantism occurs before epiphyseal plates closes, tumour is arge enough to compress pituitary and cause hypogonadism, Acromegaly occurs after so cannot stimulate longitudinal growth so extremities get bigger}}</div><div><br></div><div>Acromegaly Symptoms:</div><div>Macroglossia&nbsp;{{c1::large tongue}}</div><div>Large Hands/Feet<br>Prognathism{{c1::protrusion of lower jaw}}<br>Skin Tags<br>Bowel hamartomas{{c1::benign tumours of the bowel}}<br>Cardiomyopathy<br>Obstructive Sleep Apnoea<br></div><div>Type 2 diabetes</div><div>Osteoporosis</div><div>Osteoarthrits</div><div><br></div><div>Gigantism symptoms;</div><div>All that but an additional one&nbsp;{{c1::growth can also be longitudinal}}</div><div><br></div>",
                        ""
                    ],
                    "guid": "B61[@,bh1|",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Treatment of Growth Hormone Excess</b><div><b><br></b></div><div>What hormone anologue would you use to inhibit the release of Growth Hormone&nbsp;{{c1::somatostatin}}</div><div><br></div><div>What receptors in particular would you target?{{c1::SSTR 2 and 5}}</div><div><br></div><div>They inhibit GH secretion and reduce tumour size</div><div><br></div><div>These hormone analogues</div><div><br></div><div>Administered {{c1::subcutaneously}}<br></div><div><br></div><div><u>Short-acting</u></div><div>{{c1::short acting octreotide}}<u><br></u>100% bioavailability<br>Peak - 30 minutes<br>T1/2 - 90 minutes<br>Duration of action 12 hours approximately<br></div><div><br></div><div><u>Long Acting</u></div><div>{{c1::Microsphere bound preparation (octreotide)<br>Gel preparation (Lanreotide)}}(2)<br>Circulates for 2 - 3 weeks<br>Slow release of hormone from spheres<br>Intramuscular Injection fortnightly<u><br></u></div><div><br></div><div>Side effects of these</div><div>{{c1::GI Upset}} - 50%<br>{{c1::Gallstones}} - 25%<br>{{c1::Diabetes Mellitus}} - &lt;5%<br>Local skin reactions<br></div><div><br></div><div>What else can they be used for?</div><div>{{c1::Neuroendocrine tumours<br>Acute Variceal Bleeding<br>Splanchnic vasoconstriction<br>TSHoma}}(4)<br></div><div><br></div><div>You can also inhibit the Growth hormone receptor using&nbsp;</div><div>{{c1::Pegvisomant}}<br></div><div>Subcutaneous administration<br>Daily injection<br>Titrated to IGF-1<br></div><div><br></div><div>Does this cure the condition?{{c1::No, only treats symptoms, may actually increase tumour size, due to decrease in IGF-1}}</div><div><br></div>",
                        "<img src=\"paste-419b245e3c75ea17e642c70f7e0bb6040489e906.jpg\">"
                    ],
                    "guid": "O-2{pvt0r:",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        }
    ],
    "crowdanki_uuid": "9698beb1-7dd0-11eb-935e-af478fea30f9",
    "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
    "deck_configurations": [
        {
            "__type__": "DeckConfig",
            "autoplay": true,
            "crowdanki_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "dyn": false,
            "interdayLearningMix": 0,
            "lapse": {
                "delays": [
                    10.0
                ],
                "leechAction": 1,
                "leechFails": 8,
                "minInt": 1,
                "mult": 0.0
            },
            "maxTaken": 60,
            "name": "Default",
            "new": {
                "bury": false,
                "delays": [
                    1.0,
                    10.0
                ],
                "initialFactor": 2500,
                "ints": [
                    1,
                    1,
                    0
                ],
                "order": 0,
                "perDay": 100
            },
            "newMix": 0,
            "newPerDayMinimum": 0,
            "replayq": true,
            "rev": {
                "bury": false,
                "ease4": 1.3,
                "hardFactor": 1.2,
                "ivlFct": 1.0,
                "maxIvl": 5,
                "perDay": 500
            },
            "reviewOrder": 0,
            "timer": 0
        }
    ],
    "desc": "",
    "dyn": 0,
    "extendNew": 0,
    "extendRev": 0,
    "media_files": [],
    "name": "2.2::Drugs and Disease",
    "note_models": [
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n.cloze {\n font-weight: bold;\n color: blue;\n}\n.nightMode .cloze {\n color: lightblue;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Text",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back Extra",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Cloze",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{cloze:Text}}<br>\n{{Back Extra}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Cloze",
                    "ord": 0,
                    "qfmt": "{{cloze:Text}}"
                }
            ],
            "type": 1
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic-b2764",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
            "css": "/* GENERAL CARD STYLE */\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* OCCLUSION CSS START - don't edit this */\n#io-overlay {\n  position:absolute;\n  top:0;\n  width:100%;\n  z-index:3\n}\n\n#io-original {\n  position:relative;\n  top:0;\n  width:100%;\n  z-index:2;\n  visibility: hidden;\n}\n\n#io-wrapper {\n  position:relative;\n  width: 100%;\n}\n/* OCCLUSION CSS END */\n\n/* OTHER STYLES */\n#io-header{\n  font-size: 1.1em;\n  margin-bottom: 0.2em;\n}\n\n#io-footer{\n  max-width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.8em;\n  font-style: italic;\n}\n\n#io-extra-wrapper{\n  /* the wrapper is needed to center the\n  left-aligned blocks below it */\n  width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.5em;\n}\n\n#io-extra{\n  text-align:center;\n  display: inline-block;\n}\n\n.io-extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.io-field-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}\n\n#io-revl-btn {\n  font-size: 0.5em;\n}\n\n/* ADJUSTMENTS FOR MOBILE DEVICES */\n\n.mobile .card, .mobile #content {\n  font-size: 120%;\n  margin: 0;\n}\n\n.mobile #io-extra-wrapper {\n  width: 95%;\n}\n\n.mobile #io-revl-btn {\n  font-size: 0.8em;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "ID (hidden)",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Header",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Image",
                    "ord": 2,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Question Mask",
                    "ord": 3,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Footer",
                    "ord": 4,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Remarks",
                    "ord": 5,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Sources",
                    "ord": 6,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Extra 1",
                    "ord": 7,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Extra 2",
                    "ord": 8,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Answer Mask",
                    "ord": 9,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Original Mask",
                    "ord": 10,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Image Occlusion Enhanced",
            "req": [
                [
                    0,
                    "any",
                    [
                        2
                    ]
                ]
            ],
            "sortf": 1,
            "tmpls": [
                {
                    "afmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Answer Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n{{#Footer}}<div id=\"io-footer\">{{Footer}}</div>{{/Footer}}\n<button id=\"io-revl-btn\" onclick=\"toggle();\">Toggle Masks</button>\n<div id=\"io-extra-wrapper\">\n  <div id=\"io-extra\">\n    {{#Remarks}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Remarks</div>{{Remarks}}\n      </div>\n    {{/Remarks}}\n    {{#Sources}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Sources</div>{{Sources}}\n      </div>\n    {{/Sources}}\n    {{#Extra 1}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 1</div>{{Extra 1}}\n      </div>\n    {{/Extra 1}}\n    {{#Extra 2}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 2</div>{{Extra 2}}\n      </div>\n    {{/Extra 2}}\n  </div>\n</div>\n\n<script>\n// Toggle answer mask on clicking the image\nvar toggle = function() {\n  var amask = document.getElementById('io-overlay');\n  if (amask.style.display === 'block' || amask.style.display === '')\n    amask.style.display = 'none';\n  else\n    amask.style.display = 'block'\n}\n\n// Prevent original image from loading before mask\naFade = 50, qFade = 0;\nvar mask = document.querySelector('#io-overlay>img');\nfunction loaded() {\n    var original = document.querySelector('#io-original');\n    original.style.visibility = \"visible\";\n}\nif (mask === null || mask.complete) {\n    loaded();\n} else {\n    mask.addEventListener('load', loaded);\n}\n</script>\n{{/Image}}\n",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "IO Card",
                    "ord": 0,
                    "qfmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Question Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n<div id=\"io-footer\">{{Footer}}</div>\n\n<script>\n// Prevent original image from loading before mask\naFade = 50, qFade = 0;\nvar mask = document.querySelector('#io-overlay>img');\nfunction loaded() {\n    var original = document.querySelector('#io-original');\n    original.style.visibility = \"visible\";\n}\nif (mask === null || mask.complete) {\n    loaded();\n} else {\n    mask.addEventListener('load', loaded);\n}\n</script>\n{{/Image}}\n"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "afe9bf23-7dce-11eb-b4f3-a0b2d6ecb02c",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic (and reversed card)-defa1",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ],
                [
                    1,
                    "any",
                    [
                        1
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                },
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Front}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 2",
                    "ord": 1,
                    "qfmt": "{{Back}}"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic (and reversed card)",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ],
                [
                    1,
                    "any",
                    [
                        1
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                },
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Front}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 2",
                    "ord": 1,
                    "qfmt": "{{Back}}"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Add Reverse",
                    "ord": 2,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic (optional reversed card)",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ],
                [
                    1,
                    "all",
                    [
                        1,
                        2
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                },
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Front}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 2",
                    "ord": 1,
                    "qfmt": "{{#Add Reverse}}{{Back}}{{/Add Reverse}}"
                }
            ],
            "type": 0
        }
    ],
    "notes": []
}